000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki|ţp|N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1538|3011|lyfalmen|V0045|1516|00|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1538||1538|3011|
000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól||||||
000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|32880|43147|lyfsjukr|||00|2|0|24,0000|Icepharma hf|Roche|Epóetín||32880||32880|43147|
000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|49396|63874|lyfsjukr|||00|2|0|36,0000|Icepharma hf|Roche|Epóetín||49396||49396|63874|
000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||||
000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10428|15172|lyfalmen|V0457|11026|00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10428||10428|15172|
000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|30394|40504|lyfalmen|V0475|32089|00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30394||30394|40504|
000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|39528|51967|lyfalmen|||00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||39528||39528|51967|
000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|21262|29043|lyfalmen|V0456|20537|00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21262||21262|29043|
000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|4947|7140|lyfsjukr|||00|1|0|0,0400|Vistor hf|Ferring|Atosíban||4947||4947|7140|
000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|7483|14541|vetalmen|||00|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||7483||7483|14541|
000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|13250|18511|lyfsjukr|||00|5|0|0,2300|Vistor hf|Ferring|Atosíban||13250||13250|18511|
000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|19929|27370|lyfalmen|||00|0|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||19929||19929|27370|
000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|38683|50907|lyfalmen|||00|1|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||38683||38683|50907|
000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|DKK|5259|8101|lyfalmen|||00|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||5259||5259|8101|
000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr|||00|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657|
000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||00|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139|
000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3229|5324|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||||3229|5324|
000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|27538|36920|lyfalmen|||02|10|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||27538||27538|36920|
000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1780|3342|lyfalmen|||06|5|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen||1780||1780|3342|
000552|G04BE0105|Caverject  Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|4808|7484|lyfalmen|||23|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4808||4808|7484|
000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|3526|5731|lyfalmen|||00|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3526||3526|5731|
000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|IKR|||lyflausa|||00|8|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen||||||
000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5285|8137|lyfalmen|||00|24|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen||5285||5285|8137|
000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7003|10107|lyfsjukr|||00|1000|0|1,0000|Icepharma hf|Fresenius Kabi|Fitusambönd||7003||7003|10107|
000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|3031|5054|lyfalmen|||00|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||3031||3031|5054|
000784|G04BE0105|Caverject  Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3731|6011|lyfalmen|||23|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3731||3731|6011|
000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||||
000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||||
000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|162425|205726|lyfsjukr|||00|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||162425||162425|205726|
000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|22107|29627|lyfsjukr|||02|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||22107||22107|29627|
001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|5641|8141|lyfsjukr|||02|0|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||5641||5641|8141|
001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|1440|2877|lyfalmen|V0037|2353|00|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1440||1440|2877|
001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|6289|9510|lyfalmen|||00|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6289||6289|9510|
001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|20808|28473|lyfalmen|V0115|18549|00|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||20808||20808|28473|
001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2254|3991|lyfalmen|||43|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2254||2254|3991|
001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|ţpakki||C09CA02|01.08.2001||R|A|3|0|0|0|0|ABH|0|0|0|100|XEU|10482|15246|lyfalmen|||00|98|0|98,0000|Icepharma hf|Abbott Healthcare Products B.V.|Eprosartan||10482||10482|15246|
001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|28207|37282|lyfsjukr|||02|2|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||28207||28207|37282|
001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|2533|3262|lyfalmen|V0278|3084|00|28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||1721||1721|3262|
001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6039|9168|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insulín aspart||6039||6039|9168|
001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4139|6569|lyfalmen|||10|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4139||4139|6569|
001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2115|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2115|
001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4267|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4267|
001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|21738|29164|lyfsjukr|||00|4104|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||21738||21738|29164|
001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|VIF|0|0|1|100|CHF|14797|20930|lyfalmen|V0034|18236|00|25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíđ (sykurflétta)||14797||14797|20930|
001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|31675|41635|lyfsjukr|||00|6160|0|6,1600|Icepharma hf|Fresenius Kabi|Blöndur||31675||31675|41635|
001792|N02BA0109|Alka-Seltzer|freyđit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||00|20|0|2,1600|Icepharma hf|Bayer AB|Acetýlsalicýlsýra||||||
001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|2397|3459|lyfsjukr|||02|10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||2397||2397|3459|
001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|3892|6231|lyfalmen|V0444|6231|06|15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíđ||3892||3892|6231|
001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|809|1849|lyfalmen|V0004|737|00|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||688||688|1849|
001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1946|3303|lyfalmen|V0291|3303|00|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1751||1751|3303|
001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|6936|10395|lyfalmen|V0294|10395|00|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10395|
001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|1|100|SEK|4147|6580|lyfalmen|||00|45|0|45,0000|Icepharma hf|Bioglan AB|Capsaicin||4147||4147|6580|
001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|3353|5494|lyfalmen|V0292|5494|00|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5494|
001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|8862|13030|lyfalmen|V0161|12824|43|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||8862||8862|13030|
001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4215|5809|lyfalmen|V0004|2948|00|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3583||3583|5809|
001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|5263|8107|lyfalmen|V0293|8107|00|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8107|
001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8369|10639|lyfalmen|V0011|4457|0|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7114||7114|10639|
002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1329|2453|lyfalmen|V0005|1575|00|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1130||1130|2453|
002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5899|6909|lyfalmen|V0005|6300|00|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4387||4387|6909|
002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|5146|7947|lyfalmen|||00|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5146||5146|7947|
002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5165|6913|lyfalmen|V0011|3980|00|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4390||4390|6913|
002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25590|33998|lyfsjukr|||00|5760|0|5,7600|Icepharma hf|Fresenius Kabi|Blöndur||25590||25590|33998|
002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12827|15822|lyfalmen|V0011|7959|00|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||10903||10903|15822|
002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9407|11847|lyfalmen|V0012|8116|00|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7997||7997|11847|
002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|3093|5138|lyfalmen|||02|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín aspart||3093||3093|5138|
002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|17057|18736|lyfalmen|V0012|16232|00|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||13049||13049|18736|
002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001|31.10.2011|R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|5385|8274|lyfalmen|||00|120|0|120,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||5385||5385|8274|
002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||||
002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|DKK|16969|23655|lyfalmen|||00|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||16969||16969|23655|
002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|101356|129084|lyfsjukr|||00|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||101356||101356|129084|
002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|51585|66622|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||51585||51585|66622|
002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|26097|34634|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||26097||26097|34634|
002391|G03AA1201|Yasmin|töflur|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BYP|0|0|0|100|SEK|3094|5140|lyfalmen|||00|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||||3094|5140|
002413|G03AA1204|Yasmin 28|töflur|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BYP|0|0|0|100|SEK|3094|5140|lyfalmen|||00|84|0|0,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3094||3094|5140|
002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín||||||
002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín||||||
002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1641|3152|lyfalmen|V0362|3152|00|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín||1641||1641|3152|
002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|214313|270845|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||214313||214313|270845|
002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|SEK|3346|5837|vetorma|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3346||3346|5837|
002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1246|2612|lyfalmen|||07|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||1246||1246|2612|
002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|29398|38777|lyfsjukr|||02|1|0|0,0000|Vistor hf|Allergan|Clostridium botulinum toxín-A||29398||29398|38777|
002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002|30.11.2011|R|A|1|0|1|E|0|MSE|0|0|0|100|SEK|73605|94734|lyfalmen|||00|1|0|14,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||73605||73605|94734|
003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|14024|15157|lyfalmen|V0089|4320|00|98|0|196,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||10417||10417|15157|
003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|10366|15088|lyfalmen|V0515|13402|00|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||10366||10366|15088|
003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|243846|307909|lyfsjukr|||02|2|0|0,0000|Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||243846||243846|307909|
003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|17898|24821|lyfalmen|V0253|22616|00|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||17898||17898|24821|
003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|34776|46003|lyfalmen|V0516|42172|00|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||34776||34776|46003|
003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|9958|14529|lyfalmen|||00|1|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||9958||9958|14529|
003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|14804|20938|lyfalmen|||00|1|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||14804||14804|20938|
003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BYP|0|0|0|100|SEK|183906|232685|lyfsjukr|||02|150|0|0,0000|Icepharma hf|Bayer Pharma AG|Gadóbútról||183906||183906|232685|
003310|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9002|13222|lyfalmen|V0356|12084|0|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9002||9002|13222|
003325|R03AK0702|Symbicort mite Turbuhaler|innúđadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|8344|12322|lyfalmen|||00|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8344||8344|12322|
003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|ţpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|DKK|58918|76301|lyfalmen|||00|100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||58918||58918|76301|
003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|4246|6716|lyfalmen|||00|28|0|14,0000|Icepharma hf|Takeda Europe -|Píóglítazón||4246||4246|6716|
003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|3205|5292|lyfalmen|||00|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3205||3205|5292|
003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|14669|20769|lyfalmen|||00|98|0|49,0000|Icepharma hf|Takeda Europe -|Píóglítazón||14669||14669|20769|
003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|6422|9692|lyfalmen|||00|28|0|28,0000|Icepharma hf|Takeda Europe -|Píóglítazón||6422||6422|9692|
003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|21917|29865|lyfalmen|||00|98|0|98,0000|Icepharma hf|Takeda Europe -|Píóglítazón||21917||21917|29865|
003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|869|2096|lyfalmen|||00|10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||869||869|2096|
003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1017|1977|lyfalmen|V0151|1977|00|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|1977|
003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|585|1708|lyfalmen|V0468|951|67|20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||585||585|1708|
003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2389|4175|lyfalmen|V0322|4175|00|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||2389||2389|4175|
003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|72432|92785|lyfsjukr|||00|60|0|7,5000|Vistor hf|Abbott Laboratories A/S|Lopinavír||72432||72432|92785|
003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2120|3807|lyfalmen|V0469|2284|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2120||2120|3807|
004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|21730|29154|lyfsjukr|||00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||21730||21730|29154|
004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7888|11698|lyfalmen|||00|250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7888||7888|11698|
004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||||||
004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|3983|6356|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||3983||3983|6356|
004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|A|5|0|0|0|0|PER|0|1|0|100|DKK|590|1714|lyfalmen|||00|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||590||590|1714|
004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|1056|2352|lyfalmen|||10|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1056||1056|2352|
004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PER|0|1|0|100|DKK|5454|8368|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5454||5454|8368|
004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|7358|10973|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7358||7358|10973|
004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|10336|15046|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10336||10336|15046|
004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|ţpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|632|1772|lyfalmen|V0366|1054|00|10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||632||632|1772|
004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|0|0|ORG|0|1|0|100|DKK|5907|8988|lyfalmen|||00|66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||5907||5907|8988|
004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|20994|28230|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Pfizer ApS|Voricónazól||20994||20994|28230|
004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1649|3163|lyfalmen|V0366|3162|00|30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1649||1649|3163|
004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|6874|10311|lyfalmen|||0|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||6874||6874|10311|
004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|4616|7222|lyfalmen|V0458|7220|00|100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4616||4616|7222|
004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|4779|9349|vetalmen|||16|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||4779||4779|9349|
004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3236|5334|lyfalmen|||00|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3236||3236|5334|
004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|620|1755|lyfalmen|||00|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||620||620|1755|
004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4316|6811|lyfalmen|V0226|2706|00|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4316||4316|6811|
004489|N02AX0208|Zytram|forđatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6096|9246|lyfalmen|V0227|4151|00|56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6096||6096|9246|
004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|8114|12007|lyfalmen|V0228|5358|00|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8114||8114|12007|
004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2111|3795|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir  mótefnavakar||2111||2111|3795|
004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3480|5668|lyfalmen|V0494|3178|00|90|0|180,0000|Vistor hf|Aventis Pharma |Glímepíríđ||3480||3480|5668|
004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4404|lyfalmen|V0318|4404|00|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4404|
004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|K|3|0|1|0|1|EMA|0|0|0|100|SEK|34821|45583|lyfsjukr|||00|1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||34821||34821|45583|
004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|1413|2840|lyfalmen|||20|25|0|25,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||1413||1413|2840|
004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dćla|einnotadćl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3116|5170|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir  mótefnavakar||3116||3116|5170|
004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|2092|lyfalmen|V0071|2092|00|28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2092|
004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5614|7346|lyfalmen|V0320|7346|00|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||4707||4707|7346|
004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|1969|lyfalmen|V0062|1969|00|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||776||776|1969|
004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4605|lyfalmen|V0317|4605|00|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4605|
004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|926|1850|lyfalmen|V0067|1850|00|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||689||689|1850|
004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1688|
004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|37981|49549|lyfsjukr|||00|5|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||37981||37981|49549|
004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3340|lyfalmen|V0318|2466|00|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3340|
004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan||||||
004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|135295|171678|lyfsjukr|||00|19|0|28,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||135295||135295|171678|
004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|K|3|0|1|0|1|EMA|0|0|0|100|SEK|174104|220383|lyfsjukr|||00|5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||174104||174104|220383|
004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10323|15029|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10323||10323|15029|
004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|6859|7353|lyfalmen|V0250|6955|0|100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||4712||4712|7353|
004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|8862|8573|lyfalmen|V0251|5765|10|100|0|22,2222|Icepharma hf|Pfizer ApS|Gabapentín||5604||5604|8573|
004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|647|1792|lyfalmen|||41|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||647||647|1792|
004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|14826|16808|lyfalmen|V0282|15289|00|56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||11624||11624|16808|
004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PER|0|0|0|100|DKK|5397|7789|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5397||5397|7789|
004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|372|1416|lyfalmen|V0352|693|41|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||372||372|1416|
004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|654|1802|lyfalmen|V0352|1213|41|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||654||654|1802|
004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1237|2600|lyfalmen|V0352|2600|41|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1237||1237|2600|
005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1710|3247|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1710||1710|3247|
005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2307|4063|lyfalmen|||00|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||||2307|4063|
005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|8735|6991|lyfalmen|V0148|4208|00|90|0|90,0000|Vistor hf|Yamanouchi Europe|Tamsúlósín||4447||4447|6991|
005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|DKK|1104|2418|lyfalmen|||10|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||1104||1104|2418|
005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|DKK|1271|2646|lyfalmen|||10|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||1271||1271|2646|
005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|DKK|1739|3286|lyfalmen|||10|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1739||1739|3286|
005241|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|27005|36251|lyfalmen|V0356|36251|00|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27005||27005|36251|
005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|49616|64627|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||49616||49616|64627|
005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|3254|5359|lyfalmen|||00|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3254||3254|5359|
005330|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Jođ/pólývídón||||||
005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||||
005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1122|2442|lyfalmen|||00|2|0|0,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||1122||1122|2442|
005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.04.1996||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|60012|77674|lyfalmen|V0451|77194|00|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||60012||60012|77674|
005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1481|2933|lyfalmen|||24|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1481||1481|2933|
005503|N05AH0301|Zyprexa|húđuđtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|29446|18171|lyfalmen|V0283|15274|00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||12599||12599|18171|
005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|ţpakki||M05BA04|01.08.2001|30.09.2011|R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|4187|6635|lyfalmen|||00|4|0|28,0000|Vistor hf|M.S.D.|Alendrónsýra||4187||4187|6635|
005526|N05AH0301|Zyprexa|húđuđtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|37450|49359|lyfalmen|||00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||37450||37450|49359|
005538|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1201|2550|lyfalmen|||23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1201||1201|2550|
005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.08.2001|30.09.2011|R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|10734|5727|lyfalmen|||00|12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra||3523||3523|5727|
005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0,0000|Actavis Group hf|Actavis hf|Blöndur||||||
005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6236|9438|lyfalmen|||00|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6236||6236|9438|
005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6571|9896|lyfalmen|||0|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||||6571|9896|
005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|3912|6259|lyfalmen|||00|0|0|0,0000|Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||3912||3912|6259|
005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1592|3085|lyfalmen|||00|30|0|15,0000|Icepharma hf|Servier|Glíklazíđ||1592||1592|3085|
005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|2775|4703|lyfalmen|V0020|3662|00|60|0|30,0000|Icepharma hf|Servier|Glíklazíđ||2775||2775|4703|
005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|7367|10985|lyfalmen|V0020|10985|00|180|0|90,0000|Icepharma hf|Servier|Glíklazíđ||7367||7367|10985|
005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4048|6445|lyfalmen|V0020|5493|00|90|0|45,0000|Icepharma hf|Servier|Glíklazíđ||4048||4048|6445|
005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra||||||
005747|G03CA0317|Aerodiol|nefúđi|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003|30.09.2011|R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6352|9597|lyfalmen|||00|180|0|90,0000|Icepharma hf|Servier|Estradíól||6352||6352|9597|
005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|1781|3344|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1781||1781|3344|
005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|ţpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|GZE|0|0|0|100|SEK|71355|91433|lyfsjukr|||00|15|0|0,0000|Vistor hf|Genzyme Europe B.V.|Flúdarabín||71355||71355|91433|
005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6620|8977|lyfalmen|V0324|4631|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5899||5899|8977|
005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|3139|4872|lyfalmen|V0035|3556|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2898||2898|4872|
005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|17880|31191|vetorma|||16|5|0|0,0000|Vistor hf|Merial (MSD)|||17880||17880|31191|
005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6240|9443|lyfalmen|V0325|4132|00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6240||6240|9443|
005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|GZE|0|0|0|100|SEK|88255|112643|lyfsjukr|||00|20|0|0,0000|Vistor hf|Genzyme Europe B.V.|Flúdarabín||88255||88255|112643|
005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|10528|14085|lyfalmen|V0325|7378|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||9633||9633|14085|
005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|5042|7386|lyfalmen|V0175|4056|00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4736||4736|7386|
005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|2981|4985|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||2981||2981|4985|
005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|ţpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3482|5671|lyfalmen|||59|8|0|2,0000|Icepharma hf|Roche|Meflókvín||3482||3482|5671|
005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|879|2110|lyfalmen|||00|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||879||879|2110|
005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|10220|14888|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||10220||10220|14888|
005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|16299|20615|lyfalmen|V0326|7378|00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14546||14546|20615|
005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3556|5772|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3556||3556|5772|
005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6441|8665|lyfalmen|V0246|4426|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5671||5671|8665|
005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9407|12382|lyfalmen|V0072|3717|00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||8388||8388|12382|
005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|12620|18198|lyfalmen|V0327|4132|00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12620||12620|18198|
005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4673|7300|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4673||4673|7300|
005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|12785|17590|lyfalmen|V0073|3717|00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||12136||12136|17590|
006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|83843|107105|lyfsjukr|||00|2|0|0,7500|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||83843||83843|107105|
006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|5760|8787|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insulín aspart||5760||5760|8787|
006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|DKK|103984|132382|lyfsjukr|||00|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||103984||103984|132382|
006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|5587|8550|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín aspart||5587||5587|8550|
006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|156130|197826|lyfsjukr|||00|3|0|1,5000|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||156130||156130|197826|
006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|DKK|79412|101545|lyfsjukr|||00|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||79412||79412|101545|
006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1434|2869|lyfalmen|||00|4|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||1434||1434|2869|
006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|A||0|0|0|0|REP|0|0|1|100|SEK|2489|4312|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2489||2489|4312|
006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2711|4616|lyfalmen|||43|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||2711||2711|4616|
006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|1|0|0|100|DKK|8782|17035|vetalmen|||00|50|0|0,0000|Vistor hf|Boehringer Ingelheim|||8782||8782|17035|
006558|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.03.2011||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|12555|18116|lyfalmen|||00|10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||12555||12555|18116|
006579|D05AX5201|Daivobet|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|6957|10424|lyfalmen|||00|60|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||6957||6957|10424|
006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|12325|17827|lyfalmen|||00|120|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12325||12325|17827|
006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||||||
006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|0,0000|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel||||||
006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|14589|20669|lyfalmen|||00|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||14589||14589|20669|
007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4399|6925|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4399||4399|6925|
007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|700|1865|lyfalmen|||00|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||700||700|1865|
007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|25314|48779|vetalmen|||27|20|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||25314||25314|48779|
007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13300|19051|lyfalmen|V0117|19051|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13300||13300|19051|
007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|2050|3712|lyfalmen|||00|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2050||2050|3712|
007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6634|9982|lyfalmen|||00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||6634||6634|9982|
007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|20076|27555|lyfalmen|V0118|27555|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||20076||20076|27555|
007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|5205|8028|lyfalmen|||00|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5205||5205|8028|
007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8337|12312|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8337||8337|12312|
007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|25115|33879|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||25115||25115|33879|
007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|162756|206141|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter|Prótein C||162756||162756|206141|
007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|310591|391674|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter|Prótein C||310591||310591|391674|
007278|C08CA0302|Lomir Retard|forđahlk|2,5|mg|30|stk|1|ţpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1999|3642|lyfalmen|||10|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||1999||1999|3642|
007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|2909|4887|lyfalmen|V0377|4207|00|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||2909||2909|4887|
007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|97898|124744|lyfsjukr|||00|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||97898||97898|124744|
007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|ţpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||||||
007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|279880|353132|lyfsjukr|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||279880||279880|353132|
007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PER|0|0|0|100|DKK|3218|5309|lyfalmen|||06|2|0|0,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3218||3218|5309|
007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|8361|12067|lyfsjukr|||02|50|0|0,0000|Icepharma hf|Clintec parenteral SA|||8361||8361|12067|
007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|117856|149792|lyfsjukr|||00|100|0|0,0000|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||117856||117856|149792|
007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|23289|31110|lyfsjukr|||00|250|0|0,0000|Vistor hf|Abbott Scandinavia AB|Sevóflúran||23289||23289|31110|
007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|100|DKK|1961|3421|vetorma|||16|7|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1961|3421|
007505|G04BD0702|Detrusitol Retard|forđahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|6222|9419|lyfalmen|||00|30|0|10,5000|Icepharma hf|Pfizer ApS|Tólteródín||6222||6222|9419|
007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3538|5747|lyfalmen|V0079|5747|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3538||3538|5747|
007538|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|4939|7664|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||4939||4939|7664|
007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|4476|6460|lyfsjukr|||00|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4476||4476|6460|
007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21406|29224|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||21406||21406|29224|
007549|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|9626|14075|lyfalmen|||00|60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||9626||9626|14075|
007760|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|6388|9646|lyfalmen|||00|30|0|21,0000|Icepharma hf|Pfizer ApS|Tólteródín||6388||6388|9646|
007769|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|21686|29575|lyfalmen|||00|100|0|70,0000|Icepharma hf|Pfizer ApS|Tólteródín||21686||21686|29575|
007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3035|lyfalmen|V0290|3035|00|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1555||1555|3035|
007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|3986|6360|lyfalmen|||00|3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||3986||3986|6360|
007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0|0,0000|Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0|0,0000|Icepharma hf|Baxter|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1243|2608|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Ólópatadín||1243||1243|2608|
007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|179237|226825|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjađ)||179237||179237|226825|
007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0|15,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||||
007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|20440|27535|lyfsjukr|||00|10|0|0,0000|Ísaga ehf|AGA AB|Nituroxíđ||20440||20440|27535|
007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1905|lyfalmen|||00|30|1|10,0000|Lyfjaver ehf|Lyfjaver - óskráđ lyf|Betametasón||729||729|1905|
008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|44815|58125|lyfsjukr|||00|1|0|0,1300|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjađ)||44815||44815|58125|
008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|SEK|589|1713|lyfalmen|||00|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||589||589|1713|
008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002|31.10.2011|R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|3798|6103|lyfalmen|||00|1|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3798||3798|6103|
008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|23058|30820|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||23058||23058|30820|
008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|28608|37786|lyfsjukr|||00|8000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||28608||28608|37786|
008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|DKK|5486|8412|lyfalmen|||00|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5486||5486|8412|
008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|55009|70919|lyfsjukr|||00|4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||55009||55009|70919|
008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|110019|139956|lyfsjukr|||00|4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||110019||110019|139956|
008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|87672|111911|lyfsjukr|||00|4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||87672||87672|111911|
008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|129695|164650|lyfsjukr|||00|4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||129695||129695|164650|
008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|152354|193087|lyfsjukr|||00|4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||152354||152354|193087|
008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||||
008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1520|2987|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1520||1520|2987|
008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|277|1286|lyfalmen|||20|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||277||277|1286|
008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|35676|46656|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||35676||35676|46656|
008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|27936|36942|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||27936||27936|36942|
008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|542|1649|lyfalmen|||33|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||542||542|1649|
008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|32641|42847|lyfsjukr|||00|8000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||32641||32641|42847|
008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|889|1972|lyfalmen|||00|20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||778||778|1972|
008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|2876|4842|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2876||2876|4842|30.11.2011
008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1222|2579|lyfalmen|||33|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1222||1222|2579|
008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|2869|4832|lyfalmen|V0226|4832|00|100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||2869||2869|4832|
008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4755|7412|lyfalmen|V0227|7412|00|100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||4755||4755|7412|
008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|6417|9568|lyfalmen|V0228|9568|00|100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||6331||6331|9568|
008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|153200|194149|lyfsjukr|||02|2|0|0,0000|Vistor hf|Genzyme BV|Thýrótrópín||153200||153200|194149|
008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|SEK|798|1999|lyfalmen|V0153|1999|00|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||798||798|1999|
008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|SEK|694|1857|lyfalmen|V0154|1857|00|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||694||694|1857|
008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|0|0|0|100|USD|4793|8361|vetorma|||00|1000|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||4793||4793|8361|
008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|12651|24464|vetalmen|||00|50|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||12651||12651|24464|
008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|ţpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||||
008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|ţpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|4070|6475|lyfalmen|||00|100|0|100,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||4070||4070|6475|
008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|ţpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||||
008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2879|4846|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2879||2879|4846|
008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|108728|138336|lyfsjukr|||00|2|0|0,0000|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||108728||108728|138336|
008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|114695|145825|lyfsjukr|||00|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||114695||114695|145825|
008831|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|MAB|0|0|1|100|DKK|3065|5100|lyfalmen|||00|15|0|15,0000|Vistor hf|Meda AB|Pímekrólímus||3065||3065|5100|
008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3538|5747|lyfalmen|V0094|5747|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||3538||3538|5747|
008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PER|0|0|0|100|DKK|1929|3546|lyfalmen|||20|60|0|60,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1929||1929|3546|
008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6019|9141|lyfalmen|V0145|8564|00|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6019|9141|
008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|11857|17127|lyfalmen|V0145|17127|00|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||11857|17127|
009065|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|MAB|0|0|1|100|DKK|5172|7982|lyfalmen|||00|30|0|30,0000|Vistor hf|Meda AB|Pímekrólímus||5172||5172|7982|
009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|K||0|0|0|1|FMC|0|0|0|100|XEU|8732|12602|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8732||8732|12602|
009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|K||0|0|0|1|FMC|0|0|0|100|XEU|8732|12602|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8732||8732|12602|
009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|IPI|0|0|1|100|DKK|14242|20233|lyfalmen|||03|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||14242||14242|20233|
009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|K||0|0|0|1|FMC|0|0|0|100|XEU|8732|12602|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8732||8732|12602|
009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|51953|67084|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer ApS|Voricónazól||51953||51953|67084|
009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1736|
009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|5426|8330|lyfalmen|||00|30|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||5426||5426|8330|
009340|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1136|2461|lyfalmen|||23|8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1136||1136|2461|
009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1253|2621|lyfalmen|V0130|1595|23|8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1253||1253|2621|
009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1450|2891|lyfalmen|V0131|2342|23|8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1450||1450|2891|
009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1816|3392|lyfalmen|V0132|2600|23|8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1816||1816|3392|
009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7224|10426|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7224||7224|10426|
009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7224|10426|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7224||7224|10426|
009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7224|10426|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7224||7224|10426|
009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|198320|250774|lyfsjukr|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Voricónazól||198320||198320|250774|
009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|5256|8097|lyfalmen|||00|30|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||5256||5256|8097|
009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|59346|76362|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||59346||59346|76362|
009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|8677|12777|lyfalmen|||02|180|0|0,0000|Vistor hf|Dentsply Limited|Mepívakaín||8677||8677|12777|
009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|8167|12079|lyfalmen|||00|180|0|0,0000|Vistor hf|Dentsply Limited|Prílókaín í blöndum||8167||8167|12079|
009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8013|11869|lyfalmen|||17|180|0|0,0000|Vistor hf|Dentsply Limited|Lídókaín í blöndum||8013||8013|11869|
009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|9392|13755|lyfalmen|||00|180|0|0,0000|Vistor hf|Dentsply Limited|Prílókaín í blöndum||9392||9392|13755|
009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8181|12099|lyfalmen|||17|180|0|0,0000|Vistor hf|Dentsply Limited|Lídókaín í blöndum||8181||8181|12099|
009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|8041|11907|lyfalmen|||02|180|0|0,0000|Vistor hf|Dentsply Limited|Mepívakaín||8041||8041|11907|
010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|2164|3868|lyfalmen|V0329|2396|00|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2164||2164|3868|
010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|4120|6543|lyfalmen|V0330|2795|00|30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4120||4120|6543|
010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|5888|8962|lyfalmen|||00|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||5888||5888|8962|
010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|100|DKK|225633|285052|lyfsjukr|||00|60|0|30,0000|Icepharma hf|Roche Registration Limited|Valgancíklóvír||225633||225633|285052|
010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|DKK|7236|10443|lyfsjukr|||00|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7236||7236|10443|
010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|12788|18408|lyfalmen|V0331|5137|00|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||12788||12788|18408|
010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|18031|24988|lyfalmen|V0332|8483|00|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||18031||18031|24988|
010290|N06DX0101|Ebixa|dropar|10|mg/g|50|g|1|fl||N06DX01|01.08.2010||R|A||0|0|E|0|LBK|0|0|0|100|DKK|14253|20247|lyfalmen|||00|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14253|20247|
010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|23105|31356|lyfalmen|||00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||23105||23105|31356|
010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3692|5958|lyfalmen|||00|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||3692||3692|5958|
010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|7348|10959|lyfalmen|||51|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir  mótefnavakar||7348||7348|10959|
010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|12500|18047|lyfalmen|||00|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||12500||12500|18047|
010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|ELA|0|0|0|100|DKK|73761|128672|vetorma|||00|1000|0|0,0000|Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||73761||73761|128672|
010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|6650|10004|lyfalmen|||00|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6650||6650|10004|
010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|7047|10171|lyfsjukr|||00|2500|0|0,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||7047||7047|10171|
010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9179|13248|lyfsjukr|||00|1000|0|1,0000|Icepharma hf|Fresenius Kabi|Amínósýrur||9179||9179|13248|
010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1183|2526|lyfalmen|||00|5|0|0,0000|Icepharma hf|Santen Oy|Levófloxacín||1183||1183|2526|
010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|5519|8457|lyfalmen|V0207|1442|00|4|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5519||5519|8457|
010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5783|8346|lyfsjukr|||00|7500|0|7,5000|Icepharma hf|Baxter Medical AB|Kolvetni||5783||5783|8346|
010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|8893|12835|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Baxter Medical AB|Kolvetni||8893||8893|12835|
010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|3934|5678|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Kolvetni||3934||3934|5678|
010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2255|3255|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Kolvetni||2255||2255|3255|
010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|8564|12622|lyfalmen|V0377|12622|00|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||8564||8564|12622|
010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|8882|12819|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||8882||8882|12819|
010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6376|9202|lyfsjukr|||00|7500|0|7,5000|Icepharma hf|Baxter Medical AB|Elektrólýtar||6376||6376|9202|
010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|3870|5585|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||3870||3870|5585|
010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|14267|5716|lyfalmen|V0207|4326|00|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3515||3515|5716|
010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2083|3006|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||2083||2083|3006|
010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACT|0|0|0|100|DKK|352323|444048|lyfsjukr|||00|56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||352323||352323|444048|
010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACT|0|0|0|100|DKK|352323|444048|lyfsjukr|||00|56|0|28,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||352323||352323|444048|
010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|1358|2740|lyfalmen|||10|28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||1340||1340|2740|
010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||00|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín||||||
010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4936|7230|lyfalmen|V0006|7230|10|100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||4622||4622|7230|
010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|3182|4353|lyfalmen|V0006|4049|10|56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||2519||2519|4353|
010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|47504|61500|lyfsjukr|||03|10|0|0,0000|Icepharma hf|Baxter Medical AB|Bleómýcín||47504||47504|61500|
010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|3076|4439|lyfsjukr|||03|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3076||3076|4439|
010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|ţpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2959|4955|lyfalmen|||00|28|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2959||2959|4955|
010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|20177|27682|lyfalmen|||00|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20177||20177|27682|
010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|19942|27387|lyfalmen|||00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19942||19942|27387|
010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||00|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín||||||
011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|34354|45474|lyfalmen|||00|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34354||34354|45474|
011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|34120|45180|lyfalmen|||00|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34120||34120|45180|
011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|18526|25610|lyfalmen|||00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||18526||18526|25610|
011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|DKK|4507|7073|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4507||4507|7073|
011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|DKK|4683|7313|lyfalmen|||00|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4683||4683|7313|
011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|20276|26236|lyfalmen|V0327|7378|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||19025||19025|26236|
011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|DKK|1195|2542|lyfalmen|||00|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1195||1195|2542|
011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|XEU|767|1957|lyfalmen|||00|28|0|7,0000|Actavis Group hf|Actavis hf|Lósartan||767||767|1957|
011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|7397|11026|lyfalmen|V0457|11026|00|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||7397||7397|11026|
011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|12029|17456|lyfalmen|||02|5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12029||12029|17456|
011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|XEU|1061|2359|lyfalmen|||00|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1061||1061|2359|
011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|2926|3688|lyfalmen|V0069|3688|00|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||2033||2033|3688|
011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9027|13256|lyfalmen|V0357|12115|00|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9027||9027|13256|
011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|6969|10441|lyfalmen|||00|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6969||6969|10441|
011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6549|9452|lyfsjukr|||02|10000|0|0,0000|Icepharma hf|Baxter Medical AB|Mannitól||6549||6549|9452|
011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PER|0|0|0|100|DKK|2429|3506|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Pfizer ApS|Esketamín||2429||2429|3506|
011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|9147|13420|lyfalmen|||00|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9147||9147|13420|
011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|1925|3829|vetalmen|||00|25|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||1925||1925|3829|
011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PER|0|0|0|100|DKK|4951|7146|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Pfizer ApS|Esketamín||4951||4951|7146|
011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1556|3036|lyfalmen|||00|64|0|28,8000|Gróco ehf|Oy Leiras Finland Ab|Estradíól||1556||1556|3036|
011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|88239|112622|lyfsjukr|||00|168|0|33,6000|Icepharma hf|Roche Registration Limited|Ribavirin||88239||88239|112622|
011810|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|MAB|0|0|1|100|DKK|10290|14984|lyfalmen|||00|60|0|60,0000|Vistor hf|Meda AB|Pímekrólímus||10290||10290|14984|
011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1486|1977|lyfalmen|V0152|1977|00|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|1977|
011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|4738|6605|lyfalmen|V0323|6605|00|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||4165||4165|6605|
011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4299|6205|lyfsjukr|||02|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4299||4299|6205|
011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|2487|3589|lyfsjukr|||02|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||2487||2487|3589|
011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|7982|11826|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||7982|11826|
012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|DKK|40576|52805|lyfsjukr|||00|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||40576||40576|52805|
012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|12633|18214|lyfalmen|||00|90|0|90,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||12633||12633|18214|
012260|R01AC0301|Lastin|nefúđi|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1460|2905|lyfalmen|||00|20|0|35,7143|Vistor hf|Meda AB|Azelastínum||1460||1460|2905|30.11.2011
012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|5998|9112|lyfalmen|||00|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||5998||5998|9112|
012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|ţpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|487|1574|lyfalmen|||00|30|0|15,0000|Vistor hf|Aventis Pharma |Glímepíríđ||487||487|1574|
012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|11654|16849|lyfalmen|||00|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||11654||11654|16849|
012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|DKK|446798|562614|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Wyeth Europe|Díbótermín alfa||446798||446798|562614|
012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1890|lyfalmen|||08|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1890|
012921|G03AA1301|Evra|forđapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4560|7145|lyfalmen|||00|9|0|0,0000|Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4560||4560|7145|
012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|6599|9934|lyfalmen|||00|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||6599||6599|9934|
013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6164|9339|lyfalmen|||00|30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6164||6164|9339|
013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|6962|13541|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||6962||6962|13541|
013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|9306|13638|lyfalmen|||00|30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9306||9306|13638|
013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1753|3487|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||1753||1753|3487|
013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|ţpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1075|2378|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Lansóprazól||1075||1075|2378|31.10.2011
013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|22151|29682|lyfsjukr|||00|2|0|0,0000|Ísaga ehf|AGA AB|Nituroxíđ||22151||22151|29682|
013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|6836|9866|lyfsjukr|||17|2|0|0,0000|Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||6836||6836|9866|
013259|B02BD0901|BeneFIX|sts|||250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|29536|38950|lyfsjukr|||00|250|0|0,5600|Icepharma hf|Wyeth Europe|Storkuţáttur IX||29536||29536|38950|
013270|B02BD0901|BeneFIX|sts|||500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|49992|64622|lyfsjukr|||00|500|0|1,1100|Icepharma hf|Wyeth Europe|Storkuţáttur IX||49992||49992|64622|
013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|A||0|0|E|0|ANO|0|0|0|100|XEU|3366|4619|lyfalmen|V0042|4619|00|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2713||2713|4619|
013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4572|8951|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4572||4572|8951|
013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|10669|20659|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||10669||10669|20659|
013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1119|2226|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||1119||1119|2226|
013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|183766|232509|lyfsjukr|||00|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||183766||183766|232509|
013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|A||0|1|0|1|AZD|0|0|0|100|SEK|396798|441351|lyfsjukr|||00|30|0||Vistor hf|AstraZeneca A/S DK|||350174||350174|441351|
013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|30923|40691|lyfsjukr|||00|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||30923||30923|40691|
013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|122511|155634|lyfsjukr|||00|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||122511||122511|155634|
013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|61257|78760|lyfsjukr|||00|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||61257||61257|78760|
013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|5417|8318|lyfalmen|||00|28|0||Vistor hf|M.S.D.|Ezetimíb||5417||5417|8318|
013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|DKK|18445|25508|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb||18445||18445|25508|
013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003|30.11.2011|R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|151614|192158|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||151614||151614|192158|
013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|1315|2706|lyfalmen|||00|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1315||1315|2706|
013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0,0000|Actavis Group hf|Actavis Group hf|Blöndur|||||1438|
013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|2513|4345|lyfalmen|||00|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2513||2513|4345|
013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1419|2848|lyfalmen|||00|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1419||1419|2848|
013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|397|1450|lyfalmen|||00|30|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||397||397|1450|
013718|M05BA0801|Zometa|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|37385|48801|lyfsjukr|||00|5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||37385||37385|48801|
013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|4692|7326|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4692||4692|7326|
013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|A||0|0|B|0|SPL|0|0|1|100|DKK|965|2227|lyfalmen|||00|1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||965|2227|
013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2569|lyfalmen|V0168|2569|00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2569|
013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6200|9389|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||6200||6200|9389|
013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|2582|4439|lyfalmen|||51|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín (manna)||2582||2582|4439|
013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|4631|7242|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||4631||4631|7242|
013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|377366|475477|lyfsjukr|||00|30|0|0,0000|Vistor hf|Novartis Europharm Ltd|Imatiníb||377366||377366|475477|
014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|2499|4326|lyfalmen|||71|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín (manna)||2499||2499|4326|
014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|8793|12690|lyfsjukr|||00|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8793||8793|12690|
014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|18132|25115|lyfalmen|||00|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||18132||18132|25115|
014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|57151|74084|lyfalmen|||AC|3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||57151||57151|74084|
014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|29765|39238|lyfsjukr|||00|5908|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||29765||29765|39238|
014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|sk|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|A||0|0|0|0|AZD|0|0|0|100|SEK|27080|36345|lyfalmen|V0357|36345|00|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27080||27080|36345|
014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1505|2966|lyfalmen|||00|30|0|30,0000|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1505||1505|2966|
014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||29|4|0|0,0000|Vistor hf|McNeil Sweden AB|Levókabastín||||||
014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|19771|26695|lyfsjukr|||00|3944|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||19771||19771|26695|
014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25882|34364|lyfsjukr|||00|5908|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||25882||25882|34364|
014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|flaska||P01AB01|01.08.2009||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|4073|lyfalmen|||00|100|1||Distica|Distica - óskráđ lyf|Metrónídazól||||2314|4073|
014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|A|3|0|0|0|0|VET|0|0|0|100|XEU|2289|4553|vetalmen|||00|45|0|0,0000|Dýraheilsa ehf|Vetcare Ltd.|||||2289|4553|
014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|BOY|0|0|0|100|SEK|17943|24878|lyfalmen|||23|1|0|1825,0000|Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||17943||17943|24878|
014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|82680|105646|lyfsjukr|||0|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||82680|105646|
014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PAL|0|0|0|100|XEU|5690|11098|vetalmen|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5690||5690|11098|
014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|240926|304245|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíđ||240926||240926|304245|
014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2296|4048|lyfalmen|||10|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2296||2296|4048|
014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|1303|2690|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||1303||1303|2690|
014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|62970|80910|lyfsjukr|||00|2|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||62970||62970|80910|
014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|100750|128324|lyfsjukr|||00|2|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||100750||100750|128324|
014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|A||0|0|E|0|MYL|0|0|0|100|SEK|856|2078|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||||856|2078|
014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|19294|26573|lyfalmen|||00|60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||19294||19294|26573|
014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|A||0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||00|20|0||Artasan ehf|Norgine A/S|Makrógól 3350||||||
014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|58222|75428|lyfalmen|||00|60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||58222||58222|75428|
014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|38755|50997|lyfalmen|||00|60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||38755||38755|50997|
015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|24,0000|Icepharma hf|Pharma Nord ApS|Glúkósamín||||||
015230|R01AC0301|Lastin|nefúđi|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|748|1931|lyfalmen|||00|10|0|17,8571|Vistor hf|Meda AB|Azelastínum||748||748|1931|
015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|72,0000|Icepharma hf|Pharma Nord ApS|Glúkósamín||||||
015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|XEU|3191|5272|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||3191||3191|5272|
015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|8597|12668|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín detemír||8597||8597|12668|
015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|XEU|1104|2396|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1088||1088|2396|
015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2760|4683|lyfalmen|||00|100|1|33,3333|Lyfjaver ehf|Lyfjaver - óskráđ lyf|Betametasón||2760||2760|4683|
015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1090|2398|lyfalmen|V0129|1614|23|8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1090||1090|2398|
015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2003|3530|lyfalmen|V0234|3530|00|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1917||1917|3530|
015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2861|4653|lyfalmen|V0233|4653|00|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||2738||2738|4653|
015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|10243|14919|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín detemír||10243||10243|14919|
015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|345502|435488|lyfsjukr|||00|1|0|0,0000|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||345502||345502|435488|
015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|91832|117132|lyfsjukr|||00|1|0|0,0000|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||91832||91832|117132|
015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5311|8173|lyfalmen|||00|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5311||5311|8173|
015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13502|19304|lyfalmen|||00|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13502||13502|19304|
015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5311|8173|lyfalmen|||00|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5311||5311|8173|
015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14596|20677|lyfalmen|V0264|20676|00|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14596||14596|20677|
015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|70443|90288|lyfsjukr|||43|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70443||70443|90288|
015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|70443|90288|lyfsjukr|||43|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70443||70443|90288|
015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|61255|78758|lyfsjukr|||43|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||61255||61255|78758|
015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5311|8173|lyfalmen|||00|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5311||5311|8173|
015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13360|19126|lyfalmen|||00|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13360||13360|19126|
015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|70443|90288|lyfsjukr|||43|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70443||70443|90288|
015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|22588|30707|lyfalmen|||00|120|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||22588||22588|30707|
015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|47050|61407|lyfalmen|||00|120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||47050||47050|61407|
015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3186|5558|vetorma|||16|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3186||3186|5558|
015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|4477|7810|vetorma|||16|12|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4477||4477|7810|
015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|2842|4958|vetorma|||16|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2842||2842|4958|
015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3564|6217|vetorma|||16|3|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3564||3564|6217|
015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|ţpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|4541|7119|lyfalmen|V0200|5442|10|50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4541||4541|7119|
015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3993|6966|vetorma|||16|8|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3993||3993|6966|
015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|2006|3651|lyfalmen|||0|10|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||||2006|3651|
015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|2253|3989|lyfalmen|||00|10|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||2253||2253|3989|
015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1509|2972|lyfalmen|||02|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1509||1509|2972|
015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3186|5558|vetorma|||16|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3186||3186|5558|
015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|A|3|0|0|0|0|GSK|0|1|0|100|GBP|1925|3541|lyfalmen|||00|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1925||1925|3541|
016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14424|20462|lyfalmen|V0117|19440|00|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14424||14424|20462|
016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1121|2441|lyfalmen|V0432|1266|02|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1121||1121|2441|
016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|21599|29466|lyfalmen|V0118|28117|00|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||21599||21599|29466|
016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1188|2532|lyfalmen|V0432|2532|02|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1188||1188|2532|
016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|2467|4282|lyfalmen|V0236|3696|00|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2467||2467|4282|
016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|ţpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|IKR|||lyflausa|||00|60|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||||||
016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|ţpakki|frostţ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|7488|11151|lyfalmen|||00|28|0|11,2000|Vistor hf|Janssen-Cilag AB|Risperídón||7488||7488|11151|
016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2658|4543|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2658||2658|4543|
016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|6691|10060|lyfalmen|||00|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6691||6691|10060|
016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|MSE|0|0|0|100|SEK|4976|7714|lyfalmen|||00|0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||4976||4976|7714|
016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10147|14788|lyfalmen|||00|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||10147||10147|14788|
016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1753|3305|lyfalmen|||00|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1753||1753|3305|
016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|14740|20858|lyfalmen|||00|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||14740||14740|20858|
016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|8848|13011|lyfalmen|||10|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||8848||8848|13011|
016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|ţpakki|frostţ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|3974|6344|lyfalmen|||00|28|0|5,6000|Vistor hf|Janssen-Cilag AB|Risperídón||3974||3974|6344|
016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PER|0|0|0|100|DKK|96280|122714|lyfsjukr|||00|70|0|7,0000|Icepharma hf|Pfizer ApS|Voricónazól||96280||96280|122714|
016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1,5|0|1|0|1|PER|0|0|0|100|DKK|4263|6153|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Pfizer ApS|Cýtarabín||4263||4263|6153|
016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2616|4486|lyfalmen|||00|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2616||2616|4486|
016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|17586|24430|lyfalmen|||00|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17586||17586|24430|
016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||7085|
016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|34354|45474|lyfalmen|V0295|45472|00|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34354||34354|45474|
016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2296|lyfalmen|V0169|2296|00|12|0|12,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2296|
016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|185210|234321|lyfsjukr|||00|2|0|180,0000|Icepharma hf|Roche|Epóetín||185210||185210|234321|
016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005|31.10.2011|R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|141854|179909|lyfsjukr|||00|6|0|0,0000|Icepharma hf|Ipsen Ltd.|Sómatrópín||141854||141854|179909|
016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|7840|11632|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||7840||7840|11632|
016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005|31.10.2011|R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|47285|61225|lyfsjukr|||00|2|0|0,0000|Icepharma hf|Ipsen Ltd.|Sómatrópín||47285||47285|61225|
016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3069|5106|lyfalmen|V0433|5106|10|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3069||3069|5106|
016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|5665|8657|lyfalmen|V0240|8657|10|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5665||5665|8657|
016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|61284|79271|lyfalmen|||00|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||61284||61284|79271|
016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|90302|115688|lyfalmen|||00|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||90302||90302|115688|
016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|29182|38983|lyfalmen|||00|28|0|0,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||29182||29182|38983|
016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|56993|73886|lyfalmen|||00|2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||56993||56993|73886|
016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|19777|27180|lyfalmen|||00|0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||19777||19777|27180|
016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|29637|39554|lyfalmen|||00|1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||29637||29637|39554|
016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|ţpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2014|3662|lyfalmen|V0497|3234|00|14|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2014||2014|3662|
016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|A||0|0|0|0|PER|0|0|0|100|DKK|3562|5780|lyfalmen|V0007|5780|00|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3562|5780|
016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|ţpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|4066|6469|lyfalmen|V0497|6469|00|28|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||4066||4066|6469|
016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|ţpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|7854|11651|lyfalmen|V0007|10115|00|98|0|49,0000|Icepharma hf|Pfizer ApS|Lansóprazól||7854||7854|11651|
016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|ţpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|6531|9841|lyfalmen|||00|56|0|56,0000|Icepharma hf|Pfizer ApS|Lansóprazól||6531||6531|9841|31.10.2011
016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GIS|0|0|0|100|XEU|39829|51868|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||39829||39829|51868|
016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|ţpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|13974|19897|lyfalmen|||00|98|0|98,0000|Icepharma hf|Pfizer ApS|Lansóprazól||13974||13974|19897|
016979|N02AE0103|Norspan|forđapl|5|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3155|5223|lyfalmen|||00|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3155||3155|5223|
016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PAL|0|0|0|100|DKK|18848|36364|vetalmen|||16|60|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||18848||18848|36364|
017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25590|33998|lyfsjukr|||00|4824|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||25590||25590|33998|
017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|1535|3007|lyfalmen|||03|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1535||1535|3007|
017111|A09AA0201|Combizym|töflur|||100|stk|1|ţpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1438|2874|lyfalmen|||10|100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1438||1438|2874|
017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|264967|334416|lyfsjukr|||00|5|0|0,0000|Icepharma hf|SkyPharma PLC|Cýtarabín||264967||264967|334416|
017145|C08DB0102|Cardizem Retard|forđatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|7933|11759|lyfalmen|||10|60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||7933||7933|11759|
017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|174598|221003|lyfsjukr|||00|1|0|0,0000|Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||174598||174598|221003|
017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|40441|52636|lyfsjukr|||00|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||40441||40441|52636|
017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1369|2780|lyfalmen|V0046|2180|00|100|0|33,3333|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1369||1369|2780|
017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIN|0|0|0|100|XEU|128402|163027|lyfsjukr|||00|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||128402||128402|163027|
017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|48063|62678|lyfalmen|||00|28|0|28,0000|Icepharma hf|Roche|Íbandrónsýra||48063||48063|62678|
017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|149255|189674|lyfalmen|||00|84|0|84,0000|Icepharma hf|Roche|Íbandrónsýra||149255||149255|189674|
017266|N02AE0103|Norspan|forđapl|10|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|5477|8400|lyfalmen|||00|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5477||5477|8400|
017326|N02AE0103|Norspan|forđapl|20|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|10429|15174|lyfalmen|||00|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||10429||10429|15174|
017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2707|4610|lyfalmen|||00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||2707||2707|4610|
017331|A04AD1201|Emend|hylki|0| |3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|DKK|9062|13079|lyfsjukr|||00|3|0|0,0000|Vistor hf|M.S.D.|Aprepitant||9062||9062|13079|
017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|XEU|890|2125|lyfalmen|||00|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||890||890|2125|
017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|2921|4903|lyfalmen|||00|30|0|150,0000|Vistor hf|Recip AB|Prednisón||2921||2921|4903|
017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|ţpakki||N07CA01|01.06.1999|30.09.2011|R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|3789|6091|lyfalmen|||00|100|0|66,6667|Medico ehf|Solvay Duphar |Betahistín||3789||3789|6091|
017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1459|2653|lyfalmen|V0168|2569|00|20|0|12,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1276||1276|2653|
017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|6727|13089|vetalmen|||00|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||6727||6727|13089|
017763|N06DA0401|Reminyl|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|39393|51798|lyfalmen|V0350|31231|00|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Galantamín||39393||39393|51798|
017773|N06DA0401|Reminyl|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|12835|18467|lyfalmen|V0348|11571|00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Galantamín||12835||12835|18467|
017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10470|15230|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||10470||10470|15230|
017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|42342|55499|lyfalmen|||00|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||42342||42342|55499|
017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|9562|13988|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9562||9562|13988|
018268|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BYP|0|0|0|100|SEK|6969|10441|lyfalmen|||00|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||6969||6969|10441|
018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|2278|4024|lyfalmen|||00|28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2278||2278|4024|
018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|3345|5483|lyfalmen|||00|28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3345||3345|5483|
018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|10796|15676|lyfalmen|||00|98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||10796||10796|15676|
018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|7514|11186|lyfalmen|||00|98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||7514||7514|11186|
018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3770|6065|lyfalmen|||02|0|0|0,0000|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||3770||3770|6065|
018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|4117|6539|lyfalmen|||02|0|0|0,0000|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4117||4117|6539|
018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|8929|13122|lyfalmen|||00|98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||8929||8929|13122|
018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2481|lyfalmen|V0243|2481|00|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1150||1150|2481|
018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|2798|4735|lyfalmen|||00|28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2798||2798|4735|
018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|8293|12252|lyfalmen|||00|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8293||8293|12252|
018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|13737|19122|lyfsjukr|||03|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||13737||13737|19122|
018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|ţpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|1466|2913|lyfalmen|V0070|2460|00|14|0|7,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1466||1466|2913|
018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|20332|27876|lyfalmen|||00|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||20332||20332|27876|
018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|2933|4920|lyfalmen|V0070|4920|00|28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||2933||2933|4920|
018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MKA|0|0|1|100|SEK|943|2197|lyfalmen|V0414|1878|00|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||943||943|2197|
018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|5873|8941|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5873||5873|8941|
018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|16555|23136|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||16555||16555|23136|
018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|34561|45733|lyfalmen|||00|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||34561||34561|45733|
018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|120986|153720|lyfsjukr|||00|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited|Glatíramer acetat||120986||120986|153720|
018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|ţpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|2923|4906|lyfalmen|||00|30|0|60,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||2923||2923|4906|
018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|ţpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|9445|13828|lyfalmen|||00|100|0|200,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||9445||9445|13828|
018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|VII|0|0|0|100|GBP|57767|74380|lyfsjukr|||43|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||57767||57767|74380|
018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|598|1725|lyfalmen|||00|100|0|50,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||598||598|1725|
018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1293|2572|vetalmen|||27|100|0|0,0000|Icepharma hf|Kela Laboratoria NV|||1293||1293|2572|
018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9964|14538|lyfalmen|V0221|11239|00|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||9964||9964|14538|
019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|ţpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|14760|20883|lyfalmen|V0346|16320|00|56|0|37,3300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14760||14760|20883|
019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|A||0|0|0|1|GEH|0|0|0|100|NOK|21055|28307|lyfsjukr|||02|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||21055||21055|28307|
019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|ţpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|14760|20883|lyfalmen|V0345|16320|00|56|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14760||14760|20883|
019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|7122|10650|lyfalmen|V0220|8872|00|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7122||7122|10650|
019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|23763|31705|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||23763||23763|31705|
019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|6661|10019|lyfalmen|V0343|7783|00|28|0|4,6667|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||6661||6661|10019|
019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|3949|6309|lyfalmen|V0219|5534|00|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||3949||3949|6309|
019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|32991|43286|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||32991||32991|43286|
019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|33827|44335|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||33827||33827|44335|
019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|41333|53755|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||41333||41333|53755|
019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9269|13587|lyfalmen|V0223|12945|00|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||9269||9269|13587|
019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|13733|19594|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||13733||13733|19594|
019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|4710|7350|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||4710||4710|7350|
019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|52107|67277|lyfsjukr|||00|1|0|0,0000|Gróco ehf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||52107||52107|67277|
019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|THE|0|0|0|100|XEU|744703|936485|lyfsjukr|||00|10|0|0,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||744703||744703|936485|
019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|stk|10 áf.spr|QJ51CE09|01.04.2010||R|A||0|0|0|0|VET|0|0|0|100|DKK|21214|40907|vetalmen|||00|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||21214|40907|
019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|6850|10278|lyfalmen|||00|56|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6850||6850|10278|
019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|52517|67791|lyfsjukr|||AC|4|0|0,0000|Icepharma hf|Roche Registration Limited|Bevacizúmab||52517||52517|67791|
019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|6850|10278|lyfalmen|||00|56|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6850||6850|10278|
019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|17246|24003|lyfalmen|||00|140|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||17246||17246|24003|31.10.2011
019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|601|1730|lyfalmen|||00|100|0|100,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||601||601|1730|
019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|3750|5412|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3750||3750|5412|
019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|628|1766|lyfalmen|||00|250|0|250,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||628||628|1766|
019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|16476|22560|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||16476||16476|22560|
019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|195022|246635|lyfsjukr|||AC|16|0|0,0000|Icepharma hf|Roche Registration Limited|Bevacizúmab||195022||195022|246635|
019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1085|2392|lyfalmen|V0159|2390|10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1085||1085|2392|
019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|198606|251133|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||198606||198606|251133|
019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12915|18568|lyfalmen|||00|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12915||12915|18568|
019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12915|18568|lyfalmen|||00|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12915||12915|18568|
019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|55810|72401|lyfalmen|||00|1|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||55810||55810|72401|
019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12915|18568|lyfalmen|||00|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12915||12915|18568|
019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12915|18568|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12915||12915|18568|
019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12915|18568|lyfalmen|||00|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12915||12915|18568|
019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|787828|990607|lyfsjukr|||02|6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||787828||787828|990607|
019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|381|1429|lyfalmen|||00|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||381||381|1429|
019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|65460|84035|lyfsjukr|||00|30|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||65460||65460|84035|
019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1625|3080|lyfalmen|V0160|3080|10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1588||1588|3080|
020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||43|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Ferrósúlfat||||||
020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||||
020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|2921|4903|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2921||2921|4903|
020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|25523|34391|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||25523||25523|34391|
020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2751|4671|lyfalmen|||04|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2751||2751|4671|
020277|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.02.2007||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|579|1699|lyfalmen|V0333|1526|00|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||579||579|1699|
020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||||
020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|6819|10235|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6819||6819|10235|
020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|53224|69156|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||53224||53224|69156|
020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6061|9199|lyfalmen|||00|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||6061||6061|9199|
020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|13504|19307|lyfalmen|||00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||13504||13504|19307|
020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|24019|32503|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||24019||24019|32503|
020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|605|1735|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||605||605|1735|
020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|5706|8713|lyfalmen|||00|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||5706||5706|8713|
020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1842|3427|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1842||1842|3427|
020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|16617|23214|lyfalmen|||00|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||16617||16617|23214|
020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|ţpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|20,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||||
020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|0,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel||||||
020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2226|3883|vetorma|||16|8|0|0,0000|Vistor hf|Merial SAS|||2226||2226|3883|
020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|156489|198276|lyfsjukr|||00|4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||156489||156489|198276|
020861|QP52AF0202|Twinhip Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|A||0|0|0|0|VET|0|0|0|100|XEU|2603|4541|vetorma|||16|52|0||Dýraheilsa ehf|Vetcare Ltd.|||2603||2603|4541|
020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2026|3679|lyfalmen|||00|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2026||2026|3679|30.11.2011
020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|A||0|0|0|0|SEV|0|0|0|100|DKK|3016|5033|lyfalmen|||00|30|0|37,5000|Icepharma hf|Servier|Perindópríl||3016||3016|5033|
021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.09.1998|30.09.2011|R|A|3|0|0|B|0|MSD|0|0|0|100|DKK|5855|8917|lyfalmen|||63|28|0|28,0000|Vistor hf|M.S.D.|Montelúkast||5855||5855|8917|
021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2423|4222|lyfalmen|||00|60|0|60,0000|Icepharma hf|Galderma Nordic AB|Adapalen||2423||2423|4222|
021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|ţpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|827|1884|lyfalmen|||00|12|0|7,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1884|
021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.04.2010||R|K||0|0|*|0|DAC|0|0|0|100|DKK|3334|5468|lyfalmen|||06|2|0|0,0000|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||||3334|5468|30.09.2011
021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2296|lyfalmen|V0169|2296|00|12|0|12,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1015||1015|2296|
021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|A|2|0|0|E|0|ACA|0|0|1|100|IKR|453|1318|lyfalmen|V0188|1318|00|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||300||300|1318|
021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1018|2300|lyfalmen|||00|10|0|0,0000|Actavis Group hf|Gerhard Mann|Dexpantenól||1018||1018|2300|
021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|A|2|0|0|E|0|ACA|0|0|1|100|IKR|1187|2044|lyfalmen|V0189|2044|00|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||831||831|2044|
021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|16864|23524|lyfalmen|||02|4|0|55,5600|Icepharma hf|Bayer Schering Pharma AG|Testósterón||16864||16864|23524|
021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|DKK|17167|23904|lyfalmen|V0490|11483|63|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||17167||17167|23904|
021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|ţpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||||
021417|R01AD0504|Rhinocort (D.A.C.)|nefúđi|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|A||0|0|E|0|DAC|0|0|1|100|SEK|1630|3088|lyfalmen|V0443|3088|24|120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||1594||1594|3088|
021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl||||||
021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|DKK|17440|24247|lyfalmen|||63|98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||17440||17440|24247|
021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1583|2285|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||1583||1583|2285|
021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|4401|6928|lyfalmen|||00|30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4401||4401|6928|
021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|13469|19263|lyfalmen|||00|100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||13469||13469|19263|
021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14102|20057|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14102||14102|20057|
021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|7118|10644|lyfalmen|||00|30|0|9,0000|Vistor hf|Ferring AB, Svíţjóđ|Desmópressín||7118||7118|10644|
021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|A||0|0|B|0|FER|0|0|0|100|DKK|15125|21341|lyfalmen|||00|60|0|40,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15125||15125|21341|
021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|15834|21754|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||15834||15834|21754|
021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|22674|30815|lyfalmen|||00|100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||22674||22674|30815|
021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|15834|21754|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||15834||15834|21754|
021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24372|32946|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||24372||24372|32946|
021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4396|6921|lyfalmen|||00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4396||4396|6921|
021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|9105|13141|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||9105||9105|13141|
021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PER|0|0|0|100|DKK|4595|6632|lyfsjukr|||02|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4595||4595|6632|
021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19512|26847|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||19512||19512|26847|
021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|3835|6153|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3835||3835|6153|
021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.01.2010||R|A||0|0|0|0|DAC|0|0|0|100|SEK|5766|7720|lyfalmen|||00|28|0|37,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4980||4980|7720|30.11.2011
021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|21614|29008|lyfsjukr|||00|2500|0|2,5000|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||21614||21614|29008|
021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|5301|8159|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5301||5301|8159|
021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|18267|25284|lyfalmen|||00|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||18267||18267|25284|
022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|19512|26847|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||19512||19512|26847|
022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|84021|107329|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||84021||84021|107329|
022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|A||0|0|0|1|BAM|0|0|0|100|SEK|120584|153215|lyfsjukr|||00|1200|0|1,2000|Icepharma hf|Baxter Medical AB|Albúmín||120584||120584|153215|
022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ||||||
022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|7211|10772|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||7211||7211|10772|
022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|8451|12468|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||8451||8451|12468|
022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|DKK|25914|34881|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||25914||25914|34881|
022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|K||0|0|*|0|SAA|0|0|0|100|NOK|5369|8252|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5369||5369|8252|
022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|9012|13235|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||9012||9012|13235|
022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|294042|370905|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||294042||294042|370905|
022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|324499|409129|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||324499||324499|409129|
022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005|31.10.2011|R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|584|1256|lyfalmen|||00|20|0|20,0000|Actavis Group hf|Actavis hf|Paroxetín||255||255|1256|
022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|11310|19730|vetorma|||00|24|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||11310||11310|19730|
022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|24029|32516|lyfalmen|||02|1|0|0,0000|Vistor hf|Allergan|Clostridium botulinum toxín-A||24029||24029|32516|
022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2274|3967|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2274||2274|3967|
022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|1300|2686|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1300||1300|2686|
022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|ţpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|1384|2414|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1384|2414|
022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|3840|2645|lyfalmen|V0056|2532|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1270||1270|2645|
022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|6751|3664|lyfalmen|V0057|3480|00|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2015||2015|3664|
022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2153|3756|vetorma|||00|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2153||2153|3756|
022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|630|1769|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||630||630|1769|
022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1889|3491|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1889||1889|3491|
022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|1394|2432|vetorma|||00|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||1394||1394|2432|
022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4691|7324|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4691||4691|7324|
022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A||0|0|B|0|ACA|0|1|0|100|IKR|2129|2921|lyfalmen|V0321|2921|00|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|2921|
022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|1974|lyfalmen|V0321|1753|00|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|1974|
022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005|31.10.2011|R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|1207|2504|lyfalmen|||00|50|0|50,0000|D.A.C. ehf|D.A.C. ehf|Metótrexat||1167||1167|2504|
022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|13605|19434|lyfalmen|V0091|5233|00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||13605||13605|19434|
022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|25111|33874|lyfalmen|||00|8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||25111||25111|33874|
022802|L01XC0401|MabCampath|irţ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|220835|279030|lyfsjukr|||00|3|0|0,0000|Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||220835||220835|279030|
022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|12556|18117|lyfalmen|||00|4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||12556||12556|18117|
022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2807|
022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2755|lyfalmen|V0124|2755|67|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2755|
022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4125|lyfalmen|V0125|4125|67|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4125|
022962|V01AA1104|Alutard SQ, hrossavćrur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24372|32946|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||24372||24372|32946|
022970|V01AA1104|Alutard SQ, hrossavćrur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19512|26847|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19512||19512|26847|
023047|G04BD1001|Emselex|forđatfl|7,5|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5672|8666|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5672||5672|8666|
023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|84015|107321|lyfsjukr|||00|30|0|0,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||84015||84015|107321|
023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|25794|34731|lyfalmen|||00|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||25794||25794|34731|
023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|40271|52900|lyfalmen|||00|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||40271||40271|52900|
023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|20393|27953|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20393||20393|27953|
023146|G04BD1001|Emselex|forđatfl|15|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5729|8744|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5729||5729|8744|
023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|20600|28212|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20600||20600|28212|
023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|4742|6955|lyfalmen|V0250|6955|00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||4421||4421|6955|
023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|3551|5765|lyfalmen|V0251|5765|00|100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||3551||3551|5765|
023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|1|100|XEU|18495|25571|lyfalmen|||00|34|0|0,0000|Vistor hf|Dentsply DeTrey GmbH|Blöndur||18495||18495|25571|
023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|7421|10710|lyfsjukr|||00|0|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||7421||7421|10710|
023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|28536|37695|lyfsjukr|||00|0|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||28536||28536|37695|
023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|21609|29002|lyfsjukr|||00|0|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||21609||21609|29002|
023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|51463|66469|lyfsjukr|||00|0|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||51463||51463|66469|
023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|34775|45525|lyfsjukr|||00|0|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||34775||34775|45525|
023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|8283|11954|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||8283||8283|11954|
023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|103651|131965|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||103651||103651|131965|
023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|20709|27872|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||20709||20709|27872|
023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|14917|20603|lyfsjukr|||00|0|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||14917||14917|20603|
023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|36014|47080|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||36014||36014|47080|
023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|72029|92279|lyfsjukr|||00|100|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||72029||72029|92279|
023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006|31.10.2011|R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|8861|13029|lyfalmen|||00|3|0|14,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||8861||8861|13029|
023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|180633|228577|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||180633||180633|228577|
023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|144059|182677|lyfsjukr|||00|200|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||144059||144059|182677|
023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006|31.10.2011|R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|17721|24599|lyfalmen|||00|6|0|28,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||17721||17721|24599|
023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|13183|18904|lyfalmen|||00|4|0|21,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13183||13183|18904|
023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|135502|171938|lyfsjukr|||00|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||135502||135502|171938|
023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|26435|30618|lyfalmen|V0029|12371|00|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||22517||22517|30618|
023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|3614|5851|lyfalmen|||00|12|0|60,0000|Icepharma hf|Santen Oy|Tímólól||3614||3614|5851|
023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|56818|73189|lyfsjukr|||00|120|0|100,0000|Icepharma hf|Roche|Saquínavír||56818||56818|73189|
023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|IPI|0|0|0|100|DKK|76924|98422|lyfsjukr|||00|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||76924||76924|98422|
024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|DKK|2941|4931|lyfalmen|||00|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2941||2941|4931|
024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|DKK|77688|99381|lyfsjukr|||00|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||77688||77688|99381|
024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|2514|4346|lyfalmen|||00|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2514||2514|4346|
024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|19435|26750|lyfalmen|||00|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||19435||19435|26750|
024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|1774|2560|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||1774||1774|2560|
024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|22737|30417|lyfsjukr|||00|3944|0|3,9400|Icepharma hf|Fresenius Kabi|Blöndur||22737||22737|30417|
024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|14484|20537|lyfalmen|V0456|20537|00|28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||||14484|20537|
024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|64103|82809|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||64103||64103|82809|
024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24372|32946|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||24372||24372|32946|
024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7673|11404|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7673||7673|11404|
024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|424|1487|lyfalmen|||00|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||424||424|1487|
024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7673|11404|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7673||7673|11404|
024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12928|18584|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12928||12928|18584|
024510|V04CL0004|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12928|18584|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12928||12928|18584|
024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12950|18612|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12950||12950|18612|
024532|V04CL0007|Soluprick SQ ALK203 - Háliđagras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12928|18584|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12928||12928|18584|
024559|V04CL0008|Soluprick SQ ALK214 -Axhnođapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12928|18584|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12928||12928|18584|
024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13082|18777|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13082||13082|18777|
024576|V04CL0010|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12928|18584|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12928||12928|18584|
024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5532|8475|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5532||5532|8475|
024589|V04CL0012|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|12928|18584|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12928||12928|18584|
024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|70287|90570|lyfalmen|||00|100|0|360,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||70287||70287|90570|
024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13082|18777|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13082||13082|18777|
024603|V04CL0001|Soluprick  Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1575|3062|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1575||1575|3062|
024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5532|8475|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5532||5532|8475|
024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7673|11404|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7673||7673|11404|
024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7673|11404|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7673||7673|11404|
024681|V04CL0002|Soluprick  Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1575|3062|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1575||1575|3062|
025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|638|1780|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||638||638|1780|
025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19512|26847|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19512||19512|26847|
025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húđ|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|1944|3567|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1944||1944|3567|
025180|R03BA0201|Pulmicort|innúđal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|2120|3807|lyfalmen|||0|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||2120||2120|3807|
025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|19512|26847|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19512||19512|26847|
025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|PAD|0|0|1|100|DKK|958|2218|lyfalmen|||08|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||958||958|2218|
025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|ţpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|0|0|MSD|0|0|0|100|DKK|13855|19747|lyfalmen|||00|12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra og kólekalsíferól||13855||13855|19747|
025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|84361|107756|lyfsjukr|||00|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||84361||84361|107756|
025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|78797|100773|lyfsjukr|||00|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||78797||78797|100773|
025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|1|0|0|100|DKK|9669|18738|vetalmen|||00|20|0|0,0000|Vistor hf|Boehringer Ingelheim|||9669||9669|18738|
025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|16737|23364|lyfalmen|||00|30|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||16737||16737|23364|
025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|19865|27290|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||19865||19865|27290|
025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|6354|9599|lyfalmen|||00|28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||6354||6354|9599|
025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003|31.10.2011|R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|34776|46003|lyfalmen|||00|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||34776||34776|46003|
025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.2010||R|A||0|0|*|0|DAC|0|0|0|100|DKK|1901|3508|lyfalmen|V0369|2913|06|5|0|16,6667|D.A.C. ehf|D.A.C. ehf|Dorzólamíđ||1901||1901|3508|
025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|5295|8151|lyfalmen|V0205|6722|00|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5295||5295|8151|
025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|14189|20167|lyfalmen|V0205|20167|00|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||14189||14189|20167|
025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003|31.10.2011|R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|18566|25660|lyfalmen|||00|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||18566||18566|25660|
025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003|31.10.2011|R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|26853|36060|lyfalmen|||00|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||26853||26853|36060|
025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|53762|69831|lyfalmen|||00|100|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||53762||53762|69831|
025747|C01BB0101|Xylocard  100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|7232|10438|lyfsjukr|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7232||7232|10438|
025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24372|32946|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||24372||24372|32946|
025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|A||0|1|0|1|CEE|0|0|0|100|XEU|58056|74743|lyfsjukr|||00|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||58056|74743|
025958|M01AE0218|Naproxen Mylan|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|985|2255|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||985||985|2255|
025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|4745|8277|vetorma|||16|1|0|0,0000|Vistor hf|Merial (MSD)|||4745||4745|8277|
025976|M01AE0218|Naproxen Mylan|töflur|500|mg|25|stk|1|glas||M01AE02|01.12.2009||R|A||0|0|E|0|MYL|0|0|1|100|SEK|511|1606|lyfalmen|||00|25|0|25,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||511||511|1606|
025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|A||0|0|B|0|POF|0|0|0|100|XEU|13769|11501|lyfalmen|V0490|11483|63|98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||7744||7744|11501|
025994|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|2616|3386|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1812||1812|3386|
025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|A||0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||10|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ||||||
026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|A|5|0|0|E|0|POF|0|0|0|100|IKR|820|2029|lyfalmen|V0447|2029|10|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2029|
026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|9348|16307|vetorma|||16|2|0|0,0000|Vistor hf|Merial (MSD)|||9348||9348|16307|
026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|23689|32089|lyfalmen|V0475|32089|00|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||23689||23689|32089|
026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19512|26847|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19512||19512|26847|
026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|K||0|1|0|1|PFM|0|0|0|100|DKK|43037|55894|lyfsjukr|||00|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||43037||43037|55894|
026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|K||0|1|0|1|PFM|0|0|0|100|DKK|215211|271972|lyfsjukr|||00|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||215211||215211|271972|
026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0||Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|1834|3416|lyfalmen|||00|14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1834|3416|
026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|6948|10412|lyfalmen|||00|56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||6948|10412|
026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|3622|5862|lyfalmen|||00|14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3622|5862|
026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|14347|20365|lyfalmen|||00|56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||14347|20365|
026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|21499|29341|lyfalmen|||00|56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||21499|29341|
026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|28652|38318|lyfalmen|||00|56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||28652|38318|
026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1422|2853|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1422||1422|2853|
026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|A||0|0|0|0|DAC|0|0|1|100|SEK|1638|3080|lyfalmen|V0160|3080|10|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1588||1588|3080|
026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|A||0|0|0|0|DAC|0|0|1|100|SEK|1127|2390|lyfalmen|V0159|2390|10|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1084||1084|2390|
027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|423|1486|lyfalmen|||00|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||423||423|1486|
027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|ţpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2724|4634|lyfalmen|V0199|3492|10|50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2724||2724|4634|
027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|A||0|0|*|0|ALA|0|0|0|100|USD|2335|4102|lyfalmen|||00|5|0|0,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2335||2335|4102|
027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MYL|0|0|0|100|SEK|6950|10415|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Cýpróterón||6950||6950|10415|
027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|29798|32462|lyfalmen|V0341|32446|00|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||23986||23986|32462|
027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|33441|34870|lyfalmen|V0342|34870|00|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||25905||25905|34870|
027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|ţpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1722|3263|lyfalmen|||00|14|0|1,7500|Vistor hf|Eisai Ltd|Zonisamíđ||1722||1722|3263|
027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|7180|10729|lyfalmen|||00|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||7180||7180|10729|
027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|9461|13850|lyfalmen|||00|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||9461||9461|13850|
027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|12300|17796|lyfalmen|V0255|17473|00|56|0|28,0000|Vistor hf|Eisai Ltd|Zonisamíđ||12300||12300|17796|
027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|848|2067|lyfalmen|V0153|1999|00|100|0|33,3300|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||848||848|2067|
027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|847|2066|lyfalmen|V0154|1857|00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||847||847|2066|
027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SPE|0|0|0|100|DKK|101411|129153|lyfsjukr|||00|105|0|0,7500|Vistor hf|SP Europe|Posacónazól||101411||101411|129153|
027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|20692|28328|lyfalmen|||00|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20692||20692|28328|
027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|32206|42778|lyfalmen|||00|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||32206|42778|
027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|23915|32373|lyfalmen|||00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||23915||23915|32373|
027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|47455|61915|lyfalmen|||00|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||47455||47455|61915|
027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|59780|77383|lyfalmen|||00|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||59780|77383|
028045|G03AB0001|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB|01.11.2009||R|A||0|0|0|0|BAP|0|0|0|100|SEK|4957|7688|lyfalmen|||00|84|0||Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||4957||4957|7688|
028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|A|2|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||||||
028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|DKK|24492|33097|lyfalmen|V0386|33097|00|196|0|98,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||24492||24492|33097|
028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3544|5085|lyfalmen|V0364|5077|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3054||3054|5085|
028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|ţpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|3967|6334|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||3967|6334|
028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|DKK|18950|26142|lyfalmen|V0120|26142|00|196|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||18950|26142|
028179|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|98|stk|1|ţpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|13792|19668|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||13792|19668|
028190|C09XA5201|Rasilez HCT|filmhtfl|175|mg|28|stk|1|ţpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|3967|6334|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||3967|6334|
028201|C09XA5201|Rasilez HCT|filmhtfl|175|mg|98|stk|1|ţpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|13792|19668|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||13792|19668|
028212|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|28|stk|1|ţpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4573|7163|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||4573|7163|
028224|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|98|stk|1|ţpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15907|22323|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||15907|22323|
028235|C09XA5201|Rasilez HCT|filmhtfl|325|mg|28|stk|1|ţpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4573|7163|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||4573|7163|
028246|C09XA5201|Rasilez HCT|filmhtfl|325|mg|98|stk|1|ţpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15907|22323|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||15907|22323|
028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|57205|73675|lyfsjukr|||00|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||57205||57205|73675|
028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2550|4396|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir  mótefnavakar||2550||2550|4396|
028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21406|29224|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||21406||21406|29224|
028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|8191|12112|lyfalmen|||02|1|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Hundaćđi, dauđ veira||8191||8191|12112|
028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|1854|3444|lyfalmen|V0202|3444|00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||1854||1854|3444|
028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2079|3751|lyfalmen|V0428|3272|10|50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2079||2079|3751|
028498|C08DB0102|Cardizem Retard|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|5307|8167|lyfalmen|||10|60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||5307||5307|8167|
028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1278|2656|lyfalmen|||00|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2656|
028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|5812|8158|lyfalmen|V0245|8158|00|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5300||5300|8158|
028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|10358|15077|lyfalmen|||00|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||10358|15077|
028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|803|1192|lyfalmen|V0266|1192|00|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||208||208|1192|
028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|1|0|0|100|DKK|8024|15580|vetalmen|||27|10|0|0,0000|Icepharma hf|Orion Corporation (I)|||8024||8024|15580|
028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|A||0|0|B|0|POF|0|0|0|100|XEU|4627|7237|lyfalmen|||63|28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||||4627|7237|
028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|5229|3870|lyfalmen|V0267|3735|00|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||2166||2166|3870|
028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|18852|12934|lyfalmen|V0269|12934|00|100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||8792||8792|12934|
028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|899|2137|lyfalmen|||02|24|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||899||899|2137|
028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|1362|2771|lyfalmen|V0179|1807|10|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||1362||1362|2771|
028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|4998|7744|lyfalmen|V0179|7744|10|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||4998||4998|7744|
028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|577|1697|lyfalmen|V0180|839|10|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||577||577|1697|
028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|563|1678|lyfalmen|V0180|1678|10|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1678|
028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|2031|3686|lyfalmen|V0180|3356|10|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||2031||2031|3686|
029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1062|2360|lyfalmen|||24|16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1062|2360|
029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|7660|11386|lyfalmen|||00|28|0|28,0000|Icepharma hf|Servier|Agómelatín||7660||7660|11386|
029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|21849|29780|lyfalmen|||00|84|0|84,0000|Icepharma hf|Servier|Agómelatín||21849||21849|29780|
029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|ţpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|607|1738|lyfalmen|||00|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||607||607|1738|
029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|248|1247|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||248|1247|
029307|A07EA0603|Entocort enema (D.A.C.)|endaţ.dr|0,02|mg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.01.2007||R|A||0|0|B|0|DAC|0|0|0|100|SEK|7574|11118|lyfalmen|V0385|11118|56|7|0|7,0000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||7464||7464|11118|
029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|ţpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|7633|9250|lyfalmen|V0109|2229|00|98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6099||6099|9250|
029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|A||0|1|0|1|EIS|0|0|0|100|SEK|63740|81876|lyfsjukr|||00|2|0||Vistor hf|Eisai Ltd|Eribulin||63740||63740|81876|
029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|A|2|0|1|0|1|AGP|0|0|0|100|XEU|22744|30426|lyfsjukr|||00|50|0|0,0000|Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||22744||22744|30426|
029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|K|3|0|1|0|1|AGP|0|0|0|100|XEU|5881|8488|lyfsjukr|||00|5|0|0,0000|Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||5881||5881|8488|
029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|A|3|0|1|0|1|AGT|0|0|0|100|XEU|4517|6519|lyfsjukr|||00|5|0|0,0000|Actavis Group hf|Actavis Group hf|Írinótekan||4517||4517|6519|
029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5036|7796|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5036|7796|
029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|15816|22208|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||15816|22208|
029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5036|7796|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5036|7796|
029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|15816|22208|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||15816|22208|
029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|A||0|0|0|0|GAN|0|0|1|100|SEK|6407|9672|lyfalmen|||00|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||6407||6407|9672|
029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|101321|129040|lyfsjukr|||00|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||101321||101321|129040|
029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|202642|256198|lyfsjukr|||00|1|0|16,6600|Vistor hf|Amgen Europe B.V.|||202642||202642|256198|
029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
030313|G04CA0206|Tamsulosin Portfarma|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.05.2011||R|A||0|0|E|0|POF|0|0|0|100|SEK|4766|4212|lyfalmen|V0148|4208|00|90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||2416||2416|4212|
030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|22485|30578|lyfalmen|V0255|30578|00|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||22485||22485|30578|
030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||00|60|0|25,0000|Icepharma hf|Laboratories Expansvience|Glúkósamín||||||
030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|9326|13665|lyfalmen|V0277|13663|00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||9326||9326|13665|
030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|2975|4977|lyfalmen|V0276|4976|00|100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||2975||2975|4977|
030754|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|770|l|1|hylki|kćlt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
030765|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|11000|l|1|hylki|kćlt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|K||0|0|0|0|LHS|0|0|0|100|XEU|16280|28400|vetorma|||00|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||16280|28400|
030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|974|2240|lyfalmen|V0051|2240|00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||974||974|2240|
031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|1420|2850|lyfalmen|||00|100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||1420||1420|2850|
031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|3|0|0|0|0|NHE|0|0|1|100|DKK|1245|2610|lyfalmen|||23|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S-A|Skópólamín||1245||1245|2610|
031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3184|5263|lyfalmen|||17|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3184||3184|5263|
031314|L01AX0301|Temodal|hylki|20|mg|20|sk-pokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|66234|85006|lyfsjukr|||00|20|0||Vistor hf|Schering-Plough|Temozolomid||66234||66234|85006|
031325|L01AX0301|Temodal|hylki|100|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|80696|103156|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||80696||80696|103156|
031348|L01AX0301|Temodal|hylki|140|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010|30.09.2011|R|A||0|1|0|1|SCP|0|0|0|100|DKK|116292|147829|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||116292||116292|147829|
031371|L01AX0301|Temodal|hylki|180|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010|30.09.2011|R|A||0|1|0|1|SCP|0|0|0|100|DKK|148590|188363|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||148590||148590|188363|
031394|L01AX0301|Temodal|hylki|250|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|177911|225161|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||177911||177911|225161|
031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2085|3760|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2085||2085|3760|
031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6002|9118|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín aspart||6002||6002|9118|
031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|23505|31381|lyfsjukr|||00|5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||23505||23505|31381|
031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1989|3628|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1989||1989|3628|
032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|9735|14050|lyfsjukr|||0|4|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||9735|14050|
032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|14230|19741|lyfsjukr|||0|10|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||14230|19741|
032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|49235|63672|lyfsjukr|||0|50|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||49235|63672|
032190|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032202|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032236|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032247|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032258|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032270|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032281|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032304|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|21335|29135|lyfalmen|||00|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21335||21335|29135|
032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|3839|6697|vetorma|||27|50|0|0,0000|Vistor hf|Merial (MSD)|||3839||3839|6697|
032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|14984|26139|vetorma|||27|200|0|0,0000|Vistor hf|Merial (MSD)|||14984||14984|26139|
033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|A||0|1|0|1|FER|0|0|0|100|DKK|21624|29021|lyfsjukr|||00|1|0|29,6300|Vistor hf|Ferring|Degarelix||||21624|29021|
033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|A||0|1|0|1|FER|0|0|0|100|DKK|43128|56008|lyfsjukr|||00|2|0|44,4400|Vistor hf|Ferring|Degarelix||||43128|56008|
033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||L|A||0|0|0|0|NOB|1|0|0|100|XEU|1238|2160|vetorma|||16|7|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||||1238|2160|
033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|A||0|0|0|0|LHS|0|0|0|100|XEU|9265|17963|vetalmen|||27|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||9265|17963|
033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1201|2550|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Dexametasón||1201||1201|2550|
033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|A||0|0|*|0|WIH|0|0|0|100|XEU|47136|60437|lyfalmen|V0185|58695|00|100|0|100,0000|Portfarma ehf|Williams & Halls|Letrózól||46277||46277|60437|
033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|80006|102290|lyfsjukr|||43|60|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||80006||80006|102290|
033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|104355|132848|lyfsjukr|||43|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||104355||104355|132848|
034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2509|4990|vetalmen|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||2509|4990|
034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|755|1940|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||755||755|1940|
034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|23020|30773|lyfsjukr|||00|25|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||23020||23020|30773|
034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8223|12156|lyfalmen|||0|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8223|12156|
034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8223|12156|lyfalmen|||0|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8223|12156|
034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006|31.10.2011|R|K|2|0|0|0|0|CHE|0|0|1|100|SEK|2377|4159|lyfalmen|||00|300|0|10,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||2377||2377|4159|
034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1854|3444|lyfalmen|V0367|2628|00|6|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1854||1854|3444|
034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3179|5256|lyfalmen|V0367|5256|00|12|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3179||3179|5256|
034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|172189|217980|lyfsjukr|||00|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||172189||172189|217980|
035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|7553|10901|lyfsjukr|||02|25|0|0,0000|Vistor hf|LEO Pharma A/S|Prótamín||7553||7553|10901|
035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|2294|3311|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||2294||2294|3311|
035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|16190|22678|lyfalmen|||10|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16190||16190|22678|
035222|N06DA0403|Reminyl (D.A.C.)|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|SEK|13116|18820|lyfalmen|||00|28|0|14,0000|D.A.C. ehf|D.A.C. ehf|Galantamín||13116||13116|18820|31.10.2011
035234|M01AB5502|Arthrotec (D.A.C.)|töflur|50,2|mg|100|stk|1|ţpakki|0,2+50 mg|M01AB55|01.05.2009|31.10.2011|R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|3938|6294|lyfalmen|||0|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Díklófenaknatríum í blöndum||3938||3938|6294|
035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3538|5747|lyfalmen|V0079|5747|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3538|5747|
035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3253|lyfalmen|V0244|3253|00|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1715||1715|3253|
035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PER|0|0|0|100|DKK|121830|154779|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Pfizer ApS|Pegaptaníb||121830||121830|154779|
035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|10146|14787|lyfalmen|||00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10146||10146|14787|
036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|A||0|0|0|0|GZE|0|0|0|100|XEU|30928|37438|lyfalmen|||00|180|0||Vistor hf|Genzyme Europe B.V.|Sevelamer||27951||27951|37438|
036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|141185|179070|lyfsjukr|||00|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||141185||141185|179070|
036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|5899|8977|lyfalmen|||00|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||5899||5899|8977|
036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|2876|4842|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||2876|4842|30.11.2011
036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|8432|12442|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8432||8432|12442|
036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|A||0|1|0|1|ABL|0|0|0|100|DKK|6147|8872|lyfsjukr|||00|30|0|2,5000|Vistor hf|Abbott Laboratories A/S|Ritonavír||6147||6147|8872|
036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|199363|252083|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer Limited|Sunitíníb||199363||199363|252083|
036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|397647|500929|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer Limited|Sunitíníb||397647||397647|500929|
036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|793622|997878|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer Limited|Sunitíníb||793622||793622|997878|
036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|807|2011|lyfalmen|||00|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||807||807|2011|
036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1419|2848|lyfalmen|||08|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1419||1419|2848|
036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|GSC|0|0|0|100|IKR|||lyflausa|||00|30|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Silíkonsambönd||||||
036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2800|4738|lyfalmen|||08|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2800||2800|4738|
036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|849|2069|lyfalmen|||00|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||849||849|2069|
037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|11823|17081|lyfalmen|||00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||11823||11823|17081|
037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|21704|29598|lyfalmen|||00|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||21704||21704|29598|
037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|42446|55629|lyfalmen|||00|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||42446||42446|55629|
037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2546|4390|lyfalmen|V0434|4390|00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2546||2546|4390|
037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1164|2500|lyfalmen|||0|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1164||1164|2500|
037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2196|
037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3612|
037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|8308|12272|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8308|12272|
038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1427|lyfalmen|||00|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1427|
038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|ţpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2303|lyfalmen|V0321|1753|00|60|0|60,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1020||1020|2303|
038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3084|lyfalmen|V0321|2921|00|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3084|
038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1054|2349|lyfalmen|||00|50|0|50,0000|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1054||1054|2349|
038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|2551|4397|lyfalmen|||00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2551||2551|4397|
038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|176862|223844|lyfsjukr|||00|1|0|0,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||176862||176862|223844|
038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|K||0|1|0|1|WTE|0|0|0|100|DKK|76443|97818|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||76443||76443|97818|
038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|ţpakki||N07CA01|01.12.1982|30.09.2011|R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|2513|4345|lyfalmen|||00|100|0|33,3333|Medico ehf|Solvay Duphar |Betahistín||2513||2513|4345|
039005|L01XA0301|Eloxatin|irţ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|41067|53422|lyfsjukr|||00|10|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||41067||41067|53422|
039014|L01XA0301|Eloxatin|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|68650|88038|lyfsjukr|||00|20|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||68650||68650|88038|
039575|D01AE1503|Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|A|5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||||||
039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|A||0|0|0|0|SAA|0|0|0|100|NOK|4568|7156|lyfalmen|||00|20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||4568|7156|
039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|A||0|0|0|0|SAA|0|0|0|100|NOK|22384|30451|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||22384|30451|
039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|glas||N06AX03|01.06.2010||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|3276|5389|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||3276||3276|5389|
039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|566|1682|lyfalmen|||00|98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||566||566|1682|
039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|637|1779|lyfalmen|||00|98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||637||637|1779|
039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1306|2694|lyfalmen|||00|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1306||1306|2694|
039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1883|3483|lyfalmen|||00|22|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1883||1883|3483|
039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|472|681|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||472||472|681|
039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1630|2977|lyfalmen|V0110|2959|00|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||1513||1513|2977|
039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|8272|9880|lyfalmen|V0182|9880|00|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||6559||6559|9880|
039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|643|928|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||643||643|928|
039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|1792|2539|lyfalmen|V0033|2539|00|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||1193||1193|2539|
040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1311|1892|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1311||1311|1892|
040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|SAL|0|0|0|100|IKR|||lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1652|
040822|C10AA0504|Atorvastatin Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|4539|2456|lyfalmen|V0112|2456|00|100|0|50,0000|Portfarma ehf|Portfarma|Atorvastatín||1132||1132|2456|
041423|G03AA1203|Yasminelle|töflur|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BYP|0|0|0|100|SEK|3276|5389|lyfalmen|||00|63|0|0,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3276||3276|5389|
041704|QI09AX0001|Improvac|stl|300|mcg|20|ml|12|fl||QI09AX00|01.08.2010||R|K||0|0|0|0|IPF|1|0|0|100|DKK|28303|49373|vetorma|||00|240|0||Icepharma hf|Pfizer Limited|GnRF hliđstćđa samtengd próteini||||28303|49373|
041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4432|7731|vetorma|||AA|100|0|0,0000|Icepharma hf|Intervet International B.V.|||4432||4432|7731|
041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,0000|D.A.C. ehf|D.A.C. ehf|Díklófenak||||||
041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006|30.11.2011|R|A|3|0|0|0|0|TMC|0|0|0|100|SEK|199819|253132|lyfalmen|||02|100|0|0,0000|TMC Pharma Services Ltd|TMC Pharma Services Ltd|Gadófosveset||199819||199819|253132|
041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|A||0|0|B|0|MYL|0|1|0|100|SEK|1172|2511|lyfalmen|||00|90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1172|2511|
041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum||||||
042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1507|2969|lyfalmen|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1507||1507|2969|
042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|12680|17796|lyfsjukr|||00|500|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||12680||12680|17796|
042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2559|3693|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2559||2559|3693|
042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3094|4465|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3094||3094|4465|
042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4380|6321|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4380||4380|6321|
042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4489|6479|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4489||4489|6479|
042357|N07BA0141|Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín||||||
042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5718|8253|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||5718||5718|8253|
042368|A06AB0602|Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|2216|3939|lyfalmen|||00|500|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2216|3939|
042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7057|10185|lyfsjukr|||00|4000|0|4,0000|Icepharma hf|Fresenius Kabi|Kolvetni||7057||7057|10185|
042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3824|5519|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3824||3824|5519|
042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2927|4224|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2927||2927|4224|
042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2237|3229|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2237||2237|3229|
042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2800|4041|lyfsjukr|||02|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2800||2800|4041|
042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3675|5304|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||3675||3675|5304|
042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2510|3623|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2510||2510|3623|
042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|1808|2609|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||1808||1808|2609|
042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6136|8856|lyfsjukr|||00|4000|0|4,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||6136||6136|8856|
042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2048|2956|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2048||2048|2956|
042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dćla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|779|1973|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||779||779|1973|
042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2899|4184|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2899||2899|4184|
042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dćlur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|14891|21048|lyfalmen|||02|10|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||14891||14891|21048|
042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|1353|2691|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1353||1353|2691|
042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|2016|4010|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2016||2016|4010|
042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|2703|5363|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2703||2703|5363|
042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|5408|10557|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5408||5408|10557|
042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|6218|12112|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||6218||6218|12112|
042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2441|3523|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2441||2441|3523|
042669|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MYL|0|0|0|100|SEK|383|1431|lyfalmen|||00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||383||383|1431|30.09.2011
043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3141|4533|lyfsjukr|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||3141||3141|4533|
043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|4770|5754|lyfalmen|||24|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3543||3543|5754|
043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|5807|8381|lyfsjukr|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||5807||5807|8381|
043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|568|1684|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||568||568|1684|
043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1236|2598|lyfalmen|||10|30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1236||1236|2598|
043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
043935|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|100,0000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat||||||
044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|CHF|12904|18236|lyfalmen|V0034|18236|00|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíđ (sykurflétta)||12651||12651|18236|
044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|384161|484005|lyfsjukr|||00|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||384161|484005|
044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|542119|682242|lyfsjukr|||00|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||542119|682242|
044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|23329|31637|lyfalmen|||00|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||23329||23329|31637|
044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|89110|114192|lyfalmen|||00|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||89110||89110|114192|
044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|2700|4601|lyfalmen|||00|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2700||2700|4601|
045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dćlur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|7444|11090|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||7444||7444|11090|
045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1050|2229|lyfalmen|V0109|2229|00|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||966||966|2229|
045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|868|2024|lyfalmen|V0108|2024|00|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||816||816|2024|
045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|2875|4149|lyfsjukr|||00|10|0|0,2500|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||2875||2875|4149|
045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|5749|8297|lyfsjukr|||00|10|0|0,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||5749||5749|8297|
045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|A||0|0|0|0|AGT|0|0|1|100|XEU|379|1426|lyfalmen|||04|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||379||379|1426|
046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|21320|41110|vetalmen|||27|10|0|0,0000|Icepharma hf|Pfizer vet.|||21320||21320|41110|
046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|1036|2325|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1036||1036|2325|
046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|3964|6330|lyfalmen|V0382|6330|02|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||3964||3964|6330|
046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|XEU|682|1840|lyfalmen|V0021|1840|00|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||682||682|1840|
046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|XEU|1121|2441|lyfalmen|V0022|2441|00|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1121||1121|2441|
046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|XEU|1409|2835|lyfalmen|V0023|2835|00|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1409||1409|2835|
046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|6602|9939|lyfalmen|V0383|9939|02|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6602||6602|9939|
046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|10746|15607|lyfalmen|||00|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||10746||10746|15607|31.10.2011
046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|A||0|0|*|0|POF|0|1|0|100|XEU|3389|4184|lyfalmen|V0279|3909|00|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||2395||2395|4184|
047042|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|74101|94879|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||74101||74101|94879|
047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1005|2282|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1005||1005|2282|
047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||00|10|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684|
047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||00|50|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564|
047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|148183|187852|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||148183||148183|187852|
047941|N03AX2101|Trobalt|filmhtfl|300|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|24932|33649|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||24932||24932|33649|
047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|12706|13880|lyfalmen|V0420|13880|00|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||9483||9483|13880|
047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|24061|27862|lyfalmen|V0421|27862|00|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||20321||20321|27862|
048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5219|7532|lyfsjukr|||02|250|0|0,0000|Icepharma hf|Baxter Medical AB|Albúmín||5219||5219|7532|
048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|8821|12731|lyfsjukr|||00|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8821||8821|12731|
048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8238|11889|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Baxter Medical AB|Albúmín||8238||8238|11889|
048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|2722|4631|lyfalmen|V0324|4631|00|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2722||2722|4631|
048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|2528|3556|lyfalmen|V0035|3556|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1936||1936|3556|
048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|7846|7378|lyfalmen|V0325|7378|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4730||4730|7378|
048133|N06AB1004|Esopram|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|2983|4056|lyfalmen|V0175|4056|00|28|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2302||2302|4056|
048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|7708|7378|lyfalmen|V0326|7378|00|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4730||4730|7378|
048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|3954|4426|lyfalmen|V0246|4426|00|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2572||2572|4426|
048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|15415|7378|lyfalmen|V0327|7378|00|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4730||4730|7378|
048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|MAB|0|0|0|100|DKK|1180|2522|lyfalmen|||00|100|0|0,0000|Vistor hf|Meda AB|Klídín og geđlyf||1180||1180|2522|
048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|14024|19960|lyfalmen|||00|98|0|196,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||14024||14024|19960|
048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|4071|6476|lyfalmen|||00|100|0|66,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||4071||4071|6476|
048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1810|3383|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1810||1810|3383|
048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|62188|76985|lyfalmen|V0187|58944|00|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||59463||59463|76985|
048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|A||0|1|0|1|GZE|0|0|0|100|XEU|995020|1250633|lyfsjukr|||00|1|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||995020||995020|1250633|
048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GSH|0|0|1|100|DKK|486|1572|lyfalmen|V0230|1481|00|100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||486||486|1572|
049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|2465|4279|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2465||2465|4279|
049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|17492|24312|lyfalmen|||00|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||17492||17492|24312|
049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2418|4215|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2418||2418|4215|
049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||23|60|0|60,0000|Vistor hf|McNeil Sweden AB|Ketókónazól||||||
049524|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007|30.09.2011|R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3377|5527|lyfalmen|||00|2|0|0,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3377||3377|5527|
049533|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007|30.09.2011|R|A|3|0|0|*|0|ALC|0|0|0|100|USD|9938|14502|lyfalmen|||00|8|0|0,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||9938||9938|14502|
049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|6587|9918|lyfalmen|||23|5|0|5,0000|Icepharma hf|Galderma Nordic AB|Amorolfín||6587||6587|9918|
049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1059|2024|lyfalmen|V0108|2024|00|98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||816||816|2024|
049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2229|lyfalmen|V0109|2229|00|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||966||966|2229|
049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1827|3019|lyfalmen|V0110|3019|00|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1544||1544|3019|
049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4928|lyfalmen|V0123|4446|00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4928|
049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|1205|2556|lyfalmen|V0496|2541|00|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1205||1205|2556|
049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|1589|3081|lyfalmen|||00|30|0|30,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||1589||1589|3081|
049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|2483|3717|lyfalmen|||00|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||2054||2054|3717|
049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól||||||
049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól||||||
049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|62188|80405|lyfalmen|V0470|70854|00|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||62188||62188|80405|
050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BAP|0|0|0|100|SEK|558846|703234|lyfsjukr|||00|112|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||558846||558846|703234|
050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|72408|92755|lyfsjukr|||00|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||72408|92755|
050483|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|7584|10134|lyfalmen|V0012|9090|00|56|0|74,6700|Portfarma ehf|Portfarma|Esómeprazól||6745||6745|10134|
050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||00|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||||
050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3340|5476|lyfalmen|||00|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3340||3340|5476|
050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|13083|18779|lyfalmen|||00|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||13083||13083|18779|
050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|5553|5122|lyfalmen|V0042|4619|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3081||3081|5122|
050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|4937|7629|lyfalmen|V0002|7629|00|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4914||4914|7629|
050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|A||0|0|E|0|AGT|0|0|0|100|IKR|4744|7230|lyfalmen|V0006|7230|00|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4622||4622|7230|
050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|A||0|0|E|0|AGT|0|0|0|100|IKR|11336|8129|lyfalmen|||00|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||5279||5279|8129|
051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.07.1994|31.10.2011|L|A|2|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír||||||
051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1716|3255|lyfalmen|||10|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1716||1716|3255|
051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|60|0|0,0000|D.A.C. ehf|D.A.C. ehf|Ketóprófen||||||
051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|A||0|0|B|0|DAC|0|0|0|100|DKK|6956|10423|lyfalmen|||00|60|0||D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||6956||6956|10423|
051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1773|3333|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1773||1773|3333|
051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1406|2701|lyfalmen|V0363|2697|00|30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1311||1311|2701|
051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3824|5914|lyfalmen|V0365|5903|00|100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3660||3660|5914|
051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|0|0|1|UCB|0|0|0|100|DKK|30608|40296|lyfsjukr|||00|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||30608||30608|40296|
051686|N05AE0402|Zeldox (DAC)|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2011||R|A|4|0|0|*|0|DAC|0|1|0|100|DKK|27314|36638|lyfalmen|V0455|36638|00|56|0|56,0000|D.A.C. ehf|D.A.C. ehf|Ziprasidon||27314||27314|36638|
051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|1642|2532|lyfalmen|V0056|2532|00|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||1188||1188|2532|
051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|2779|3480|lyfalmen|V0057|3480|00|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||1881||1881|3480|
052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|211|1196|lyfalmen|V0047|1196|00|20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||211||211|1196|
052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|497|1587|lyfalmen|V0305|949|00|50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||497||497|1587|
052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|346370|436577|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||346370||346370|436577|
052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|A||0|0|0|0|MYL|0|0|1|100|SEK|352|1389|lyfalmen|V0439|1389|00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||352|1389|
052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|1129|2452|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1129||1129|2452|
052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|724|1898|lyfalmen|V0305|1898|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||724||724|1898|
052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|723567|909959|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||723567||723567|909959|
052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|641309|806725|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||641309||641309|806725|
052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|3721|5998|lyfalmen|V0375|5218|00|3|0||Vistor hf|Allergan|Tímólól í blöndum||3721||3721|5998|
052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|10780|15654|lyfalmen|V0375|15654|00|9|0||Vistor hf|Allergan|Tímólól í blöndum||10780||10780|15654|
052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|D.A.C. ehf|D.A.C. ehf|Acíklóvír||||||
052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|37460|48895|lyfsjukr|||00|8212|0|8,2000|Icepharma hf|Fresenius Kabi|Blöndur||37460||37460|48895|
052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|30453|40101|lyfsjukr|||00|7698|0|7,7100|Icepharma hf|Fresenius Kabi|Blöndur||30453||30453|40101|
052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995|31.10.2011|R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|45646|59168|lyfsjukr|||63|10|0|8,3333|Actavis Group hf|Pharmachemie|Kalsíumfólínat||45646||45646|59168|
052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|32148|42228|lyfsjukr|||00|7680|0|7,6800|Icepharma hf|Fresenius Kabi|Blöndur||32148||32148|42228|
052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26897|35638|lyfsjukr|||00|7200|0|7,2000|Icepharma hf|Fresenius Kabi|Blöndur||26897||26897|35638|
052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36172|47278|lyfsjukr|||00|7880|0|7,9000|Icepharma hf|Fresenius Kabi|Blöndur||36172||36172|47278|
052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33588|44035|lyfsjukr|||00|7616|0|7,6000|Icepharma hf|Fresenius Kabi|Blöndur||33588||33588|44035|
053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2334|4100|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2334||2334|4100|30.11.2011
053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|2209|3929|lyfalmen|||23|63|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2209||2209|3929|
053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|62984|80927|lyfsjukr|||00|120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||62984||62984|80927|
053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5524|8464|lyfalmen|||10|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||5524||5524|8464|
053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|5972|9077|lyfalmen|||02|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir  mótefnavakar||5972||5972|9077|
053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|38980|51279|lyfalmen|V0453|43671|00|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||38980||38980|51279|
053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|32719|43422|lyfalmen|V0454|39351|00|100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||32719||32719|43422|
053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|ţpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|626|1764|lyfalmen|V0060|1676|00|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||626||626|1764|
053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|15260|21511|lyfalmen|||00|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||15260||15260|21511|
053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|A||0|0|0|0|OTS|0|1|0|100|DKK|1567|3051|lyfalmen|||00|1|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1567||1567|3051|
053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PER|0|0|0|100|DKK|1168|2505|lyfalmen|||20|30|0|30,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1168||1168|2505|
054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|A||0|0|B|0|AGP|0|0|0|100|XEU|7902|11717|lyfalmen|V0490|11717|63|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||7902||7902|11717|
054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2639|4517|lyfalmen|||02|0|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2639||2639|4517|
054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||||
054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|65386|83942|lyfsjukr|||00|56|0|22,4000|Icepharma hf|Roche Registration Limited|Ribavirin||65386||65386|83942|
054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCN|0|0|1|100|SEK|1079|2383|lyfalmen|||00|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1079||1079|2383|
054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|A|3|0|0|0|0|ACA|0|1|0|100|XEU|1720|3260|lyfalmen|V0061|3260|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1720||1720|3260|
054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|A||1|0|0|0|REB|0|0|0|100|DKK|4858|9501|vetalmen|||27|10|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Buprenorphinhýdróklóríđ||||4858|9501|
054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|7867|13724|vetorma|||16|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7867||7867|13724|
055164|S01AX2201|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AX22|01.08.2010||R|A||0|0|0|0|ALA|0|0|1|100|USD|1662|3181|lyfalmen|||00|5|0||Vistor hf|Alcon Laboratories Ltd.|Moxífloxasín hýdróklóríđ||||1662|3181|
055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|770|1961|lyfalmen|||10|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||770||770|1961|
055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|9425|13800|lyfalmen|||10|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9425||9425|13800|
055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|4350|6858|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Pýrazínamíđ||4350||4350|6858|
055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|2208|3775|lyfalmen|V0467|3775|00|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2096||2096|3775|
055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4539|2456|lyfalmen|V0112|2456|00|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1132||1132|2456|
056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|6185|3174|lyfalmen|V0113|3174|00|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1657||1657|3174|
056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|5976|lyfalmen|V0114|5976|00|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||3705||3705|5976|
056183|B01AC2401|Brilique|filmhtfl|90|mg|100|stk|1|ţpakki||B01AC24|01.06.2011||R|A||0|0|E|0|AZA|0|0|0|100|SEK|18080|25050|lyfalmen|V0459|24095|00|100|0|50,0000|Vistor hf|AstraZeneca AB|Ticagrelor||18080||18080|25050|
056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|A|5|0|0|0|0|CES|1|0|0|100|XEU|27565|48086|vetorma|||00|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||27565||27565|48086|
056514|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.11.2009|30.11.2011|R|K||0|1|0|1|SOI|0|0|0|100|DKK|86538|110488|lyfsjukr|||00|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||86538||86538|110488|
056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1254|2623|lyfalmen|||10|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1254||1254|2623|
056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til skömmtunar|N06AX16|01.10.2011||R|A||0|0|B|0|AGP|0|0|0|100|XEU|3800|6106|lyfalmen|||00|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3800|6106|
056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|til skömmtunar|N06AX16|01.10.2011||R|A||0|0|B|0|AGP|0|0|0|100|XEU|3800|6106|lyfalmen|||00|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3800|6106|
056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|237751|300260|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||237751||237751|300260|
056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|59346|76362|lyfsjukr|||00|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||59346||59346|76362|
057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3538|5747|lyfalmen|V0094|5747|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||3538|5747|
057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|11256|16305|lyfalmen|||00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||11256|16305|
057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|12017|16964|lyfsjukr|||02|5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||12017||12017|16964|
057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|6909|9971|lyfsjukr|||02|5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||6909||6909|9971|
057367|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl|lausn|J06BA02|01.10.2011||R|K||0|0|0|1|BAA|0|0|0|100|SEK|240347|303518|lyfsjukr|||00|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||240347||240347|303518|
057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|A||0|0|E|0|POF|0|0|0|100|SEK|23005|31231|lyfalmen|V0350|31231|00|84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||23005||23005|31231|
057422|B05XA3102|Tracel|irţ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4999|7215|lyfsjukr|||00|200|0|0,2000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||4999||4999|7215|
057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|3810|5499|lyfsjukr|||02|5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||3810||3810|5499|
057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|A||0|1|0|1|JAS|0|0|0|100|SEK|538872|678167|lyfsjukr|||00|120|0||Vistor hf|Janssen-Cilag AB|Abírateron||538872||538872|678167|
057703|J01DD0401|Rocephalin|irţ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|25328|33669|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||25328||25328|33669|
058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|IPI|0|0|1|100|DKK|20618|28235|lyfalmen|||0|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||20618|28235|
058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|436|1504|lyfalmen|||02|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||436||436|1504|
058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|A||0|1|0|1|GGL|0|0|0|100|GBP|125906|159895|lyfsjukr|||00|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||125906||125906|159895|
058283|QI01AD040|Avipro Thymovac|frţlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|165608|288895|vetorma|||00|5000|0|0,0000|Icepharma hf|Lohmann Animal Health|||||165608|288895|
058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|251575|438860|vetorma|||00|10000|0|0,0000|Icepharma hf|Lohmann Animal Health|||||251575|438860|
058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|17783|24677|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||17783||17783|24677|
058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1014|2294|lyfalmen|||00|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1014||1014|2294|
058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|102530|130558|lyfsjukr|||00|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||102530||102530|130558|
058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1248|2615|lyfalmen|||43|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1248||1248|2615|
058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2326|4089|lyfalmen|||43|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2326||2326|4089|
058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dćla|einnota dćla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4225|6687|lyfalmen|||51|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4225||4225|6687|
059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|A||0|0|E|0|AGT|0|0|0|100|IKR|2540|4382|lyfalmen|V0006|4049|0|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2540||2540|4382|
059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1493|2950|lyfalmen|||00|250|0|20,8300|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1493||1493|2950|
059295|S01AA0104|Kloramfenikol - Lyfjaver|augnsm|1|%|5|g|1|túpa||S01AA01|01.08.2011||R|A||0|0|E|0|LVR|0|0|1|100|IKR|2207|3926|lyfalmen|||07|5|1||Lyfjaver ehf|Lyfjaver ehf|Klóramfeníkól||2207||2207|3926|
059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|101352|129556|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||101352||101352|129556|
059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|32257|42842|lyfalmen|||51|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||32257||32257|42842|
059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|92594|118088|lyfsjukr|||00|30|0|0,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||92594||92594|118088|
059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|A||0|0|E|0|BPC|0|0|0|100|SEK|40203|46233|lyfalmen|||00|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||34959||34959|46233|
059870|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.11.2010||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|56207|72899|lyfalmen|||00|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||56207||56207|72899|
060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|385101|485661|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||385101||385101|485661|
060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|192567|244031|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||192567||192567|244031|
060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|96288|123201|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||96288||96288|123201|
060848|N06AA0402|Anafranil Retard|forđatfl|75|mg|100|stk|1|ţpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|5762|8789|lyfalmen|||10|100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||5762||5762|8789|
060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1969|
061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|2808|5564|vetalmen|||0|4|0|0,0000|Icepharma hf|Pfizer Animal Health|||||2808|5564|
061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1471|2926|vetalmen|||0|4|0|0,0000|Icepharma hf|Pfizer Animal Health|||||1471|2926|
061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|8691|16861|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Animal Health|||||8691|16861|
061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|A||0|0|E|0|DAC|0|0|0|100|DKK|7138|10672|lyfalmen|V0133|10672|00|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||7138||7138|10672|
061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||23|50|0|0,0000|Icepharma hf|Pfizer ApS|Píroxíkam||||||
061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|7139|10673|lyfalmen|V0133|10672|00|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7139||7139|10673|
061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|1739|3034|vetorma|||16|26|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||1739|3034|
061715|L01XE0901|Torisel|irţ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|DKK|163402|206952|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Wyeth Europe|Temsirolímus||163402||163402|206952|
061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|4536|6547|lyfsjukr|||00|10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||4536||4536|6547|
061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|16198|22211|lyfsjukr|||00|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||16198||16198|22211|
061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|22805|30503|lyfsjukr|||00|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||22805||22805|30503|
062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|469|1549|lyfalmen|||10|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||469||469|1549|
062265|M01AB0505|Voltaren|eţ-stíll|50|mg|10|stk|1|pakki||M01AB05|01.11.2010||R|A||0|0|E|0|NOH|0|0|1|100|DKK|365|1407|lyfalmen|||04|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||365||365|1407|
062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|A||0|1|*|0|AGP|0|0|0|100|XEU|60878|61816|lyfalmen|V0187|58944|00|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||47376||47376|61816|
062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|1685|3212|lyfalmen|||00|10|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||1685||1685|3212|
062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|6799|9813|lyfsjukr|||02|20|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||6799||6799|9813|
062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|464|670|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||464||464|670|
062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0||Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|946|2201|lyfalmen|||10|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||946||946|2201|
062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|1887|3489|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1887||1887|3489|
062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|18394|32087|vetorma|||16|1000|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||18394||18394|32087|
062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|39707|51715|lyfsjukr|||00|2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||39707||39707|51715|
062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|48480|62725|lyfsjukr|||00|2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||48480||48480|62725|
062935|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.11.1998|30.09.2011|R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1833|3415|lyfalmen|||23|63|0|63,0000|Icepharma hf|Pfizer ApS|Gestóden og östrógen||1833||1833|3415|
062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|15991|22428|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||15991||15991|22428|
063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|4301|6791|lyfalmen|||00|10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||4301||4301|6791|
063340|D05AX0202|Daivonex (D.A.C.)|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.12.2009||R|A||0|0|B|0|DAC|0|0|0|100|DKK|5384|8272|lyfalmen|||00|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Kalcípótríól||5384||5384|8272|31.10.2011
063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2918|
063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|XEU|2589|4449|lyfalmen|V0123|4446|00|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||2589||2589|4449|
063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|1648|3162|lyfalmen|V0366|3162|00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||1648||1648|3162|
063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|4615|7220|lyfalmen|V0458|7220|00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||4615||4615|7220|
063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|7949|11472|lyfsjukr|||17|2|0|0,0000|Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7949||7949|11472|
063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2588|4515|vetorma|||16|12|0|0,0000|Vistor hf|Fort Dodge Veterinär GmbH|||2588||2588|4515|
063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|994|2267|lyfalmen|||10|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||994||994|2267|
063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|2082|3755|lyfalmen|||10|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2082||2082|3755|
064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|1107417|1391691|lyfsjukr|||00|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1107417|1391691|
064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|442967|557806|lyfsjukr|||00|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||442967|557806|
064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|2186|3898|lyfalmen|||10|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2186||2186|3898|
064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|4429671|5561120|lyfsjukr|||00|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4429671|5561120|
064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|2214836|2781502|lyfsjukr|||00|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2214836|2781502|
064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|840|2056|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir  mótefnavakar||840||840|2056|
064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|A||0|0|0|1|OCT|0|0|0|100|DKK|59795|76925|lyfsjukr|||00|1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||59795||59795|76925|
065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|1994|3635|lyfalmen|||38|25|0|0,0000|Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1994||1994|3635|
065314|G01AF0201|Canesten|sk-stíll|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||25|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól||||||
065332|G01AF0201|Canesten|sk-stíll|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól||||||
065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|15323|21113|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||15323||15323|21113|
065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PER|0|0|0|100|DKK|2557|3713|lyfalmen|V0376|2153|06|2|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2051||2051|3713|
065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.06.2011||R|A||0|1|*|0|LVR|0|0|0|100|SEK|60010|77194|lyfalmen|V0451|77194|00|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||59629||59629|77194|
065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|K|3|0|0|*|0|PER|0|0|0|100|DKK|7665|10933|lyfalmen|V0376|6460|06|8|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||7329||7329|10933|
065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|101|IKR|||lyflausa|||23|14|0|17,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|8,5000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065778|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.12.2009||R|K||0|1|0|1|WTE|0|0|0|100|DKK|148183|187852|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||148183||148183|187852|
065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|4752|6858|lyfsjukr|||02|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4752||4752|6858|
065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|ţpakki||C09CA01|01.03.1999|30.09.2011|R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|1972|3605|lyfalmen|||00|28|0|7,0000|Vistor hf|M.S.D.|Lósartan||1972||1972|3605|
066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|A||0|0|0|0|DOR|1|0|0|100|DKK|4172|8183|vetalmen|||00|100|0||Icepharma hf|Dopharma Reserch B.V|||4172||4172|8183|
066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6825|10244|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||6825||6825|10244|
066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|33622|44078|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||33622||33622|44078|
066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|A||0|0|0|0|GOG|0|0|1|100|DKK|865|2091|lyfalmen|||23|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||865||865|2091|
066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr|||02|120|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603|
066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|1516|2981|lyfalmen|V0036|2981|70|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1516||1516|2981|
066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||||
066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|A||0|1|0|1|AGP|0|0|0|100|XEU|15608|21471|lyfsjukr|||00|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||15608||15608|21471|
067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|8822|12732|lyfsjukr|||00|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8822||8822|12732|
067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|ţpakki||N07CA01|01.04.1993|30.09.2011|R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7524|11200|lyfalmen|||00|84|0|56,0000|Medico ehf|Solvay Duphar |Betahistín||7524||7524|11200|
067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCN|0|0|0|100|SEK|1439|2876|lyfalmen|||00|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1439||1439|2876|
067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|K||0|0|*|0|APC|0|0|0|100|DKK|1894|2516|lyfalmen|V0376|2153|06|2|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1176||1176|2516|
067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1567|2771|lyfalmen|V0179|1807|10|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||1362||1362|2771|
067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|5748|7744|lyfalmen|V0179|7744|10|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||4998||4998|7744|
067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|664|1697|lyfalmen|V0180|839|10|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1697|
067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|612|1678|lyfalmen|V0180|1678|10|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1678|
067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2031|3686|lyfalmen|V0180|3356|10|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||2031||2031|3686|
067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|14199|17855|lyfalmen|V0419|17855|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||12347||12347|17855|
068043|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|2|glas|sk-úđari|R01AA07|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|20|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||||
068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|6227|12129|vetalmen|||27|50|0|0,0000|Icepharma hf|Vétoquinol AG|||6227||6227|12129|
068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|A||0|1|0|1|GTS|0|0|0|100|GBP|76805|98273|lyfsjukr|||00|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||76805||76805|98273|
068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|1762|3318|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1762||1762|3318|
068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|5834|8888|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||5834||5834|8888|
068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|2565|3702|lyfsjukr|||00|400|0|0,4000|Actavis Group hf|Braun|Natríumklóríđ||2565||2565|3702|
068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|3193|4608|lyfsjukr|||00|400|0|0,4000|Actavis Group hf|Braun|Kalíumklóríđ||3193||3193|4608|
068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
068951|V07AB09|Sterilt Vann B. Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
068960|V07AB09|Sterilt Vann B. Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||||
069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|ţpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3297|lyfalmen|V0123|2223|00|14|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1747||1747|3297|
069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|ţpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|17190|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||11903||11903|17190|
069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|A||0|0|B|0|LYF|0|0|0|100|XEU|438|1407|lyfalmen|V0448|1407|00|100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||365||365|1407|
070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|18166|25158|lyfalmen|||00|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||18166|25158|
070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|26274|35333|lyfalmen|||00|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||26274|35333|
070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|34027|45063|lyfalmen|||00|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||34027|45063|
070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|46428|60150|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||46428||46428|60150|
070359|L01DB0701|Novantrone|irţ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|MEB|0|0|0|100|USD|30586|40268|lyfsjukr|||00|10|0|0,0000|Vistor hf|Meda AB (V)|Mítoxantrón||30586||30586|40268|
070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PAB|1|0|0|100|DKK|8461|16419|vetalmen|||27|100|0|0,0000|Vistor hf|Pharmaxim AB|||8461||8461|16419|
070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|12347|17855|lyfalmen|||00|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||12347||12347|17855|
071076|QA12CE9902|Selevitan, vet.|kyrni|||1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PAB|0|0|0|100|SEK|6204|12085|vetalmen|||16|1250|0|0,0000|Vistor hf|Pharmaxim AB|||6204||6204|12085|
071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|XEU|712|1881|lyfalmen|||00|100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||712||712|1881|
071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|65513|84101|lyfsjukr|||00|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||65513||65513|84101|
071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|327564|412975|lyfsjukr|||00|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||327564||327564|412975|
071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|A||0|0|*|0|ASA|0|1|0|100|SEK|8516|12557|lyfalmen|||00|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||8516|12557|
071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|11090|12085|lyfalmen|V0144|10752|00|12|0|24,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||8171||8171|12085|
071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|A||0|1|0|1|GZE|0|0|0|100|SEK|88255|112643|lyfsjukr|||00|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||88255|112643|
072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|A||0|0|E|0|PSA|0|0|0|100|XEU|3216|3545|lyfalmen|V0009|3545|00|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||1928||1928|3545|
072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|7170|13940|vetalmen|||27|5|0|0,0000|Vistor hf|Orion-Farmos|||7170||7170|13940|
072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|300|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|A||0|0|E|0|PSA|0|0|0|100|XEU|10112|12721|lyfalmen|V0029|12371|00|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||8636||8636|12721|
072520|V01AA1104|Alutard SQ, hrossavćrur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|19512|26847|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||19512||19512|26847|
072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|642|927|lyfsjukr|||02|10|0|0,0000|Vistor hf|Janssen-Cilag AB|Súfentaníl||642||642|927|
072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|151307|191773|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||151307||151307|191773|
072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|16851|23507|lyfalmen|||00|1|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||16851||16851|23507|
072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|16851|23507|lyfalmen|||00|2|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||16851||16851|23507|
073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1063|2361|lyfalmen|||00|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1063||1063|2361|
073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|3207|5294|lyfalmen|V0019|5294|10|100|0|100,0000|Medico ehf|Solvay Pharmaceuticals GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3207||3207|5294|
073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|A||0|0|E|0|GSK|0|0|0|100|GBP|3688|5952|lyfalmen|||00|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||3688||3688|5952|
073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1648|3162|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1648||1648|3162|
073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|A||0|0|*|0|AGP|0|0|0|100|XEU|52189|58695|lyfalmen|V0185|58695|00|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||44889||44889|58695|
073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|A||0|0|B|0|LYF|0|0|0|100|XEU|730|1627|lyfalmen|V0066|1627|0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||526||526|1627|
073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|311|1333|lyfalmen|V0047|1196|00|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||311||311|1333|
073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|766|1955|lyfalmen|V0305|949|00|50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||766||766|1955|
073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|978|2245|lyfalmen|V0305|1898|00|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||978||978|2245|
073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|526|1627|lyfalmen|V0439|1389|00|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||526||526|1627|
073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1430|2864|lyfalmen|||00|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1430||1430|2864|
073935|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA03|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|3796|6622|vetorma|||16|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3796||3796|6622|
073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|A|5|0|0|*|0|AEG|0|0|0|100|GBP|1311|2701|lyfalmen|||10|50|0|8,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||1311||1311|2701|
074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.12.2009||R|A||0|0|0|0|DAC|0|0|0|100|DKK|4738|7389|lyfalmen|V0142|7389|00|4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||4738||4738|7389|
074038|N02AB0304|Durogesic (D.A.C.)|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2009|30.11.2011|R|A||1|0|E|0|DAC|0|0|0|100|SEK|2569|4422|lyfalmen|||00|5|0|3,6000|D.A.C. ehf|D.A.C. ehf|Fentanýl||2569||2569|4422|
074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|3664|5920|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3664||3664|5920|
074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|10669|15502|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||10669||10669|15502|
074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4675|7303|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4675||4675|7303|
074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|13759|19627|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||13759||13759|19627|
074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4675|7303|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4675||4675|7303|
074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|A||0|0|E|0|DAC|0|0|1|100|GBP|392|1439|lyfalmen|||00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||389||389|1439|30.11.2011
074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|15444|21742|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||15444||15444|21742|
074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|17543|23899|lyfsjukr|||00|50|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||17543||17543|23899|
074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|489|1576|lyfalmen|||00|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||489||489|1576|
074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|699|1864|lyfalmen|||00|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||699||699|1864|
074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|A||0|0|0|0|AGT|0|0|0|100|DKK|1099|2411|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1099||1099|2411|
074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|21127|36855|vetorma|||58|25|0|0,0000|Vistor hf|Scan Vet Animal Health AS|||21127||21127|36855|
074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|A||0|0|B|0|AUK|0|1|0|100|GBP|404|1460|lyfalmen|V0510|1460|00|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||404||404|1460|
074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|A||0|0|B|0|AUK|0|1|0|100|GBP|738|1917|lyfalmen|V0512|1917|00|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||738||738|1917|
074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|A|3|0|0|B|0|AEG|0|0|0|100|GBP|934|2185|lyfalmen|||00|60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||934||934|2185|
074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|A|5|0|0|B|0|AEG|0|0|0|100|GBP|498|1589|lyfalmen|||00|100|0|100,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||498||498|1589|
074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1560|2401|lyfalmen|||00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1092||1092|2401|
075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|A||0|0|*|0|AEG|0|0|0|100|GBP|2496|4279|lyfalmen|||10|100|0|33,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||2465||2465|4279|
075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|4989|7732|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4989||4989|7732|
075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|14965|21140|lyfalmen|||00|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14965||14965|21140|
075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|ţpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1747|3297|lyfalmen|||69|10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||1747||1747|3297|
075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|4989|7732|lyfalmen|||00|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4989||4989|7732|
075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1959|2697|lyfalmen|V0363|2697|00|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1308||1308|2697|
075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|14965|21140|lyfalmen|||00|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14965||14965|21140|
075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|XEU|1906|3515|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||1906||1906|3515|
075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|3075|5114|lyfalmen|||00|300|0|300,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||3075||3075|5114|
075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|A||0|0|0|0|NOI|0|0|0|100|XEU|2656|4541|lyfalmen|||00|4|0||Artasan ehf|Norgine A/S|Hćgđalyf međ osmótíska verkun||||2656|4541|
075288|N05AX1203|Abilify (Lyfjaver)|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|DKK|34353|45472|lyfalmen|V0295|45472|00|56|0|18,6670|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||34353||34353|45472|
075299|M01AH0103|Celebra (Lyfjaver)|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|A|3|0|0|E|0|LVR|0|0|1|100|DKK|7031|10525|lyfalmen|V0429|10525|00|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||7031||7031|10525|
075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|A|3|0|0|E|0|LVR|0|0|1|100|DKK|13550|19365|lyfalmen|V0196|19365|00|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||13550||13550|19365|
075356|G04BD0703|Detrusitol SR|forđahlk|4|mg|84|stk|1|ţpakki||G04BD07|01.07.2011||R|A||0|0|E|0|LVR|0|0|0|100|DKK|18216|25220|lyfalmen|||00|84|0|58,8000|Lyfjaver ehf|Lyfjaver ehf|Tólteródín||||18216|25220|
075382|V04CL0030|Soluprick SQ, rauđölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075391|N05AL0502|Solian (Lyfjaver)|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|18994|26197|lyfalmen|V0289|26197|00|90|0|45,0000|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríđ||18994||18994|26197|
075402|N05AL0502|Solian (Lyfjaver)|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|6313|9543|lyfalmen|V0288|9543|00|90|0|11,2500|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríđ||6313||6313|9543|
075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075440|V04CL0026|Soluprick SQ, hesliviđur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|A||0|0|E|0|POF|0|0|0|100|XEU|4183|5474|lyfalmen|V0445|5474|00|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||3338||3338|5474|
075465|V04CL0024|Soluprick SQ, haliđagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|A||0|1|0|1|AVS|0|0|0|100|NOK|31044|40843|lyfsjukr|||00|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||31044||31044|40843|
075481|V04CL0023|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|A||0|1|0|1|AVS|0|0|0|100|NOK|116517|148111|lyfsjukr|||00|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||116517||116517|148111|
075507|V04CL0018|Soluprick SQ, axhnođapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075689|V04CL0027|Soluprick SQ, hrossavćrur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
075724|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|99839|127180|lyfsjukr|||00|1000|0|2,2200|Icepharma hf|Wyeth Europe|Storkuţáttur IX||99839||99839|127180|
075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|A|5|0|0|0|0|DEC|0|0|0|100|DKK|712|1416|vetalmen|||16|20|0||Vistor hf|Dechra Veterinary Products A/S|||712||712|1416|
075787|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|DEC|0|0|0|100|DKK|2123|4223|vetalmen|||13|25|0|0,0000|Vistor hf|Dechra Veterinary Products A/S|||2123||2123|4223|
075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|5953|8592|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||5953||5953|8592|
075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|5953|8592|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||5953||5953|8592|
075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|5973|8621|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||5973||5973|8621|
075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|A||0|0|0|0|AUK|0|0|0|100|GBP|432|1498|lyfalmen|||00|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||432||432|1498|
075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|A||0|0|0|0|AEA|0|0|1|100|XEU|459|1535|lyfalmen|||00|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||459||459|1535|
075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|A||0|0|B|0|LYF|0|0|0|100|XEU|910|1948|lyfalmen|V0449|1948|00|100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||761||761|1948|
076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|DKK|6686|10053|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6686||6686|10053|
076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|DKK|22770|30936|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||22770||22770|30936|
076181|L04AA0603|Cellcept (D.A.C.)|töflur|500|mg|50|stk|1|ţpakki||L04AA06|01.12.2009|31.10.2011|R|A||0|1|*|0|DAC|0|0|0|100|DKK|21192|22369|lyfalmen|||00|50|0|12,5000|D.A.C. ehf|D.A.C. ehf|Mýcófenólsýra||15944||15944|22369|
076361|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2LIV|V03AN01|01.12.2009||L|A||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||
076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|445|1516|lyfalmen|V0045|1516|00|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1516|
076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|1986|3271|lyfalmen|V0290|3035|00|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1728||1728|3271|
076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|1946|3569|lyfalmen|V0291|3303|00|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1946||1946|3569|
076533|N05AB0301|Trilafon|filmhtfl|2|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|899|2137|lyfalmen|||00|100|0|6,6667|Vistor hf|Schering-Plough|Perfenazín||899||899|2137|
076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1258|2628|lyfalmen|||00|100|0|13,3333|Vistor hf|Schering-Plough|Perfenazín||||1258|2628|
076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1793|3360|lyfalmen|||00|100|0|26,6667|Vistor hf|Schering-Plough|Perfenazín||||1793|3360|
076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|7268|12679|vetorma|||27|100|0|0,0000|Vistor hf|Merial (MSD)|||7268||7268|12679|
076814|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|dreifa|J07AL52|01.12.2009||R|K||0|0|0|0|GLB|0|0|0|100|GBP|6895|10234|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||6818||6818|10234|
076871|G01AF0202|Canesten (D.A.C.)|sk-stíll|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól||||||
077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|235|1229|lyfalmen|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||235||235|1229|
077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|691|1853|lyfalmen|||00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||691||691|1853|
077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.07.2010||R|A||0|0|E|0|APC|0|0|0|100|XEU|10111|12721|lyfalmen|V0029|12371|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||8636||8636|12721|
077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|773|1965|lyfalmen|||02|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||773||773|1965|
078182|D01AC0302|Pevaryl (D.A.C.)|krem|10|mg/g|30|g|1|túpa||D01AC03|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Ekónazól||||||
078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|20|0|20,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól||||||
078239|S01GX0202|Livostin (D.A.C.)|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||29|4|0||D.A.C. ehf|D.A.C. ehf|Levókabastín||||||
078250|D01AC0803|Fungoral (D.A.C.)|sápa|20|mg/ml|120|ml|1|plastf||D01AC08|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Ketókónazól||||||
078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|11524|16672|lyfalmen|V0419|16665|10|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||11524||11524|16672|
078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|523|1623|lyfalmen|||00|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||523||523|1623|
078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|797|1998|lyfalmen|||00|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||797||797|1998|
078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|121606|154498|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||121606||121606|154498|
079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|9066|6108|lyfalmen|V0069|3688|00|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3802||3802|6108|
079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2604|3758|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíđ||2604||2604|3758|
079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|4626|6676|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíđ||4626||4626|6676|
079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|7784|11234|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíđ||7784||7784|11234|
079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3715|5989|lyfalmen|||00|10|0|4,6700|Icepharma hf|Roche Registration Limited|Oseltamivír||3715||3715|5989|
079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|18768|25913|lyfalmen|||02|10|0|154,5714|Vistor hf|Schering-Plough|Perfenazín||18768||18768|25913|
079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
079370|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|A||0|0|B|0|ACA|0|1|0|100|XEU|3482|5671|lyfalmen|V0315|5671|00|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3482||3482|5671|
079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2107|3041|lyfsjukr|||03|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2107||2107|3041|
080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1445|lyfalmen|V0176|1445|00|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1445|
080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1780|lyfalmen|V0418|1780|00|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1780|
080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1792|lyfalmen|V0177|1792|00|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1792|
080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2505|lyfalmen|V0411|2505|00|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2505|
080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|A||0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen|||27|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745|
080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|A||0|0|0|0|ANI|1|0|0|100|XEU|4076|7999|vetalmen|||27|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4076|7999|
080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||05|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól||||||
080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|A||0|0|0|0|BAN|1|0|0|100|DKK|10383|18113|vetorma|||00|24|0||Icepharma hf|Bayer Animal Health GmbH|||10383||10383|18113|
080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2286|4034|lyfalmen|||00|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2286||2286|4034|
080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|A|1,5|0|0|0|0|GSK|0|1|1|100|GBP|5798|8839|lyfalmen|||00|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||5798||5798|8839|
080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|2696|3989|lyfalmen|V0143|3115|00|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2253||2253|3989|
080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|A|1,5|0|0|0|0|GSK|0|1|1|100|GBP|3011|5026|lyfalmen|||00|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3011||3011|5026|
080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|34690|60515|vetorma|||27|500|0|0,0000|Vistor hf|Merial (MSD)|||34690||34690|60515|
080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|7619|10208|lyfalmen|V0143|9345|00|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||6799||6799|10208|
080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|2976|4335|lyfalmen|V0144|3584|00|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2506||2506|4335|
080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|15212|20974|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Pfizer ApS|Ídarúbicín||15212||15212|20974|
080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|11091|12220|lyfalmen|V0144|10752|00|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||8270||8270|12220|
080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|29989|39519|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Pfizer ApS|Ídarúbicín||29989||29989|39519|
081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.11.1998|30.09.2011|R|A|3,5|0|0|E|0|NDR|0|0|0|100|SEK|37920|49949|lyfalmen|||02|12|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||37920||37920|49949|
081507|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.05.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|6135|9300|lyfalmen|||00|4|0|8,0000|D.A.C. ehf|D.A.C. ehf|Tadalafíl||6135||6135|9300|30.11.2011
081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||
081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||
081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||
081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||
081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||
081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||
081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
081624|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||
081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||
081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|A||0|1|E|0|FEL|0|0|0|100|DKK|4687|7319|lyfalmen|||00|21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4687||4687|7319|
081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||
081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1857|2680|lyfsjukr|||02|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1857||1857|2680|
081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.04.2010||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|19885|27315|lyfalmen|V0456|20537|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||19885||19885|27315|
081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5837|8892|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5837||5837|8892|
081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|8768|12902|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8768||8768|12902|
082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|A||0|0|*|0|AGP|0|0|0|100|XEU|38556|38175|lyfalmen|V0184|38175|00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||28538||28538|38175|
082040|D07XC0101|Diprosalic|áburđur|0||100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|2280|4026|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2280||2280|4026|
082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||
082685|R03BA0502|Flixotide Diskus|innúđadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3102|4687|lyfalmen|||23|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2763||2763|4687|
082719|R03BA0502|Flixotide Diskus|innúđadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5498|8428|lyfalmen|||23|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5498||5498|8428|
082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|913|2156|lyfalmen|||00|125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||913||913|2156|
082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|4649|7267|lyfalmen|||00|20|0|3,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4649||4649|7267|
082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|5496|8426|lyfalmen|||00|20|0|6,6600|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5496||5496|8426|
082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|13324|19081|lyfalmen|||00|56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13324||13324|19081|
083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|18608|25712|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||18608||18608|25712|
083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|13915|19823|lyfalmen|V0344|13876|00|56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13915||13915|19823|
083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|7262|10841|lyfalmen|||00|20|0|13,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7262||7262|10841|
083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|77764|99476|lyfsjukr|||00|450|0|30,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||77764||77764|99476|
083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|30196|40255|lyfalmen|V0346|32640|00|112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30196||30196|40255|
083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|8355|12058|lyfsjukr|||02|11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8355||8355|12058|
084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|272|1279|lyfalmen|V0392|813|02|10|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||272||272|1279|
084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|525|1626|lyfalmen|V0392|1626|02|20|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||525||525|1626|
084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|61988|79677|lyfsjukr|||00|0|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||61988||61988|79677|
084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|80810|103299|lyfsjukr|||00|0|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||80810||80810|103299|
084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|99973|127349|lyfsjukr|||00|0|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||99973||99973|127349|
084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|20663|27815|lyfsjukr|||00|0|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||20663||20663|27815|
084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|32272|42384|lyfsjukr|||00|0|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||32272||32272|42384|
084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|41325|53745|lyfsjukr|||00|0|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||41325||41325|53745|
084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|12798|17944|lyfsjukr|||00|0|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||12798|17944|
084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|48786|63109|lyfsjukr|||00|0|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||48786|63109|
084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|150256|190454|lyfsjukr|||00|1|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||150256|190454|
084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|927|2175|lyfalmen|||00|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||927||927|2175|
084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|11005|15962|lyfalmen|||00|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||11005||11005|15962|
084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|35813|47305|lyfalmen|||00|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||35813||35813|47305|
085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|15665|22019|lyfalmen|||10|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||15665||15665|22019|
085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|K|1|0|1|*|0|GAN|0|0|0|100|NOK|43331|56740|lyfalmen|||00|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||43331||43331|56740|
085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|2653|4537|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Levófloxacín||2653||2653|4537|
085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|30196|40255|lyfalmen|V0345|32640|00|112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30196||30196|40255|
085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|764|1952|lyfalmen|||00|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||764||764|1952|
085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|20549|28148|lyfalmen|V0412|23535|00|375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||20549||20549|28148|
085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|35627|47071|lyfalmen|V0412|47071|00|750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||35627||35627|47071|
085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|A||0|1|0|1|ELD|0|0|0|100|XEU|95178|121331|lyfsjukr|||00|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||95178||95178|121331|
085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|K|3|0|0|0|0|AEU|0|0|0|100|DKK|40341|52987|lyfalmen|||00|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||40341||40341|52987|
085829|S01EB0104|Pilokarpin|augndr|2|%|0,5|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2270|4013|lyfalmen|||00|10|1|7,5000|Parlogis hf|Parlogis - óskráđ lyf|Pílókarpín||2270||2270|4013|
085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|A||0|0|*|0|API|0|0|0|100|SEK|2902|4877|lyfalmen|V0465|4213|00|3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||2902||2902|4877|
085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|A||0|0|*|0|API|0|0|0|100|SEK|8577|12640|lyfalmen|V0465|12640|00|9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||8577||8577|12640|
085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4071|5077|lyfalmen|V0364|5077|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3048||3048|5077|
086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5512|5903|lyfalmen|V0365|5903|00|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3652||3652|5903|
086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8041|11605|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8041||8041|11605|
086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|13978|19425|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||13978||13978|19425|
086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|A||0|1|E|0|FEL|0|0|0|100|DKK|30536|40682|lyfalmen|||00|600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||30536||30536|40682|
086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|A||0|1|E|0|FEL|0|0|0|100|DKK|61072|79005|lyfalmen|||00|1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||61072||61072|79005|
086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|54188|69888|lyfsjukr|||00|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |||54188||54188|69888|
086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|A||0|0|0|1|ROA|0|0|0|100|DKK|50820|65662|lyfsjukr|||00|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||50820||50820|65662|
087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|ţpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3014|5030|lyfalmen|||00|28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||3014||3014|5030|
087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd||||||
087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|VII|0|0|0|100|DKK|162695|206065|lyfsjukr|||00|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||162695||162695|206065|
087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|291|1305|lyfalmen|V0312|419|00|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||291||291|1305|
087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|256|1258|lyfalmen|V0312|1258|00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||256||256|1258|
087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2158|3859|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2158||2158|3859|
087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||01|500|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||3515|
087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|MEC|0|0|0|100|SEK|864|2089|lyfalmen|||00|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||864||864|2089|
087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|A||0|0|E|0|APC|0|0|0|100|XEU|3536|3368|lyfalmen|V0009|3309|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||1799||1799|3368|
087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|10838|13880|lyfalmen|V0420|13880|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||9483||9483|13880|
087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|A||0|0|0|0|CHP|0|0|0|100|XEU|31776|55432|vetorma|||00|104|0||Icepharma hf|Chanelle Pharmaceuticals|||31776||31776|55432|
087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|20|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra||||||
088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1306|2694|lyfalmen|||00|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1306||1306|2694|
088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1505|2966|lyfalmen|||14|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1505||1505|2966|
088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|5807|8851|lyfalmen|||14|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||5807||5807|8851|
088393|A03FA0101|Primperan|eţ-stíll|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|395|1448|lyfalmen|||04|6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||395||395|1448|
088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9892|14439|lyfalmen|||00|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9892||9892|14439|
088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|ţpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|164363|208158|lyfsjukr|||00|70|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|||||164363|208158|
088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|22994|27862|lyfalmen|V0421|27862|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||20321||20321|27862|
088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|K||0|0|*|0|POF|0|0|0|100|DKK|6440|6460|lyfalmen|V0376|6460|06|8|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||4059||4059|6460|
088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|A||0|0|0|0|PER|0|0|0|100|DKK|1769|3327|lyfalmen|||23|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og östrógen||1769||1769|3327|
089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||00|120|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||5602|
089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|VII|0|0|0|100|DKK|162695|206065|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||162695||162695|206065|
089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|A||0|0|E|0|MYD|0|0|0|100|SEK|3946|6305|lyfalmen|||00|100|0|45,0000|Actavis Group PTC ehf|Mylan dura GmbH|Mebeverín||3946||3946|6305|
090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2347|4118|lyfalmen|||00|100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2347||2347|4118|
090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|A||0|0|0|0|PAD|0|0|1|100|DKK|1605|3103|lyfalmen|||00|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1605||1605|3103|
090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007|30.11.2011|R|K|3|0|1|0|1|MKA|0|0|0|100|SEK|35323|46213|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Merck KgaA|Cetúxímab||35323||35323|46213|
090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|A||0|0|0|0|PAD|0|0|1|100|DKK|3188|5268|lyfalmen|||00|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3188||3188|5268|
090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MKA|0|0|0|100|SEK|177797|225018|lyfsjukr|||00|100|0|0,0000|Icepharma hf|Merck KgaA|Cetúxímab||177797||177797|225018|
090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|A||0|0|0|1|NOM|0|0|0|100|DKK||8469|lyfsjukr|||03|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||5868||5868|8469|
090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1776|3337|lyfalmen|||24|16|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1776||1776|3337|
090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|850|2070|lyfalmen|||00|60|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||850||850|2070|
090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|A||0|1|0|1|ACK|0|0|0|100|USD|15644|21516|lyfsjukr|||00|60|0||Vistor hf|Alcon Denmark A/S|Flúorescein||||15644|21516|
091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|A||1|0|0|0|NOH|0|0|0|100|DKK|3390|5545|lyfalmen|||00|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3390||3390|5545|
091649|L01DB0105|Doxorubicin Actavis|sts|10|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|K||0|1|0|1|APC|0|0|0|100|XEU|1810|2612|lyfsjukr|||00|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||1810|2612|
091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|K||0|1|0|1|APC|0|0|0|100|XEU|7404|10686|lyfsjukr|||00|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||7404|10686|
091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|A||0|0|E|0|CCS|0|0|1|100|DKK|4000|6379|lyfalmen|||00|30|0||Vistor hf|CCS Clean Chemical Sweden AB|Dexametasón||4000||4000|6379|
091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1258|2509|lyfalmen|V0021|1840|00|90|0|45,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1171||1171|2509|
091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|2174|3442|lyfalmen|V0022|2441|00|90|0|90,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1853||1853|3442|
091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|A||0|0|B|0|AGT|0|0|0|100|XEU|629|1768|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||629||629|1768|
092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|A|2|0|0|0|0|LBK|0|0|0|100|DKK|3897|6238|lyfalmen|||00|15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||3897|6238|
092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|1|0|0|100|DKK|9236|17907|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||9236||9236|17907|
092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|7906|10687|lyfalmen|V0009|3309|00|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7149||7149|10687|
092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
092609|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|A||0|0|E|0|NON|0|0|0|100|DKK|2288|4037|lyfalmen|||05|18|0|7,2000|Vistor hf|Novo-Nordisk|Estradíól||2288||2288|4037|
092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A||0|0|*|0|DAC|0|1|0|100|DKK|9325|13663|lyfalmen|V0277|13663|00|100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||9325||9325|13663|
092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|ţpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|24142|32658|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||24142||24142|32658|
092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|421|1483|lyfalmen|||10|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||421||421|1483|
092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|547|1656|lyfalmen|||10|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||547||547|1656|
092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|3374|4252|lyfalmen|V0203|4252|00|12|0|84,0000|Portfarma ehf|Portfarma|Alendrónsýra||2445||2445|4252|
093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|A||1|0|0|0|NOR|0|0|0|100|DKK|1155|2487|lyfalmen|||00|28|0|1,8700|Icepharma hf|Norpharma a/s|Oxýcódon||||1155|2487|
093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|A||1|0|0|0|NOR|0|0|0|100|DKK|2650|4532|lyfalmen|||00|28|0|3,7300|Icepharma hf|Norpharma a/s|Oxýcódon||||2650|4532|
093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|A||1|0|0|0|NOR|0|0|0|100|DKK|5152|7955|lyfalmen|||00|28|0|7,4700|Icepharma hf|Norpharma a/s|Oxýcódon||||5152|7955|
093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|6659|10017|lyfalmen|||00|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||6659||6659|10017|
093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|26619|46436|vetorma|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||26619||26619|46436|
093708|L01DB0701|Novantrone|irţ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|MEB|0|0|0|100|USD|15422|21237|lyfsjukr|||00|5|0|0,0000|Vistor hf|Meda AB (V)|Mítoxantrón||15422||15422|21237|
093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|A||0|1|*|0|DAC|0|0|0|100|SEK|60010|77194|lyfalmen|V0451|77194|00|1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||59629||59629|77194|
093747|C09AA0503|Ramipril Actavis (DAC)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|A||0|0|B|0|DAC|0|0|0|100|XEU|1194|2541|lyfalmen|V0496|2541|00|100|0|200,0000|D.A.C. ehf|D.A.C. ehf|Ramipríl||1194||1194|2541|
093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|16234|22733|lyfalmen|||10|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||16234||16234|22733|
093770|L02AE0304|Zoladex (D.A.C.)|vefjalyf|3,6|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|A||0|1|*|0|DAC|0|0|0|100|SEK|22244|30276|lyfalmen|V0183|30276|00|1|0|27,9070|D.A.C. ehf|D.A.C. ehf|Góserelín||22244||22244|30276|
093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|45812|59853|lyfalmen|||10|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||45812||45812|59853|
093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|K||0|1|0|1|JCI|0|0|0|100|SEK|540493|680201|lyfsjukr|||AC|0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||540493||540493|680201|
093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|K||0|1|0|1|JCI|0|0|0|100|SEK|582083|732397|lyfsjukr|||AC|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||582083||582083|732397|
093969|G03FB0507|Trisekvens (D.A.C.)|töflur|||84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2704|4606|lyfalmen|V0525|4606|23|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Noretísterón og östrógen||2704||2704|4606|
094111|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|5022|7777|lyfalmen|V0236|7392|00|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5022||5022|7777|
094122|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|7442|11088|lyfalmen|V0236|11088|00|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||7442||7442|11088|
094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1793|3567|vetalmen|||00|15|0|0,0000|Vistor hf|Boehringer Ingelheim|||1793||1793|3567|
094287|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|13080|18775|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13080||13080|18775|
094296|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|18736|25873|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||18736||18736|25873|
094305|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|84304|108161|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||84304||84304|108161|
094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|78384|100254|lyfsjukr|||00|60|0||GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||78384||78384|100254|
094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|A||0|0|0|0|APE|0|0|1|100|XEU|47639|62146|lyfalmen|||00|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||47639|62146|
094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|K||0|0|0|0|LHS|0|0|0|100|XEU|6500|11339|vetorma|||00|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6500||6500|11339|
095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|3065|lyfalmen|||00|100|1|50,0000|Distica|Distica - óskráđ lyf|||1577||1577|3065|
095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|5078|6230|lyfalmen|V0143|6230|00|8|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||3891||3891|6230|
095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|5825|8876|lyfalmen|||00|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||5825||5825|8876|
095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17552|24387|lyfalmen|||00|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17552||17552|24387|
095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17552|24387|lyfalmen|||00|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17552||17552|24387|
095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|A||0|0|0|0|POF|0|0|0|100|XEU|1928|3545|lyfalmen|||00|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1928||1928|3545|
095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|A||0|0|0|0|POF|0|0|0|100|XEU|3020|5039|lyfalmen|||00|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||3020||3020|5039|
095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|17552|24387|lyfalmen|||00|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17552||17552|24387|
095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|A||0|0|0|1|POF|0|0|0|100|XEU|2531|3653|lyfsjukr|||00|50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2531|3653|
095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|A||0|0|0|1|POF|0|0|0|100|XEU|3503|5056|lyfsjukr|||00|100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3503|5056|
095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|A||0|0|E|0|AGP|0|0|1|100|XEU|1070|1435|lyfalmen|V0225|1435|00|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||386||386|1435|
095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|3660|7200|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3660||3660|7200|
095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|4829|9445|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4829||4829|9445|
095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|8795|17060|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||8795||8795|17060|
096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2337|3373|lyfsjukr|||02|60|0|0,0000|Icepharma hf|Baxter Medical AB|Mesna||2337||2337|3373|
096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|12865|18028|lyfsjukr|||17|10|0|0,0000|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||12865||12865|18028|
096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|100573|128102|lyfsjukr|||17|100|0|0,0000|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||100573||100573|128102|
096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1974|3608|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||1974||1974|3608|
096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|16176|22660|lyfalmen|||00|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16176||16176|22660|
096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|689347|867013|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||689347||689347|867013|
096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|730745|918967|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||730745||730745|918967|
096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|768564|966430|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||768564||768564|966430|
096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|843472|1060440|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||843472||843472|1060440|
096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|16176|22660|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16176||16176|22660|
096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1321|2714|lyfalmen|||00|30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1321||1321|2714|
096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|32354|42964|lyfalmen|||00|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||32354||32354|42964|
096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|IPI|0|0|0|100|DKK|89211|113842|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Pfizer Limited|Anidulafungin||89211||89211|113842|
097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|27342|36197|lyfsjukr|||00|10000|0|10,0000|Actavis Group hf|Braun|Hýdróxyetýl sterkja||27342||27342|36197|
097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|A||0|0|0|0|AUW|1|0|0|100|XEU|8121|15766|vetalmen|||27|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||8121|15766|
097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|2203|3902|lyfalmen|V0461|3902|00|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2189||2189|3902|
097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1108|2423|lyfalmen|||00|120|0|12,0000|Vistor hf|Schering-Plough|Deslóratadín||1108||1108|2423|
097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|23026|30780|lyfsjukr|||00|20|1|0,0000|Distica|Distica - óskráđ lyf|||23026||23026|30780|
097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|A||0|0|0|0|PER|0|1|0|100|DKK|21179|28939|lyfalmen|V0335|5984|00|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||21179|28939|
097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3121|4262|lyfalmen|V0023|2835|00|90|0|135,0000|Vistor hf|Aventis Pharma |Glímepíríđ||2452||2452|4262|
097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4653|lyfalmen|V0233|4653|00|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||2738||2738|4653|
097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3530|lyfalmen|V0234|3530|00|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1917||1917|3530|
097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1103|2396|lyfalmen|V0329|2396|00|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1088||1088|2396|
098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|6599|3717|lyfalmen|V0072|3717|00|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||2054||2054|3717|
098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|8457|3717|lyfalmen|V0073|3717|00|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||2054||2054|3717|
098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|590|1714|lyfalmen|||20|30|0|30,0000|Icepharma hf|Bioglan AB|Flúócínólón||590||590|1714|
098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|590|1712|lyfalmen|||20|30|0|30,0000|Icepharma hf|Bioglan AB|Flúócínólón||588||588|1712|
098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|A||0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Icepharma hf|Bioglan AB|Klórhexidín||||||
098459|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|30|stk|1|ţpakki||N06AB03|01.05.2009||R|A|2|0|0|0|0|DAC|0|1|0|100|XEU|3133|5193|lyfalmen|V0061|3260|00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||3133||3133|5193|
098468|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2009||R|A|2|0|0|0|0|DAC|0|1|0|100|XEU|10337|15048|lyfalmen|||00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||10337||10337|15048|30.11.2011
098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2530|lyfalmen|||06|5|1|25,0000|Distica|Distica - óskráđ lyf|||1186||1186|2530|
098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|18725|25382|lyfsjukr|||02|25|0||Actavis Group hf|Braun|Flúmazeníl||18725||18725|25382|
098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|17602|24450|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||17602||17602|24450|
099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|95994|122355|lyfsjukr|||00|10|0||Vistor hf|AstraZeneca UK Ltd|Fulvestrant||95994||95994|122355|
099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|5942|9036|lyfalmen|V0284|9036|00|100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||5942||5942|9036|
099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|13642|19385|lyfalmen|V0285|19385|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||13566||13566|19385|
099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|22302|30036|lyfalmen|V0286|30036|00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||22053||22053|30036|
099705|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Jođ/pólývídón||||||
099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Jođ/pólývídón||||||
099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|2946|3941|lyfalmen|V0247|3941|00|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2218||2218|3941|
099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|4073|6023|lyfalmen|V0248|6023|00|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3740||3740|6023|
099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|8274|10105|lyfalmen|V0249|10105|00|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||6724||6724|10105|
099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|682|1840|lyfalmen|V0414|1840|00|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||682||682|1840|
100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13187|18909|lyfalmen|||00|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13187|18909|
100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13187|18909|lyfalmen|||00|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13187|18909|
101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|12590|13275|lyfalmen|||0|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9041||9041|13275|
101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|17415|24215|lyfalmen|||0|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||17415||17415|24215|
101691|C08CA0502|Adalat Oros|forđatfl|20|mg|28|stk|1|ţpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|1950|3575|lyfalmen|||00|28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||1950||1950|3575|
101709|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|6294|9517|lyfalmen|||00|98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||6294||6294|9517|
101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|A|2|0|0|0|0|AGP|0|1|0|100|XEU|1380|2795|lyfalmen|V0330|2795|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1380||1380|2795|
101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|3092|5137|lyfalmen|V0331|5137|00|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3092||3092|5137|
101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|A||0|0|B|0|APC|0|0|0|100|XEU|3879|4331|lyfalmen|V0088|4331|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||2503||2503|4331|
101760|N06AX1104|Miron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|A||0|0|0|0|AGP|0|1|0|100|XEU|5538|8483|lyfalmen|V0332|8483|00|96|0|144,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||5538||5538|8483|
101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|A||0|0|B|0|APC|0|0|0|100|XEU|4499|4408|lyfalmen|V0089|4408|00|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||2559||2559|4408|
101769|N02AX0211|Nobligan Retard (D.A.C.)|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|5155|7959|lyfalmen|V0227|7412|00|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||5155||5155|7959|
101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|SEK|16950|32719|vetalmen|||0|250|0|0,0000|Vistor hf|Boehringer Ingelheim|||||16950|32719|
101825|A09AA0206|Creon 10.000|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.09.2011||R|A||0|0|E|0|APR|0|0|0|100|DKK|3213|5303|lyfalmen|V0019|5294|10|100|0|100,0000|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||||3213|5303|
102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3657|5910|lyfalmen|V0041|3684|43|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3657||3657|5910|
102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|1833|2645|lyfsjukr|||02|50|0|0,0000|Vistor hf|AstraZeneca AB|Própófól||1833||1833|2645|
102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|2979|4299|lyfsjukr|||00|50|0|0,0000|Vistor hf|AstraZeneca AB|Própófól||2979||2979|4299|
103033|N03AX1207|Gabapentin Ranbaxy|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.08.2010||R|A||0|0|E|0|RAN|0|0|0|100|XEU|9987|13118|lyfalmen|||00|100|0|33,3300|Gróco ehf|Ranbaxy (UK) Ltd|Gabapentín||8926||8926|13118|31.10.2011
103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|3484|4263|lyfalmen|V0088|4244|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||2453||2453|4263|
103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|4409|4338|lyfalmen|V0089|4320|00|98|0|196,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||2508||2508|4338|
103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|A|3|0|0|B|0|POF|0|0|0|100|XEU|2976|3688|lyfalmen|V0069|3688|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||2033||2033|3688|
103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2465|2539|lyfalmen|V0033|2539|00|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||1193||1193|2539|
103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|9750|9454|lyfalmen|V0182|9410|00|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||6248||6248|9454|
103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|4430|6106|lyfalmen|V0334|6106|00|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3800||3800|6106|
103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|7110|6106|lyfalmen|V0335|6106|00|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3800||3800|6106|
103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1842|
103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl||||||
104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|13531|18864|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||13531||13531|18864|
104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|3155|5223|lyfalmen|||23|2|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3155||3155|5223|
104498|N05CH0101|Circadin|forđatfl|2|mg|21|stk|1|ţpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2170|3876|lyfalmen|||00|21|0|21,0000|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2170||2170|3876|
104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|8319|12287|lyfalmen|||04|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8319||8319|12287|
104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|4671|7297|lyfalmen|V0017|7297|56|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4671||4671|7297|
104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|5287|8140|lyfalmen|||10|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5287||5287|8140|
104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|129189|164015|lyfsjukr|||00|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||129189|164015|
105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4215|5807|lyfalmen|V0004|2948|00|28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3582||3582|5807|
105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|12826|15822|lyfalmen|V0011|7959|00|100|0|66,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||10903||10903|15822|
105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A||0|0|0|0|DAC|0|0|0|100|SEK|17056|20553|lyfalmen|V0012|16232|00|100|0|133,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||14497||14497|20553|
105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|3967|6334|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||3967||3967|6334|
105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|13792|19668|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||13792||13792|19668|
105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4573|7163|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4573||4573|7163|
105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|15907|22323|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||15907||15907|22323|
105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2378|4160|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2378||2378|4160|
105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2811|4753|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2811||2811|4753|
106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|A||0|0|0|0|RRL|0|0|0|100|DKK|1851|3439|lyfalmen|||00|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1851||1851|3439|
106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|A||0|0|0|0|RRL|0|0|0|100|DKK|3703|5973|lyfalmen|||00|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3703||3703|5973|
106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|2679|4572|lyfalmen|||63|14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2679||2679|4572|
106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.2009|30.09.2011|R|A|2|0|0|B|0|POF|0|0|0|100|IKR|997|1865|lyfalmen|||0|100|0|100,0000|Portfarma ehf|Portfarma|Enalapríl||700||700|1865|
106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|18116|24618|lyfsjukr|||00|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||18116||18116|24618|
106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|10018|14455|lyfsjukr|||00|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10018||10018|14455|
107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|A||0|0|*|0|RAN|0|1|0|100|XEU|2035|3691|lyfalmen|V0278|3084|00|28|0|7,0000|Gróco ehf|Ranbaxy (UK) Ltd|Olanzapín||2035||2035|3691|
107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PER|0|0|0|100|DKK|1579|3067|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1579||1579|3067|
107583|N03AF0202|Trileptal (D.A.C.)|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|5090|7870|lyfalmen|||00|100|0|30,0000|D.A.C. ehf|D.A.C. ehf|Oxkarbazepín||5090||5090|7870|31.10.2011
107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|1548|2700|vetorma|||16|6|0|0,0000|Dýraheilsa/Icevet ehf|Icevet ehf|||||1548|2700|
107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|928|2177|lyfalmen|||00|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||928||928|2177|
108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|2781|4712|lyfalmen|||63|100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2781||2781|4712|
108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|3313|5439|lyfalmen|||00|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3313||3313|5439|
108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|9832|14357|lyfalmen|||00|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9832||9832|14357|
108802|N05AH0310|Zalasta (LYFIS)|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|LYF|0|1|0|100|XEU|13816|15289|lyfalmen|V0282|15289|00|56|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||10513||10513|15289|
108845|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1150|2481|lyfalmen|||24|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1150||1150|2481|
108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1595|3089|lyfalmen|V0443|3088|24|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1595||1595|3089|
109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24372|32946|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||24372||24372|32946|
109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19512|26847|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||19512||19512|26847|
109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7575|11270|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7575||7575|11270|
109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|ţpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól||||||
109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól||||||
109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|ţpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|XEU|419|1481|lyfalmen|V0230|1481|00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||419||419|1481|
110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|400|1455|lyfalmen|V0370|961|06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||400||400|1455|
110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|520|1619|lyfalmen|V0371|917|06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||520||520|1619|
110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3LIV|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0|0,0000|Ísaga ehf|AGA AB|Súrefni||||||
110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1546|3022|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1546||1546|3022|
110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|3952|6314|lyfalmen|||10|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3952||3952|6314|
111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|5893|8969|lyfalmen|V0373|8969|06|15|0||Portfarma ehf|Portfarma|Tímólól í blöndum||5893||5893|8969|
111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GSH|0|0|1|100|DKK|752|1936|lyfalmen|||00|100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||752||752|1936|
112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|21837|29765|lyfalmen|||00|1|0|1014,9254|Vistor hf|N.V. Organon|Etónógestrel||21837||21837|29765|
112615|C01DA0201|Discotrine|forđapl|15|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|4194|6645|lyfalmen|||23|30|0|90,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||4194||4194|6645|
112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.04.2009||R|A|2|0|0|E|0|RAN|0|0|0|100|XEU|8245|4320|lyfalmen|V0203|4252|00|12|0|84,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alendrónsýra||2495||2495|4320|
113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|8542|12592|lyfalmen|V0024|11408|00|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8542||8542|12592|
113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|25390|34224|lyfalmen|V0024|34224|00|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||25390||25390|34224|
113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|8653|12744|lyfalmen|V0025|11532|00|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8653||8653|12744|
113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3736|6018|lyfalmen|||00|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3736||3736|6018|
113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|25686|34595|lyfalmen|V0025|34595|00|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||25686||25686|34595|
113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6401|9664|lyfalmen|||00|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6401||6401|9664|
113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|669066|841560|lyfsjukr|||00|112|0|0,0000|Vistor hf|Novartis Europharm Ltd|Nilotiníb||669066||669066|841560|
113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|703|1869|lyfalmen|||00|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||703||703|1869|
113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|893|2129|lyfalmen|||00|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||893||893|2129|
113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1363|2772|lyfalmen|||00|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1363||1363|2772|
114033|R03AC0210|Ventolin Diskus|innúđadu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|930|2180|lyfalmen|||23|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||930||930|2180|
114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|A||0|1|0|1|WIL|0|0|0|100|XEU|52692|68011|lyfsjukr|||00|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||52692||52692|68011|
114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|DKK|4148|6582|lyfalmen|||00|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4148||4148|6582|
114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|2367|4145|lyfalmen|V0373|2990|06|5|0|0,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2367||2367|4145|
114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.11.2010||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2221|3946|lyfalmen|||23|4|0|3,5000|Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2221||2221|3946|
114664|D10AD5301|Epiduo|hlaup|||30|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|A||0|0|0|0|GAN|0|0|0|100|SEK|3113|5166|lyfalmen|||00|30|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||3113||3113|5166|
114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|A||0|0|0|0|GAN|0|0|0|100|SEK|6094|9244|lyfalmen|||00|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||6094||6094|9244|
115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1912|3523|lyfalmen|||0|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1912||1912|3523|
115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|IKR|9164|13226|lyfsjukr|||00|10|0||Actavis Group hf|Braun|Naloxón||9164||9164|13226|
115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1535|3007|lyfalmen|||00|20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1535||1535|3007|
115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|ţpakki|hart|B01AE07|01.01.2009|30.11.2011|R|A|3|0|0|E|0|BII|0|0|0|100|DKK|10636|15457|lyfalmen|||0|30|0|10,2300|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10636||10636|15457|
115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|11470|16598|lyfalmen|||0|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11470||11470|16598|
115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1912|3523|lyfalmen|||0|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1912||1912|3523|
115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|ţpakki|hart|B01AE07|01.01.2009|30.11.2011|R|A|3|0|0|E|0|BII|0|0|0|100|DKK|10636|15457|lyfalmen|||0|30|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10636||10636|15457|
115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|11470|16598|lyfalmen|||0|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11470||11470|16598|
115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|1904|3512|lyfalmen|V0369|2913|06|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||1904||1904|3512|
115931|R03AC1202|Serevent Diskus|innúđadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3598|5829|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3598||3598|5829|
115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0|0,0000|Icepharma hf|Norpharma |Malatíón||||||
116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|3614|5216|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3614||3614|5216|
116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|1889|2726|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1889||1889|2726|
116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0|10,0000|Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum||||||
116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|2609|4476|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||2609||2609|4476|
116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2997|5007|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||2997||2997|5007|
116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen||||||
116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen||||||
116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|ţpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|761|1948|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||761||761|1948|
116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|379|1426|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||379||379|1426|
116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|ţpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|923|2170|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||923||923|2170|
116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|17780|24673|lyfalmen|||00|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||17780||17780|24673|
116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|6059|9196|lyfalmen|||00|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6059||6059|9196|
116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|6506|9807|lyfalmen|||00|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6506||6506|9807|
116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|19207|26464|lyfalmen|||00|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||19207||19207|26464|
116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|K||0|0|0|0|WLV|0|0|0|100|DKK|8287|12244|lyfalmen|||00|0|0||Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||8287||8287|12244|
117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|10476|20288|vetalmen|||00|6000|0|0,0000|Icepharma hf|Kela Laboratoria NV|||10476||10476|20288|
117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|3214|5304|lyfalmen|||10|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||3214||3214|5304|
117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4552|7134|lyfalmen|V0435|7029|00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4552||4552|7134|
117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|14490|20544|lyfalmen|||00|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||14490|20544|
117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|25609|34499|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||25609|34499|
117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|1613|3114|lyfalmen|||10|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1613||1613|3114|
117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|4428|6965|lyfalmen|||00|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4428|6965|
117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|44281|57932|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||44281|57932|
117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|51218|66638|lyfalmen|||00|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||51218|66638|
117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|K|1,6|0|1|0|1|JCI|0|0|0|100|SEK|65166|83666|lyfsjukr|||00|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||65166||65166|83666|
117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|9760|17026|vetorma|||00|250|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||9760||9760|17026|
117788|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|2271|4014|lyfalmen|||61|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2271||2271|4014|
117796|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|5429|8334|lyfalmen|||61|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||5429||5429|8334|
117820|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|8129|12027|lyfalmen|||61|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||8129||8129|12027|
117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|7317|14222|vetalmen|||00|1200|0|0,0000|Icepharma hf|Kela Laboratoria NV|||7317||7317|14222|
117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|12834|24816|vetalmen|||00|6000|0|0,0000|Icepharma hf|Kela Laboratoria NV|||12834||12834|24816|
118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4009|3260|lyfalmen|V0278|3084|00|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1720||1720|3260|
118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|5699|4184|lyfalmen|V0279|3909|00|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2395||2395|4184|
118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|22101|16055|lyfalmen|V0282|15289|00|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||11073||11073|16055|
118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|16884|15274|lyfalmen|V0283|15274|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||10502||10502|15274|
118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|2152|3851|lyfalmen|||65|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2152||2152|3851|
118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||00|4|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728|
118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín||||||
118315|M01AB0505|Voltaren|eţ-stíll|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|377|1423|lyfalmen|||04|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||377||377|1423|
118323|M01AB0505|Voltaren|eţ-stíll|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|3454|5632|lyfalmen|||04|50|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3454||3454|5632|
118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|939|2192|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||939||939|2192|
118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|17375|12793|lyfalmen|V0280|12285|00|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||8689||8689|12793|
118570|A07EC0203|Pentasa Sachets|forđakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|7563|11253|lyfalmen|V0015|10500|00|50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7563||7563|11253|
118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|23219|31499|lyfalmen|V0015|31499|00|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||23219||23219|31499|
118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|2974|4976|lyfalmen|V0276|4976|00|100|0|8,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||2974||2974|4976|
118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|9325|13663|lyfalmen|V0277|13663|00|100|0|33,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||9325||9325|13663|
118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|A||0|0|B|0|AEG|0|0|0|100|XEU|490|1578|lyfalmen|||00|120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||490||490|1578|
119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|77680|99371|lyfsjukr|||00|5|0|0,0000|Vistor hf|Amgen Europe B.V.|Panitúmúmab||77680||77680|99371|
119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen||||||
119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|431602|543543|lyfsjukr|||00|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||431602||431602|543543|
120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|431602|543543|lyfsjukr|||00|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||431602||431602|543543|
120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|SAL|0|0|0|100|USD|929|2178|lyfalmen|||06|10|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||929||929|2178|
120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|48315|62518|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Lilly ICOS Limited|Pemetrexed||48315||48315|62518|
120341|N06DA0402|Reminyl (Lyfjaver)|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|12834|18466|lyfalmen|V0348|11571|00|28|0|14,0000|Lyfjaver ehf|Lyfjaver ehf|Galantamín||12834||12834|18466|
120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.05.2008||R|A||0|0|0|0|LVR|0|0|0|100|DKK|17897|24820|lyfalmen|V0253|22616|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||17897||17897|24820|
121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5512|8448|lyfalmen|||00|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5512||5512|8448|
121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|9523|13744|lyfsjukr|||00|50|0|0,0000|Vistor hf|N.V. Organon|Rókúrón, brómíđ||9523||9523|13744|
121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|435|1502|lyfalmen|||24|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||435||435|1502|
121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|E|0|POF|0|0|0|100|XEU|8362|7869|lyfalmen|V0011|7800|00|98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||5089||5089|7869|
121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|395|1444|lyfalmen|||00|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||392||392|1444|
121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|1769|3327|lyfalmen|V0314|2186|00|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||1769||1769|3327|
121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|264|1269|lyfalmen|||00|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||264||264|1269|
122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|K||0|0|0|0|BIV|0|0|0|100|DKK|11406|19897|vetorma|||00|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||11406||11406|19897|
123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|554|1665|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||554||554|1665|
123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|863|2088|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||863||863|2088|
123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|A||0|0|0|0|ICE|0|0|0|100|USD|25484|44456|vetorma|||00|100|0||Icepharma hf|Icepharma hf|||25484||25484|44456|
123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|PCO|0|0|1|100|DKK|2436|4240|lyfalmen|||00|100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2436||2436|4240|
123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|A||0|0|B|0|AGT|0|0|0|100|XEU|246|1244|lyfalmen|||00|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||246|1244|
123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|45424|59367|lyfalmen|||00|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||45424||45424|59367|
124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|A||0|0|0|0|CHP|0|0|0|100|XEU|1828|3636|vetalmen|||00|42|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals|||||1828|3636|
124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|A||0|0|0|0|SBM|0|0|0|100|NOK|37913|49940|lyfalmen|||00|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||37913|49940|
124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1004|2281|lyfalmen|||00|30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1004||1004|2281|
124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|A|2|0|0|0|0|ACA|0|0|0|100|XEU|513|1609|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||513||513|1609|
124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|A||0|0|*|0|ALC|0|0|0|100|USD|9960|14532|lyfalmen|V0464|14532|00|8|0||K.Pétursson hf|Alcon|Tímólól í blöndum||9960||9960|14532|
124936|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|RBP|0|0|0|100|DKK|1279|1846|lyfsjukr|||00|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1279||1279|1846|
125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|844|1627|lyfalmen|V0066|1627|00|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||526||526|1627|
126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|14595|20676|lyfalmen|V0264|20676|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14595||14595|20676|
126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||10|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ||||||
126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|SKB|0|0|0|100|GBP|109886|139789|lyfsjukr|||00|10|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||109886|139789|
126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|SKB|0|0|0|100|GBP|28200|37274|lyfsjukr|||00|10|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||28200|37274|
126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|25445|33816|lyfsjukr|||00|1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||25445||25445|33816|
126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|8481|12240|lyfsjukr|||00|1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||8481||8481|12240|
126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|46019|59636|lyfsjukr|||00|50|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||46019||46019|59636|
126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|92063|117422|lyfsjukr|||00|100|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||92063||92063|117422|
126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|184061|232879|lyfsjukr|||00|200|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||184061||184061|232879|
126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|MCS|0|0|0|100|SEK|1012|2292|lyfalmen|V0447|2029|10|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1012||1012|2292|
127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|ţpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|8746|6148|lyfalmen|V0279|3909|00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3831||3831|6148|
128131|QG51BE0002|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|6393|12448|vetalmen|||0|30|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||6393||6393|12448|
128173|C08DA0108|Verapamil Mylan|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|861|2085|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Verapamíl||861||861|2085|
128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1237|2600|lyfalmen|||10|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1237||1237|2600|
128777|N02BA5102|Treo|freyđit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10,0000|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole||||||
128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|3894|5620|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Baxter Medical AB|Mesna||3894||3894|5620|
129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|31532|29973|lyfalmen|V0280|12285|00|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22003||22003|29973|
129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|34272|23066|lyfalmen|V0282|15289|00|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||16499||16499|23066|
129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|221|1210|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||221||221|1210|
129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0,0000|Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3091|
129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4397|6922|lyfalmen|||00|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||4397||4397|6922|
130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|18127|22210|lyfalmen|V0285|19385|00|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||15817||15817|22210|
130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|28694|33785|lyfalmen|V0286|30036|00|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||25040||25040|33785|
130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|K|3|0|0|0|0|MYL|0|0|1|100|SEK|2279|4025|lyfalmen|||63|10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||2279||2279|4025|
130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4013|6397|lyfalmen|||02|125|0|31,2500|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||4013||4013|6397|
130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|1|100|SEK|1781|3344|lyfalmen|||63|10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||1781||1781|3344|
130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|IPI|0|0|1|100|DKK|11419|16528|lyfalmen|||0|53|0|20,6700|Icepharma hf|Pfizer Limited|Vareniclin||||11419|16528|
130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|K|1,25|0|0|0|0|PHA|0|0|0|100|NOK|64130|104628|veteldis|||0|500|0|0,0000|Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||64130|104628|
131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|0|100|SEK|3266|5375|lyfalmen|||00|10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríđ||||3266|5375|
131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|460|1537|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||460||460|1537|
131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|725|1899|lyfalmen|||00|100|0|15,0000|Vistor hf|Recip AB|||725||725|1899|
131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|967|2230|lyfalmen|||00|100|0|50,0000|Vistor hf|Recip AB|||967||967|2230|
131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|1070|2371|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|||1070||1070|2371|
131450|B01AC0405|Clopidogrel Qualigen (Lyfjaver)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2011||R|A||0|0|E|0|LVR|0|0|0|100|XEU|2619|4404|lyfalmen|V0009|3309|00|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Klópídógrel||2556||2556|4404|
131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5514|8450|lyfalmen|V0132|8450|23|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5514||5514|8450|
131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|ţpakki||N07BA01|01.10.2008|31.10.2011|L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín||||||
131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|8782|12921|lyfalmen|V0032|11808|0|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||8782|12921|
131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|26347|35425|lyfalmen|V0032|35425|0|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||26347|35425|
131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|87823|112577|lyfalmen|||0|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||87823|112577|
132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|ţpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|246|1167|lyfalmen|||00|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||190||190|1167|
132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|A||0|0|E|0|POF|0|0|0|100|SEK|7795|11571|lyfalmen|V0348|11571|00|28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||7795||7795|11571|
132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|9297|5233|lyfalmen|V0091|5233|00|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||3162||3162|5233|
132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|7450|5195|lyfalmen|V0090|5195|00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||3134||3134|5195|
132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1447|2887|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Kódein||1447||1447|2887|
132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7575|11270|lyfalmen|||0|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7575||7575|11270|
132761|D08AG0201|Betadine|áburđur|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||23|8|0|8,0000|Icepharma hf|Norpharma a/s|Jođ/pólývídón||||||
132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|SAL|0|0|0|100|USD|1059|2356|lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1059||1059|2356|
132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol||||||
132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|ţpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1348|2751|lyfalmen|||23|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1348||1348|2751|
133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|27552|36460|lyfsjukr|||0|0|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||27552||27552|36460|
133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|36649|47877|lyfsjukr|||0|1|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||36649||36649|47877|
133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|47888|61982|lyfsjukr|||0|2|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||47888|61982|
133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|A||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||00|8|0||Vistor hf|Meda AB (V)|Makrógól 3350||||||
133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|A||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||00|20|0||Vistor hf|Meda AB (V)|Makrógól 3350||||||
133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|A||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||00|50|0||Vistor hf|Meda AB (V)|Makrógól 3350||||||
133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|8272|12223|lyfalmen|||10|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8272||8272|12223|
134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|ţpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|92548|118030|lyfsjukr|||00|14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||92548||92548|118030|
134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|1519|2985|lyfalmen|||00|50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1519||1519|2985|
134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|4008|6390|lyfalmen|V0378|5813|00|9|0||Icepharma hf|Santen Oy|Taflúprost||4008||4008|6390|
134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|12015|17438|lyfalmen|V0378|17438|00|27|0||Icepharma hf|Santen Oy|Taflúprost||12015||12015|17438|
134498|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|5|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|1580|2280|lyfsjukr|||0|5|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||1580||1580|2280|
134509|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|10|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|3816|5507|lyfsjukr|||0|10|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||||3816|5507|
134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|4734|6832|lyfsjukr|||0|25|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||4734||4734|6832|
134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|A||0|1|0|1|BRS|0|0|0|100|DKK|70443|90288|lyfsjukr|||43|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70443||70443|90288|
134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|130521|165686|lyfsjukr|||00|30|0|0,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||130521||130521|165686|
135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|53057|68469|lyfsjukr|||00|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||53057||53057|68469|
135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|A||0|0|B|0|ADG|0|0|0|100|XEU|1852|3441|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1852||1852|3441|
135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|985|2255|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||985||985|2255|
135434|R03BA0502|Flixotide Diskus|innúđadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|2175|3883|lyfalmen|||23|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2175||2175|3883|
136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|ţpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1623|3128|lyfalmen|||23|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1623||1623|3128|
136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|6759|10153|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||6759||6759|10153|
136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|2211|3191|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||2211||2211|3191|
136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|6926|9996|lyfsjukr|||00|17|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||6926||6926|9996|
136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|5105|7368|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||5105||5105|7368|
136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|7957|11484|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||7957||7957|11484|
137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|||lyfsjukr|||00|20|0||Icepharma hf|Hospira Nordic AB|Oxalíplatín||||||
137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|međ rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Gervitár og ađrar óvirkar samsetningar|||||1605|
137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Gervitár og ađrar óvirkar samsetningar|||||1985|
137679|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas|plastglas|A09AA02|01.04.1990|30.09.2011|R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|4531|7106|lyfalmen|||10|100|0|100,0000|Medico ehf|Kali-Chemie|Hvatablöndur (lípasi, próteasi o.s.frv.)||4531||4531|7106|
137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|20357|27431|lyfsjukr|||00|25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||20357||20357|27431|
137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|2112|3048|lyfsjukr|||00|10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||2112||2112|3048|
137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|5258|7589|lyfsjukr|||00|10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||5258||5258|7589|
137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|5842|8431|lyfsjukr|||00|10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||5842||5842|8431|
137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|529|763|lyfsjukr|||00|500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||529||529|763|
138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|1513|2184|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1513||1513|2184|
138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1695|3226|lyfalmen|||00|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1695||1695|3226|
139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|2990|4998|lyfalmen|||00|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S-A|Klemastín||2990||2990|4998|
140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|137035|173861|lyfsjukr|||00|20|0|0,0000|Vistor hf|N.V. Organon|Sugammadex||137035||137035|173861|
140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|342477|431691|lyfsjukr|||00|50|0|0,0000|Vistor hf|N.V. Organon|Sugammadex||342477||342477|431691|
140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1451|2892|lyfalmen|V0266|1192|00|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1451||1451|2892|
140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|11740|16616|lyfsjukr|||02|10|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11740||11740|16616|
140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|DES|0|0|0|100|DKK|636|918|lyfsjukr|||02|5|0|3,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||636||636|918|
140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín||||||
141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1240|2604|lyfalmen|V0413|1737|03|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1240||1240|2604|
141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa||N01BB20|01.11.2008||R|A||0|0|0|0|DAC|0|0|1|100|SEK|3250|5353|lyfalmen|V0208|5353|00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Blöndur||3250||3250|5353|
141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|4420|6379|lyfsjukr|||00|1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4420||4420|6379|
141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|20993|28229|lyfsjukr|||00|1|0|0,5000|D.A.C. ehf|D.A.C. ehf|Voricónazól||20993||20993|28229|
141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3849|5555|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3849||3849|5555|
141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|2743|4660|lyfalmen|||00|30|0|1,0400|Vistor hf|Boehringer Ingelheim International |Pramipexól||2743||2743|4660|
141684|G03AA1205|Yaz|filmhtfl|0||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4612|7216|lyfalmen|||0|84|0|0,0000|Icepharma hf|Bayer AB|Dróspírenón og östrógen||4612||4612|7216|
141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|8598|12669|lyfalmen|V0267|3735|00|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8598||8598|12669|
142190|C07AA0511|Propranolol Mylan|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992|30.09.2011|R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|716|1887|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Própranólól||716||716|1887|
142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3255|4698|lyfsjukr|||02|30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3255||3255|4698|
142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1067|2367|lyfalmen|||70|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1067||1067|2367|
142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|2807|4747|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2807||2807|4747|
142928|S01EE0102|Xalatan (D.A.C.)|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.09.2010||R|K||0|0|*|0|DAC|0|0|0|100|DKK|7359|7019|lyfalmen|V0376|6460|06|8|0|75,0000|D.A.C. ehf|D.A.C. ehf|Latanóprost||4468||4468|7019|
143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1442|2880|lyfalmen|||03|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1442||1442|2880|
143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|2265|3269|lyfsjukr|||03|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2265||2265|3269|
143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|2|0|0|E|0|ANS|0|0|1|100|XEU|1247|2613|lyfalmen|||07|5|0|0,0000|Vistor hf|Anstalt zur gewerblichen Produktion|Prednisólón||1247||1247|2613|
143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3693|5959|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3693||3693|5959|
143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|SAL|0|0|0|100|USD|875|2104|lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||875||875|2104|
143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1472|2921|lyfalmen|||00|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1472||1472|2921|
143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|1326|2721|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1326||1326|2721|
143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|8417|12421|lyfalmen|V0386|9456|0|56|0|28,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||8417||8417|12421|
143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|604|1734|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||604||604|1734|
143800|N05AN0101|Litarex|forđatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1202|2552|lyfalmen|||10|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1202||1202|2552|
143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|2023|3675|lyfalmen|||00|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2023||2023|3675|
144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|DKK|2086|3761|lyfalmen|||10|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2086||2086|3761|
144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|A||0|0|0|0|ORR|0|1|0|100|DKK|22938|31147|lyfalmen|||22|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||22938||22938|31147|
144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|80555|102979|lyfsjukr|||AC|2|0|22,5000|Vistor hf|Novo-Nordisk|Sómatrópín||80555||80555|102979|
144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|60207|77442|lyfsjukr|||AC|2|0|15,0750|Vistor hf|Novo-Nordisk|Sómatrópín||60207||60207|77442|
144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|37409|48831|lyfsjukr|||AC|2|0|7,4250|Vistor hf|Novo-Nordisk|Sómatrópín||37409||37409|48831|
144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|653|1801|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||653||653|1801|
144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|298|1315|lyfalmen|||00|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||298||298|1315|
144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|459|1535|lyfalmen|||00|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||459||459|1535|
145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|K||0|1|0|1|CEO|0|0|0|100|DKK||108791|lyfsjukr|||00|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||85186||85186|108791|
145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|2216|3939|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2216||2216|3939|
145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||24|30|0|0,0000|Vistor hf|Recip AB|Pýrvín||||||
145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0|0,0000|Vistor hf|Recip AB|Pýrvín||||||
145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|ţpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0|0,0000|Vistor hf|Recip AB|Pýrvín||||||
145698|N05AH0301|Zyprexa|húđuđtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|20515|19808|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13903||13903|19808|
146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|K||0|1|0|1|GGL|0|0|0|100|GBP|29743|39210|lyfsjukr|||00|1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||29743||29743|39210|
146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|3033|4377|lyfsjukr|||0|2|0|0,0000|Icepharma hf|Hospira UK Ltd|Írinótekan||3033||3033|4377|
146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|6162|8893|lyfsjukr|||0|5|0|0,0000|Icepharma hf|Hospira UK Ltd|Írinótekan||6162||6162|8893|
146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|glas|hart|N06BA09|01.01.2010||R|A||0|1|0|0|ELI|0|0|0|100|XEU|17957|24895|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||17957||17957|24895|
146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|868|2095|lyfalmen|V0351|1064|41|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||868||868|2095|
147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|2515|3630|lyfsjukr|||0|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Cýtarabín||2515||2515|3630|
147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|1474|2127|lyfsjukr|||0|10|0|0,0000|Icepharma hf|Hospira Nordic AB|Cýtarabín||1474||1474|2127|
148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|112922|144077|lyfalmen|||00|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||112922||112922|144077|
148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|853|2074|lyfalmen|||00|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||853||853|2074|
148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|6165|8898|lyfsjukr|||02|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Vínkristín||6165||6165|8898|
148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|12924|18102|lyfsjukr|||02|10|0|0,0000|Icepharma hf|Hospira Nordic AB|Vínkristín||12924||12924|18102|
148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HOS|0|0|0|100|SEK|27648|36581|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||27648||27648|36581|
148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|3637|7156|vetalmen|||27|25|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3637||3637|7156|
149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|SEK|2057|3721|lyfalmen|||00|75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||2057||2057|3721|
149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|K||0|0|*|0|POF|0|0|0|100|DKK|2177|2516|lyfalmen|V0376|2153|06|2|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1176||1176|2516|
150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|16139|22614|lyfalmen|||10|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16139||16139|22614|
150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|52489|67756|lyfsjukr|||00|2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||52489|67756|
150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|DKK|3792|6095|lyfalmen|||00|28|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||3792|6095|
150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|DKK|6290|9512|lyfalmen|V0120|7469|00|56|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||6290|9512|
150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3527|5732|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Meningókokka polysakkaríđ mótefnavakar||||3527|5732|
151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|6482|9774|lyfalmen|||02|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6482||6482|9774|
151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1171|2509|lyfalmen|||05|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1171||1171|2509|
151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|15964|22394|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||15964|22394|
151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|49293|61274|lyfalmen|||00|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||46944||46944|61274|
151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|5238|4679|lyfalmen|V0148|4208|00|90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||2757||2757|4679|
151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|1577|3065|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1577||1577|3065|
152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|2011|2902|lyfsjukr|||02|5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||2011||2011|2902|
152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|A||0|0|0|0|DAC|0|0|0|100|XEU|2932|4446|lyfalmen|V0123|4446|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||2587||2587|4446|
152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||23|25|0|0,0000|Icepharma hf|Pfizer ApS|Píroxíkam||||||
152397|R03BA0202|Pulmicort Turbuhaler|innúđadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|3820|6133|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3820||3820|6133|
152413|R03BA0202|Pulmicort Turbuhaler|innúđadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5583|8545|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5583||5583|8545|
152421|R03BA0202|Pulmicort Turbuhaler|innúđadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|10243|14919|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||10243||10243|14919|
152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|18851|12934|lyfalmen|V0269|12934|00|100|0|28,0000|Lyfis ehf|Lyfis ehf|Pramipexól||8792||8792|12934|
152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1220|2576|lyfalmen|V0181|1415|10|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1220||1220|2576|
153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín||||||
153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1748|3299|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||1748||1748|3299|
153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín||||||
153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|39864|51912|lyfsjukr|||00|1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||39864|51912|
153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2207|3926|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2207||2207|3926|
153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1544|3019|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||1544||1544|3019|
153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|2293|4044|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||2293||2293|4044|
153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GIS|0|0|0|100|DKK|229387|289763|lyfsjukr|||00|10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||229387||229387|289763|
153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|A||0|0|B|0|AGT|0|0|0|100|XEU|546|1654|lyfalmen|||00|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||546|1654|
153507|L02BG0602|Exemestan Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|A||0|0|*|0|APC|0|0|0|100|XEU|35187|46519|lyfalmen|V0452|46519|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||35187||35187|46519|
153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|4213|6671|lyfalmen|V0181|5307|10|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4213||4213|6671|
153601|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|1|lykja||B03BA03|01.06.2010||R|K|2|0|0|E|0|SAN|0|0|1|100|DKK|1574|3061|lyfalmen|||02|1|0|50,0000|Vistor hf|Sandoz A/S|Hýdroxókóbalamín||1574||1574|3061|
154464|D05AX5203|Xamiol|hlaup|||30|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|4549|7130|lyfalmen|||00|30|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4549||4549|7130|
154475|D05AX5203|Xamiol|hlaup|||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|8116|12010|lyfalmen|||00|60|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8116||8116|12010|
154484|G04CA0102|Xatral Uno|forđatfl|10|mg|30|stk|1|ţpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|3265|5374|lyfalmen|||00|30|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||3265||3265|5374|
154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|1059|2356|lyfalmen|||10|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1059||1059|2356|
154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|29233|38570|lyfsjukr|||00|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||29233||29233|38570|
154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|38300|49949|lyfsjukr|||00|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||38300||38300|49949|
154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|42081|54694|lyfsjukr|||00|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||42081||42081|54694|
154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|31145|40969|lyfsjukr|||00|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||31145||31145|40969|
154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|38313|49965|lyfsjukr|||00|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||38313||38313|49965|
154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|27447|36328|lyfsjukr|||00|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||27447||27447|36328|
154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|3800|6106|lyfalmen|||10|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3800||3800|6106|
154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|35788|46796|lyfsjukr|||00|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||35788||35788|46796|
154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|1527|2996|lyfalmen|V0259|2996|00|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1527||1527|2996|
154732|G04CA0102|Xatral Uno|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|7326|10929|lyfalmen|||00|90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7326||7326|10929|
154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|4341|6002|lyfalmen|V0334|5984|00|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3724||3724|6002|
154750|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|2392|2393|lyfalmen|V0265|2393|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1086||1086|2393|
154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|6967|6002|lyfalmen|V0335|5984|00|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3724||3724|6002|
155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|AUG|0|0|0|100|XEU|1576|3063|lyfalmen|||00|25|0|0,0000|Aspen Europe GmbH|Aspen Europe GmbH|Chlorambucíl||1576||1576|3063|
155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|2219|3943|lyfalmen|V0247|3941|00|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2219||2219|3943|
155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|3740|6023|lyfalmen|V0248|6023|00|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3740||3740|6023|
155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|6724|10105|lyfalmen|V0249|10105|00|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||6724||6724|10105|
155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1501|2961|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1501||1501|2961|
155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|522|1621|lyfalmen|||00|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||522||522|1621|
155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|6578|9906|lyfalmen|V0181|9906|00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6578||6578|9906|
156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|ţpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|6342|9583|lyfalmen|V0018|6945|00|42|0|14,0000|Icepharma hf|Roche|Orlístat||6342||6342|9583|
156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|K||0|0|*|0|ELD|0|0|0|100|XEU|5876|8945|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5876||5876|8945|
156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|K||0|0|*|0|ELD|0|0|0|100|XEU|5925|9012|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5925||5925|9012|
156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|A||0|0|0|0|REP|0|0|1|100|SEK|423|1486|lyfalmen|||00|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||423||423|1486|
156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|1775|2562|lyfsjukr|||00|15|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||1775||1775|2562|
156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|992|1432|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||992||992|1432|
156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|3356|4844|lyfsjukr|||00|45|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||3356||3356|4844|
156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|9491|13891|lyfalmen|V0018|13891|00|84|0|28,0000|Icepharma hf|Roche|Orlístat||9491||9491|13891|
156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|5324|7684|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||5324||5324|7684|
156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|A|3|0|0|0|0|JAS|0|0|0|100|SEK|850|2070|lyfalmen|||00|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||850||850|2070|
157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|A||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín||||||
157053|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2009|31.10.2011|L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín||||||
157064|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2009|31.10.2011|L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|D.A.C. ehf|D.A.C. ehf|Nikótín||||||
157086|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2009|31.10.2011|L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|D.A.C. ehf|D.A.C. ehf|Nikótín||||||
157097|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2009|31.10.2011|L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín||||||
157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|10|spr||QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|7312|12755|vetorma|||16|260|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7312||7312|12755|
157741|N05AH0311|Olanzapine Ranbaxy|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|A||0|0|*|0|RAN|0|1|0|100|XEU|2723|4632|lyfalmen|V0279|3909|00|28|0|14,0000|Gróco ehf|Ranbaxy (UK) Ltd|Olanzapín||2723||2723|4632|
157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|DKK|498|1589|lyfalmen|||07|4|1|0,0000|Distica|Distica - óskráđ lyf|||498||498|1589|
157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|A||0|0|E|0|NOH|0|0|0|100|DKK|1529|2999|lyfalmen|V0239|2999|00|100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1529||1529|2999|
158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|A||0|0|*|0|ASA|0|1|0|100|SEK|1541|3015|lyfalmen|||00|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1541|3015|
158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|A||0|0|*|0|ASA|0|1|0|100|SEK|28386|37984|lyfalmen|||00|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||28386|37984|
158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|953|2211|lyfalmen|V0239|1500|00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||953||953|2211|
158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|103743|132080|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjađ)||||103743|132080|
158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|207487|262279|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjađ)||||207487|262279|
158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|588325|740230|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjađ)||||588325|740230|
158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|52995|68391|lyfsjukr|||0|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||52995|68391|
158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|75599|96759|lyfsjukr|||0|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||75599||75599|96759|
158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|DES|0|0|0|100|DKK|822|2032|lyfalmen|||23|5|0|13,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||822||822|2032|
158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|1006|2284|lyfalmen|V0469|2284|10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1006|2284|
159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3382|5534|lyfalmen|V0219|5534|00|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3382||3382|5534|
159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|5822|8872|lyfalmen|V0220|8872|00|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5822||5822|8872|
159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|7553|11239|lyfalmen|V0221|11239|00|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||7553||7553|11239|
159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|8800|12945|lyfalmen|V0223|12945|00|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||8800||8800|12945|
159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|5202|4610|lyfalmen|V0318|2466|00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2707||2707|4610|
159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|ţpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|20363|27915|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Exemestan||20363||20363|27915|
159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|13339|12317|lyfalmen|V0320|4114|00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8341||8341|12317|
159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|1886|2579|lyfalmen|V0062|1969|00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1222||1222|2579|
159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|3265|3639|lyfalmen|V0067|1850|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1997||1997|3639|
159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|6729|4853|lyfalmen|V0071|2092|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2884||2884|4853|
159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|455|1530|lyfalmen|||72|25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||455||455|1530|
159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1564|3047|lyfalmen|||72|100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1564||1564|3047|
159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|APC|0|0|0|100|DKK|101127|128797|lyfsjukr|||00|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||101127||101127|128797|
159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|4217|8270|vetalmen|||27|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||4217||4217|8270|
160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|2223|3948|lyfalmen|V0010|3915|00|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2223||2223|3948|
160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2281|3292|lyfsjukr|||02|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2281||2281|3292|
160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|36116|47208|lyfsjukr|||00|100|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||36116||36116|47208|
160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|52586|67878|lyfsjukr|||00|150|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||52586||52586|67878|
160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|991|2263|lyfalmen|||00|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||991||991|2263|
160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2375|4156|lyfalmen|||42|50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2375||2375|4156|
160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|70153|89925|lyfsjukr|||00|200|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||70153||70153|89925|
160739|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|30|stk|1|ţpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|380|1427|lyfalmen|V0468|1427|10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||380|1427|
160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|A||0|0|E|0|BOI|0|0|1|100|DKK|1207|2558|lyfalmen|||24|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1207||1207|2558|
160945|N02AA5901|Panocod|freyđit|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.01.1992|30.09.2011|R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|398|1452|lyfalmen|||14|20|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema međ geđlyfjum||398||398|1452|
161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|73614|94268|lyfsjukr|||0|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||73614||73614|94268|
161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PER|0|0|1|100|DKK|596|1723|lyfalmen|||03|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||596||596|1723|
161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|925|1335|lyfsjukr|||03|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||925||925|1335|
161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|840|1212|lyfsjukr|||03|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||840||840|1212|
161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|609|1740|lyfalmen|||03|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||609||609|1740|
161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4900|7610|lyfalmen|V0131|7610|23|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||4900||4900|7610|
161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|60561|78363|lyfalmen|V0452|46519|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||60561||60561|78363|
161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|2879|4155|lyfsjukr|||00|2|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2879||2879|4155|
161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|A||1|1|0|1|RBP|0|0|0|100|DKK|14272|19681|lyfsjukr|||00|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||14182||14182|19681|
161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120,0000|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd||||||
162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|4977|7183|lyfsjukr|||00|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4977||4977|7183|
162115|N06AA0906|Saroten|töflur|25|mg|100|stk|1|glas||N06AA09|01.12.2011||R|A||0|0|B|0|LBK|0|1|0|100|DKK|782|1977|lyfalmen|V0512|1956|00|100|0|33,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||782||782|1977|
162149|N06AA0906|Saroten|töflur|10|mg|100|stk|1|glas||N06AA09|01.12.2011||R|A||0|0|B|0|LBK|0|1|0|100|DKK|435|1502|lyfalmen|V0510|1490|00|100|0|13,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||435||435|1502|
162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|14604|20211|lyfsjukr|||00|18|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||14604||14604|20211|
162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PER|0|0|0|100|DKK|1928|3545|lyfalmen|||00|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1928||1928|3545|
162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|A||0|0|0|0|LEV|1|0|0|100|XEU|5460|10657|vetalmen|||27|5|0||Le Vet B.V.|Le Vet B.V.|||||5460|10657|
162929|G04CA0205|Ranomax|forđahlk|0,4|mg|100|stk|1|ţpakki||G04CA02|01.04.2009||R|A|4|0|0|E|0|RAN|0|0|0|100|XEU|4771|4675|lyfalmen|V0148|4675|00|100|0|100,0000|Gróco ehf|Ranbaxy (UK) Ltd|Tamsúlósín||2754||2754|4675|
162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2175|3883|lyfalmen|||24|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2175||2175|3883|
163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1151|2482|lyfalmen|||00|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1151||1151|2482|
163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1670|3192|lyfalmen|V0351|3192|41|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1670||1670|3192|
163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|203|1185|lyfalmen|||0|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||203|1185|
163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3215|4687|lyfalmen|||24|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2763||2763|4687|
163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|PCO|0|0|0|100|IKR|8140|12042|lyfalmen|||00|454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12042|
164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|AUG|0|0|0|100|XEU|3473|5658|lyfalmen|||00|25|0|0,0000|Aspen Europe GmbH|Aspen Europe GmbH|Merkaptópúrín||3473||3473|5658|
164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3903|5633|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3903||3903|5633|
164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1,5|0|0|E|0|MYL|0|0|0|100|SEK|2937|4925|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||2937|4925|
164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|9682|14152|lyfalmen|||00|100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||9682||9682|14152|
164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|1013|2293|lyfalmen|||00|100|0|10,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1013||1013|2293|
164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|935|2186|lyfalmen|V0314|2186|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||||935|2186|
164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|7174|10721|lyfalmen|V0014|10721|98|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7174||7174|10721|
165001|C05AA0102|Proctosedyl|eţ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||||
165019|C05AA0102|Proctosedyl|eţ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||||
165306|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|A|3|0|0|0|0|LAS|1|0|0|100|XEU|6947|13512|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|||6947||6947|13512|
165431|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4400|6926|lyfalmen|||43|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4400||4400|6926|
165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4969|7705|lyfalmen|V0059|3884|43|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4969||4969|7705|
165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3207|5294|lyfalmen|V0058|2779|43|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3207||3207|5294|
165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|K||0|1|0|1|EMA|0|0|0|100|SEK|261155|329632|lyfsjukr|||00|8|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||261155||261155|329632|
165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|36116|47208|lyfsjukr|||00|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||36116||36116|47208|
165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|52586|67878|lyfsjukr|||00|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||52586||52586|67878|
165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|687|1847|lyfalmen|||00|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||687||687|1847|
165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|199|1180|lyfalmen|||00|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||199||199|1180|
165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||00|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín||||||
165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|4124|5952|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4124||4124|5952|
165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|70153|89925|lyfsjukr|||00|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||70153||70153|89925|
165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|237808|300332|lyfsjukr|||00|500|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||237808||237808|300332|
166008|QJ51RC2202|Nafpenzal vet.|spenalyf|0||3|g|20|spr||QJ51RC22|01.02.2010||R|A||0|0|0|0|INI|0|0|0|100|DKK|4706|9209|vetalmen|||16|60|0||Icepharma hf|Intervet International B.V.|||||4706|9209|
166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|1049|2342|lyfalmen|||00|10|0|1,0000|Vistor hf|Pharmaxim Sweden AB|Aceprómazín||1049||1049|2342|
166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|1885|3486|lyfalmen|||00|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1885||1885|3486|
166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PER|0|0|0|100|DKK|15283|21540|lyfalmen|||23|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||15283||15283|21540|
166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2176|3884|lyfalmen|||10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2176||2176|3884|
166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|4120|6543|lyfalmen|V0428|6543|10|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4120||4120|6543|
166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|A||0|1|0|0|IPI|0|0|0|100|DKK|134468|171117|lyfalmen|||02|1|0||Icepharma hf|Pfizer Limited|Clostridíum||||134468|171117|
166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra||||||
167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|452|1526|lyfalmen|V0333|1526|00|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||452||452|1526|
168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|605|1735|lyfalmen|||00|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||605|1735|
168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|A||0|0|E|0|AGP|0|0|0|100|IKR|4762|6926|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||4400||4400|6926|
168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3070|5107|lyfalmen|V0433|5106|10|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3070||3070|5107|
168750|C07AB0209|Metoprolol Actavis|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|1754|2892|lyfalmen|||00|98|0|31,0300|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||1451||1451|2892|31.10.2011
168761|C07AB0209|Metoprolol Actavis|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2691|4255|lyfalmen|V0050|4255|00|98|0|62,0700|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||2447||2447|4255|
168815|N03AF0105|Tegretol Retard|forđatfl|400|mg|30|stk|1|ţpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1206|2557|lyfalmen|||10|30|0|12,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1206||1206|2557|
168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5666|8658|lyfalmen|V0240|8657|10|200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||5666||5666|8658|
168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|52909|68283|lyfsjukr|||00|10|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||52909||52909|68283|
169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|230037|290579|lyfsjukr|||00|50|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||230037||230037|290579|
169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|21826|29274|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||21826||21826|29274|
169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|5182|7996|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5182||5182|7996|
169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|1407|2755|lyfalmen|V0124|2755|67|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2755|
169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|2450|4125|lyfalmen|V0125|4125|67|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4125|
169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|1168|2505|lyfalmen|V0411|2505|00|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2505|
169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|647|1792|lyfalmen|V0177|1792|00|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1792|
169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|638|1780|lyfalmen|V0418|1780|00|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1780|
169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|393|1445|lyfalmen|V0176|1445|00|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1445|
169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2894|4866|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||2894||2894|4866|
169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3116|5170|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3116||3116|5170|
170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|24434|32547|lyfsjukr|||00|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||24434|32547|
170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|60642|77988|lyfsjukr|||00|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||60642|77988|
170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5571|8528|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5571||5571|8528|
170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|114627|145739|lyfsjukr|||00|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||114627||114627|145739|
170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|DKK|3923|6274|lyfalmen|||59|100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||3923||3923|6274|
170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|DKK|6867|10301|lyfalmen|||59|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||6867||6867|10301|
170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2368|4147|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||2368||2368|4147|
170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl|.|J01GB03|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|11488|16300|lyfsjukr|||00|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||11488||11488|16300|
170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|27636|36566|lyfsjukr|||00|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||27636||27636|36566|
170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|41455|53909|lyfsjukr|||00|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||41455||41455|53909|
170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|A|2|0|0|E|0|AGP|0|0|0|100|XEU|3374|4320|lyfalmen|V0203|4252|00|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||2495||2495|4320|
170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|A||0|0|E|0|POF|0|0|0|100|IKR|12363|4326|lyfalmen|V0207|4326|00|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||2499||2499|4326|
170997|L01BC0701|Vidaza|irţ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|A||0|1|0|1|CEE|0|0|0|100|XEU|57862|74499|lyfsjukr|||00|4|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|Azasitidín||57862||57862|74499|
171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3588|5816|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||3588||3588|5816|
171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3866|6196|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||3866||3866|6196|
171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|NOK|1550|3028|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|||1550||1550|3028|
171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4380|6899|lyfalmen|V0247|3941|00|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4380||4380|6899|
171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|7210|10770|lyfalmen|V0248|6023|00|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7210||7210|10770|
171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|41670|54178|lyfsjukr|||02|75|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||41670||41670|54178|
172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|27781|36748|lyfsjukr|||02|50|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||27781||27781|36748|
172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|13021|18701|lyfalmen|V0249|10105|00|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13021||13021|18701|
172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|24438|33029|lyfalmen|||00|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||24438||24438|33029|
172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|63896|82072|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||63896||63896|82072|
172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|30160|32640|lyfalmen|V0346|32640|00|112|0|74,6700|Lyfis ehf|Lyfis ehf|Rívastigmín||24128||24128|32640|
172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|1|*|0|AUG|0|0|0|100|XEU|3508|5706|lyfalmen|||00|100|0|0,0000|Aspen Europe GmbH|Aspen Europe GmbH|Búsúlfan||3508||3508|5706|
172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|11401|16503|lyfalmen|||00|98|0|0,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||11401||11401|16503|
172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|6400|9662|lyfalmen|||10|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6400||6400|9662|
172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|11890|17172|lyfalmen|||10|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||11890||11890|17172|
172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|20628|28248|lyfalmen|||10|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||20628||20628|28248|
172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2306|4062|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum međ öđrum toxóíđum||2306||2306|4062|
172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2306|4062|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum međ öđrum toxóíđum||2306||2306|4062|
172794|M05BA0707|Risedronato Semanal Qualigen (Lyfjaver)|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.05.2011||R|A||0|0|0|0|LVR|0|0|0|100|IKR|830|2043|lyfalmen|V0207|1442|00|4|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rísedrónsýru||830||830|2043|
172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|26900|36119|lyfalmen|||10|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||26900||26900|36119|
173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|431|1497|lyfalmen|||00|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||431||431|1497|
173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2825|4772|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||2825||2825|4772|
173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3517|
173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|6031|9157|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||6031||6031|9157|
173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|ţpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|1025|2310|lyfalmen|||00|10|0|10,0000|Vistor hf|Meda AS|Tenoxíkam||1025||1025|2310|
173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|K||0|1|0|1|AMG|0|0|0|100|DKK|16714|22728|lyfsjukr|||00|2|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||16610||16610|22728|
173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|ţpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|346|1381|lyfalmen|||00|30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||346||346|1381|
173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|SEK|2881|4848|lyfalmen|||00|250|1|13,8889|Distica|Distica - óskráđ lyf|Pyridostigmin||2881||2881|4848|
173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|SEK|12617|18194|lyfalmen|||00|150|1|50,0000|Distica|Distica - óskráđ lyf|Pyridostigmin||12617||12617|18194|
173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1385|1999|lyfsjukr|||02|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1385||1385|1999|
174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|661|1812|lyfalmen|||00|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||661||661|1812|
174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|676|1832|lyfalmen|||00|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||676||676|1832|
174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|1747|3297|lyfalmen|V0368|2639|00|5|0|25,0000|Vistor hf|Allergan|Brímónidín||1747||1747|3297|
174615|N05CF0105|Zopiklon Mylan|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|256|1258|lyfalmen|V0312|1258|00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||||256|1258|
174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|5124|7917|lyfalmen|V0368|7917|00|15|0|150,0000|Vistor hf|Allergan|Brímónidín||5124||5124|7917|
175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2464|2578|lyfalmen|V0033|2539|00|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||1221||1221|2578|
176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|6663|4909|lyfalmen|V0278|3084|00|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2925||2925|4909|
177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|814|2021|lyfalmen|||43|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||814||814|2021|
177311|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|4|spr||QJ51RC22|01.04.1985|31.10.2011|R|A|2|0|0|0|0|INI|0|0|0|100|XEU|651|1295|vetalmen|||16|12|0|0,0000|Icepharma hf|Intervet International B.V.|||651||651|1295|
178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|723|1896|lyfalmen|||03|1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|1896|
179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|K||0|1|0|1|CEO|0|0|0|100|DKK||212606|lyfsjukr|||00|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||167907||167907|212606|
179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997|30.09.2011|R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|10521|15086|lyfsjukr|||00|60|0|0,0000|Vistor hf|N.V. Organon|Rókúrón, brómíđ||10521||10521|15086|
179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|ţpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|A||0|1|0|1|WIL|0|0|0|100|XEU|130801|166038|lyfsjukr|||00|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||130801||130801|166038|
180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|5637|8618|lyfalmen|||10|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5637||5637|8618|
180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||||
180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|802|2004|lyfalmen|||30|5|0|0,0000|Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||802||802|2004|
181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||23|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól||||||
181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|8096|15718|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer vet.|||8096||8096|15718|
181750|L01BA0105|Methotrexate Wyeth Lederle|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|9842|14204|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||9842||9842|14204|
181990|L01BA0105|Methotrexate Wyeth Lederle|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991|30.09.2011|R|A|3|0|1|0|1|PER|0|0|0|100|DKK|38510|50213|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||38510||38510|50213|
182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|IBV|0|0|0|100|DKK|4910|9600|vetalmen|||16|100|0|0,0000|Vistor hf|Intervet International BV|||4910||4910|9600|
183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5427|10593|vetalmen|||27|50|0|0,0000|Vistor hf|Intervet International BV|||5427||5427|10593|
183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|A||0|0|B|0|ALK|0|0|1|100|DKK|5827|8878|lyfalmen|||00|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5827|8878|
183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1196|2543|lyfalmen|||00|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1196||1196|2543|
183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|ţpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|828|2040|lyfalmen|||41|21|0|2,1000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||828||828|2040|
184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|XEU|492|1580|lyfalmen|||08|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||492||492|1580|
184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1643|2050|lyfalmen|||08|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2050|
184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|XEU|624|1761|lyfalmen|||00|15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||624||624|1761|
184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|4828|7512|lyfalmen|V0017|7297|98|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4828||4828|7512|
184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|21873|29810|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||21873||21873|29810|
184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|55589|72124|lyfalmen|V0185|58695|00|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||55589||55589|72124|
184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|XEU|1186|2530|lyfalmen|||00|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1186||1186|2530|
184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|5222|8051|lyfalmen|V0235|7628|00|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5222||5222|8051|
187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|5319|8183|lyfalmen|||00|100|1|20,0000|Distica|Distica - óskráđ lyf|||5319||5319|8183|
188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2947|4939|lyfalmen|||00|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2947||2947|4939|
188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|USD|1903|3511|lyfalmen|||00|100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíđ||1903||1903|3511|
189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|7207|10402|lyfsjukr|||00|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Deferoxamín||7207||7207|10402|
189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|2511|4342|lyfalmen|V0413|4342|03|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2511||2511|4342|
189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1034|2322|lyfalmen|V0413|1737|03|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1034||1034|2322|
189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|500|1591|lyfalmen|V0413|868|03|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||500||500|1591|
189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|A||0|1|0|1|PER|0|0|0|100|DKK|464|670|lyfsjukr|||02|1|0||Icepharma hf|Pfizer ApS|Metótrexat||464||464|670|
190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.12.1972|31.10.2011|R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|648|1794|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||648||648|1794|
190728|M01AB0101|Confortid|eţ-stíll|50|mg|10|stk|1|pakki||M01AB01|01.12.1972|31.10.2011|R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|450|1523|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||450||450|1523|
191064|B05XC03|Vitalipid Infant|irţ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|3888|5611|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||3888||3888|5611|
191247|B05XC02|Vitalipid Adult|irţ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|3704|5346|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||3704||3704|5346|
191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|3821|5515|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||3821||3821|5515|
191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|8|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A||0|0|E|0|PER|0|0|1|100|DKK|525|1626|lyfalmen|||07|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||525||525|1626|
192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|A||0|0|B|0|AGP|0|1|0|100|XEU|3852|6177|lyfalmen|||00|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3852||3852|6177|
192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1617|3119|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1617||1617|3119|
192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|451|1524|lyfalmen|||10|25|0|25,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||451||451|1524|
193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|21,6000|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2162|
193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|870|2097|lyfalmen|||02|50|0|2,5091|Vistor hf|Sandoz A/S|Kalsíumglúbíónat||870||870|2097|
194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|1071|1546|lyfsjukr|||02|2|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||1071||1071|1546|
194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2069|3738|lyfalmen|||00|100|0|16,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2069||2069|3738|
195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1798|3367|lyfalmen|||00|250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||1798||1798|3367|
195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2487|4309|lyfalmen|V0390|4309|03|5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2487||2487|4309|
195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|790|1988|lyfalmen|V0390|862|03|1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||790||790|1988|
195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|13771|17638|lyfalmen|V0012|15907|00|98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||12174||12174|17638|
195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|K||0|1|0|1|EMA|0|0|0|100|SEK|87052|111133|lyfsjukr|||00|2|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||87052||87052|111133|
195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|K||0|1|0|1|CEO|0|0|0|100|DKK||212606|lyfsjukr|||00|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||167907||167907|212606|
195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|741|1921|lyfalmen|||20|15|0|15,0000|Vistor hf|Janssen-Cilag AB|Blöndur||741||741|1921|
195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|379|1426|lyfalmen|||10|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||379||379|1426|
195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|804|2007|lyfalmen|||10|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||804||804|2007|
196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|2298|4051|lyfalmen|||00|250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||2298||2298|4051|
196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1431|2865|lyfalmen|||23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1431||1431|2865|
196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|26745|35447|lyfsjukr|||00|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||26745|35447|
197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2573|5113|vetalmen|||27|10|0|0,0000|Icepharma hf|Intervet International B.V.|||2573||2573|5113|
197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|12251|23696|vetalmen|||27|50|0|0,0000|Icepharma hf|Intervet International B.V.|||12251||12251|23696|
197343|D11AX0101|Regaine|húđlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988|31.10.2011|L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60,0000|Vistor hf|McNeil Denmark ApS|Mínoxidíl|||||6147|
197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|766|1955|lyfalmen|||06|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Nafazólín í blöndum međ öđrum efnum||766||766|1955|
197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|857|2080|lyfalmen|||00|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||857||857|2080|
197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2805|4744|lyfalmen|||00|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2805||2805|4744|
197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2126|3816|lyfalmen|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2126||2126|3816|
198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|AUG|0|0|0|100|XEU|2120|3807|lyfalmen|||00|25|0|0,0000|Aspen Europe GmbH|Aspen Europe GmbH|Melphalan||2120||2120|3807|
198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PER|0|0|0|100|DKK|7178|10360|lyfsjukr|||02|200|0|0,0000|Icepharma hf|Pfizer ApS|Flúóróúracíl||7178||7178|10360|
198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|407|587|lyfsjukr|||02|5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||407||407|587|
199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PER|0|0|0|100|DKK|36071|47629|lyfalmen|||00|100|0|0,0000|Icepharma hf|Pfizer ApS|Estramústín||36071||36071|47629|
199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|A||0|0|0|0|APC|0|0|0|100|IKR|9134|13402|lyfalmen|V0515|13402|00|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||9134||9134|13402|
199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PER|0|0|1|100|DKK|633|1773|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||633||633|1773|
199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|94201|120105|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||94201|120105|
199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|4670|7296|lyfalmen|V0126|7296|44|8|0|4,0000|Icepharma hf|Pfizer ApS|Kabególín||4670||4670|7296|
199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|56257|72485|lyfsjukr|||00|5|0|0,4000|Icepharma hf|Centocor -|Abciximab||56257||56257|72485|
300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|5200|7854|lyfalmen|||00|60|1|12,0000|Distica|Distica - óskráđ lyf|||5078||5078|7854|
370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|675|974|lyfsjukr|||02|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||675||675|974|
370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|587|847|lyfsjukr|||03|1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||587||587|847|
371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum||||||
371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum||||||
371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||9688|
371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín||||||
372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|ţpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|1766|3323|lyfalmen|||00|30|0|3,7500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||1766||1766|3323|
372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|6314|9545|lyfalmen|V0288|9543|00|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||6314||6314|9545|
372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3659|5913|lyfalmen|||00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3659||3659|5913|
372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2509|4340|lyfalmen|||23|66|0|88,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||2509||2509|4340|
373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|18995|26198|lyfalmen|V0289|26197|00|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||18995||18995|26198|
373324|R03AK0602|Seretide Diskus|innúđadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|3983|6356|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||3983||3983|6356|
373340|R03AK0602|Seretide Diskus|innúđadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|6579|9907|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6579||6579|9907|
373365|R03AK0602|Seretide Diskus|innúđadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|9081|13330|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9081||9081|13330|
373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|1581|3070|lyfalmen|V0126|1824|44|2|0|1,0000|Icepharma hf|Pfizer ApS|Kabególín||1581||1581|3070|
374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|SEK|669|1823|lyfalmen|V0500|1587|00|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||669||669|1823|
374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|5736|8278|lyfsjukr|||00|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5736||5736|8278|
374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|4599|7199|lyfalmen|||00|30|0|30,0000|Vistor hf|Yamanouchi Europe|Tamsúlósín||4599||4599|7199|
374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|11110|16105|lyfalmen|||00|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11110||11110|16105|
374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól||||||
374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|8957|13160|lyfalmen|||00|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8957||8957|13160|
374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|10631|15450|lyfalmen|||00|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10631||10631|15450|
374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|12420|17947|lyfalmen|||00|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||12420||12420|17947|
376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|A||0|0|E|0|AZA|0|0|0|100|SEK|30374|40479|lyfalmen|V0459|40479|00|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||30374||30374|40479|
376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|A||0|1|*|0|ASP|0|0|0|100|XEU|20326|27869|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||20326||20326|27869|
376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|A||0|1|*|0|ASP|0|0|0|100|XEU|93139|119249|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||93139||93139|119249|
377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4290|6776|lyfalmen|||63|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4290||4290|6776|
377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|10760|10071|lyfalmen|V0182|9880|00|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||6699||6699|10071|
379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|115055|146277|lyfsjukr|||00|2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||115055||115055|146277|
379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|162106|205326|lyfsjukr|||00|2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||162106||162106|205326|
379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|205244|259464|lyfsjukr|||00|2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||205244||205244|259464|
379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1510|2973|lyfalmen|||00|12|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1510||1510|2973|
379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1867|3461|lyfalmen|||00|12|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1867||1867|3461|
381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|A||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín||||||
381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5599|8567|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5599||5599|8567|
381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|7618|10071|lyfalmen|V0143|9345|00|12|0|12,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||6699||6699|10071|
383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6838|10261|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||6838||6838|10261|
383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|1287|2245|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1287|2245|
383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|7754|13526|vetorma|||00|20|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||7754||7754|13526|
383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0|60,0000|Actavis Group hf|Actavis hf|Ketókónazól||||||
383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|Actavis Group hf|Actavis hf|Ketókónazól||||||
383990|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|3722|7319|vetalmen|||16|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3722||3722|7319|
386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|6161|7168|lyfalmen|V0144|7168|00|8|0|16,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||4577||4577|7168|
386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|56465|73223|lyfalmen|V0184|38175|00|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||56465||56465|73223|
387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|732|1456|vetalmen|||00|100|0|0,0000|Icepharma hf|Icepharma hf|||732||732|1456|
387746|J02AA0101|Abelcet|irţ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|CEP|0|0|0|100|DKK|201183|254367|lyfsjukr|||00|200|0|28,5714|Icepharma hf|Cephalon France (I)|Amfóterícín||201183||201183|254367|
388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3251|5355|lyfalmen|V0208|5353|00|25|0|5,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||3251||3251|5355|
388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|4097|6512|lyfalmen|||00|30|0|30,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||4097||4097|6512|
388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||||||
388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|7951|11784|lyfalmen|||23|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||7951||7951|11784|
388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|A|2|0|0|E|0|APC|0|0|0|100|IKR|805|1887|lyfalmen|V0466|1887|00|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||716||716|1887|
389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2382|4166|lyfalmen|V0410|4166|23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2382||2382|4166|
389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2176|3884|lyfalmen|||23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2176||2176|3884|
389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|690|1851|lyfalmen|V0128|1851|00|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||690||690|1851|
389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|639|1781|lyfalmen|||00|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||639||639|1781|
389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|973|2238|lyfalmen|V0367|1314|00|3|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||973||973|2238|
389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|2695|3853|lyfalmen|V0143|3115|00|4|0|4,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||2153||2153|3853|
389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|5227|3735|lyfalmen|V0267|3735|00|100|0|7,2000|Lyfis ehf|Lyfis ehf|Pramipexól||2067||2067|3735|
390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|2934|4921|lyfalmen|||01|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2934||2934|4921|
390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|7032|10527|lyfalmen|V0429|10525|00|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||7032||7032|10527|
390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|2777|4706|lyfalmen|V0037|4706|00|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2777||2777|4706|
391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|13551|19366|lyfalmen|V0196|19365|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||13551||13551|19366|
391730|N01BB0203|Xylocain|úđalyf|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2618|4489|lyfalmen|||00|50|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2618||2618|4489|
392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|237808|300332|lyfsjukr|||00|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||237808||237808|300332|
392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|flaska||A04AA01|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|IKR|12000|17419|lyfalmen|||00|50|1||Distica|Distica - óskráđ lyf|Ondansetrón||||12000|17419|
393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|DKK|5647|11016|vetalmen|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5647||5647|11016|
393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|K||0|1|0|1|AMG|0|0|0|100|DKK|149396|188206|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||148465||148465|188206|
395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|A||0|0|0|0|LVR|0|0|0|100|SEK|27391|36251|lyfalmen|V0356|36251|00|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27005||27005|36251|
395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|166683|211070|lyfsjukr|||02|300|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||166683||166683|211070|
397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|K||0|1|0|1|MKA|0|0|0|100|SEK|35560|46510|lyfsjukr|||00|20|0||Icepharma hf|Merck KgaA|Cetúxímab||35560||35560|46510|
397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|9947|14356|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Roche|Capecitabín||9947||9947|14356|
397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|57032|73458|lyfsjukr|||00|120|0|0,0000|Icepharma hf|Roche|Capecitabín||57032||57032|73458|
397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|A||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||00|2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat||||||
398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|7655|9090|lyfalmen|V0012|9090|00|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||5982||5982|9090|
399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|3535|3349|lyfalmen|V0009|3309|00|28|0|28,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||1785||1785|3349|
399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3253|lyfalmen|V0244|3253|00|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1715||1715|3253|
399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|9067|13311|lyfalmen|||02|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9067||9067|13311|
399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|39707|51715|lyfsjukr|||00|2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||39707||39707|51715|
399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír||||||
400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1487|2942|lyfalmen|||06|8|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1487||1487|2942|
400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|0,0000|Actavis Group hf|Actavis hf|Blöndur||||||
400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5178|7991|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5178||5178|7991|
400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|225|1215|lyfalmen|||00|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||225||225|1215|
400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|407|1464|lyfalmen|||00|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||407||407|1464|
400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|194|1173|lyfalmen|||00|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||194||194|1173|
401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|A||0|0|E|0|AZA|0|0|0|100|SEK|10494|15263|lyfalmen|V0459|13493|00|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||10494||10494|15263|
401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|762|1950|lyfalmen|||00|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||762||762|1950|
401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1219|2575|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1219||1219|2575|
401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|1197|2545|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1197||1197|2545|
401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|1922|3537|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1922||1922|3537|
402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|655|1803|lyfalmen|||51|0|0|0,0000|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsađir  mótefnavakar||655||655|1803|
402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1679|3340|vetalmen|||58|100|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1679||1679|3340|
403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.03.2011||R|A||0|1|*|0|LYF|0|0|0|100|XEU|20690|23618|lyfalmen|V0470|23618|00|100|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||16939||16939|23618|
403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5163|10086|vetalmen|||27|20|0|0,0000|Vistor hf|Intervet International BV|||5163||5163|10086|
403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|5897|8974|lyfalmen|||10|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||5897||5897|8974|
403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|A||0|1|0|1|PER|0|0|0|100|DKK|37151|48507|lyfsjukr|||00|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||37151|48507|
403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1419|2848|lyfalmen|||06|14|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1419||1419|2848|
404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0,0000|Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1788|
404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|65435|84003|lyfsjukr|||02|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||65435||65435|84003|
404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|687|992|lyfsjukr|||02|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||687||687|992|
405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|K||0|0|0|0|AEL|1|0|0|100|XEU|8159|15839|vetalmen|||00|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||8159||8159|15839|
405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1730|3274|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1730||1730|3274|
405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|18437|25498|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||18437||18437|25498|
405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|17854|24766|lyfalmen|||00|28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||17854||17854|24766|
406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813|
406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|20372|27926|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20372||20372|27926|
406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|20718|28360|lyfalmen|||00|28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20718||20718|28360|
406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|20188|27695|lyfalmen|||00|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20188||20188|27695|
406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901|
406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|60869|78750|lyfalmen|||00|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||60869||60869|78750|
406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|68422|88229|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||68422||68422|88229|
406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|73760|94928|lyfalmen|||00|100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||73760||73760|94928|
406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|ţpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|6181|9363|lyfalmen|||00|30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6181||6181|9363|
407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2142|3838|lyfalmen|||00|100|0|12,5000|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||2142||2142|3838|
407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PER|0|0|1|100|DKK|168|1137|lyfalmen|||00|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||168||168|1137|
407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PER|0|0|0|100|DKK|366|1408|lyfalmen|||00|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||366||366|1408|
408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2885|4854|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2885||2885|4854|
408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2262|4002|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2262||2262|4002|
409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|4292|6779|lyfalmen|||08|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4292||4292|6779|
409326|N05CD0307|Flunipam|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.2011||R|A||1|0|0|0|MYL|0|0|0|100|NOK|523|1623|lyfalmen|||00|30|1|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||523||523|1623|
409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|3733|6014|lyfalmen|||00|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3733||3733|6014|
409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|4151|6586|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4151||4151|6586|
409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|12500|18047|lyfalmen|||00|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||12500||12500|18047|
409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|2981|4985|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2981||2981|4985|
409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PAB|1|0|0|100|DKK|10638|20599|vetalmen|||27|120|0|0,0000|Vistor hf|Pharmaxim AB|||10638||10638|20599|
409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|10129|14763|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||10129||10129|14763|
410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1113|2430|lyfalmen|||00|20|0|10,0000|Vistor hf|Recip AB|Klórókín||1113||1113|2430|
410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|760|1947|lyfalmen|||23|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Tretínóín||760||760|1947|
411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|665|1817|lyfalmen|||00|50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||665||665|1817|
411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|4897|7068|lyfsjukr|||02|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4897||4897|7068|
411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|24506|32638|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||24506||24506|32638|
411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|ţpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|1554|3033|lyfalmen|||67|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1554||1554|3033|
411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7169|10714|lyfalmen|||98|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7169||7169|10714|
412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.01.1990||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|22245|30277|lyfalmen|V0183|30276|00|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||22245||22245|30277|
412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3729|5382|lyfsjukr|||00|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3729||3729|5382|
412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|10057|19484|vetalmen|||02|100|0|0,0000|Vistor hf|Merial|||10057||10057|19484|
412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|K||0|1|0|1|BIN|0|0|0|100|XEU|128402|163027|lyfsjukr|||00|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||128402||128402|163027|
412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MYL|0|0|0|100|SEK|3343|5480|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3343||3343|5480|
412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|A||0|0|*|0|MYL|0|0|0|100|SEK|4106|6524|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4106||4106|6524|
414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|A||0|0|E|0|WIH|0|0|0|100|XEU|28561|34220|lyfalmen|V0342|34173|00|98|0|130,6700|Portfarma ehf|Williams & Halls|Dónepezíl||25387||25387|34220|
414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|DKK|2152|3851|lyfalmen|||00|2|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|||2152||2152|3851|
414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|3825|6140|lyfalmen|||00|90|0|54,0000|Icepharma hf|Servier|Indapamíđ||3825||3825|6140|
414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1327|2723|lyfalmen|||00|300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1327||1327|2723|
415556|B03AC0204|Venofer  (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|14796|20867|lyfalmen|V0034|18236|00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíđ (sykurflétta)||14747||14747|20867|
415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|1907|3516|lyfalmen|||05|15|0|15,0000|Vistor hf|Novo-Nordisk|Estradíól||1907||1907|3516|
416222|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|28|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997|30.09.2011|R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|3049|5078|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||3049||3049|5078|
416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|9538|9512|lyfalmen|V0088|4244|00|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||6290||6290|9512|
416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|4191|6640|lyfalmen|V0005|6300|00|28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||4191||4191|6640|
416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|PCO|0|0|0|100|GBP|4910|7624|lyfalmen|||00|300|1|15,0000|Distica|Distica - óskráđ lyf|Ranitidín||4910||4910|7624|
416829|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.03.2011||R|A|1|1|0|0|1|RBP|0|0|0|100|DKK|4925|7108|lyfsjukr|||00|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||4925||4925|7108|
416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|2902|4877|lyfalmen|||23|10|0|0,0000|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||2902||2902|4877|
416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|DKK|26109|35126|lyfalmen|||23|150|0|0,0000|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||26109||26109|35126|
416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1205|2556|lyfalmen|||00|30|0|30,0000|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1205||1205|2556|
417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|VII|0|0|0|100|GBP|40110|52221|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||40110||40110|52221|
418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|A||0|0|E|0|BII|0|0|0|100|DKK|34410|45544|lyfalmen|V0460|45544|00|180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||34410|45544|
418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|ţpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|4824|7506|lyfalmen|||10|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4824||4824|7506|
418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1608|3107|lyfalmen|||20|50|0|50,0000|Vistor hf|Schering-Plough|Betametasón||1608||1608|3107|
418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|7348|10959|lyfalmen|V0014|10721|00|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||7348||7348|10959|
418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2056|4090|vetalmen|||13|200|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||2056||2056|4090|
418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dćla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2667|5294|vetalmen|||13|200|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||2667||2667|5294|
419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|3342|5479|lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||3342||3342|5479|
419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7147|10684|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7147||7147|10684|
419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|DKK|52472|67735|lyfsjukr|||00|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||52472||52472|67735|
419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|39817|51853|lyfsjukr|||00|100|0|7,5000|Swedish Orphan International AB|Orphan  Europe (S)|Mecaptamín||39817||39817|51853|
419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|810|2015|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||810||810|2015|
420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|12114|17562|lyfalmen|||02|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12114||12114|17562|
421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1517|2983|lyfalmen|V0036|2981|70|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1517||1517|2983|
422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1483|2936|lyfalmen|V0051|2240|00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1483||1483|2936|
422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3389|5226|lyfalmen|V0050|4255|43|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3157||3157|5226|
422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5840|8896|lyfalmen|||43|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||5840||5840|8896|
422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|A|2|0|1|0|1|CSB|0|0|0|100|SEK|71859|92066|lyfsjukr|||63|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||71859||71859|92066|
422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|SEK|4685|7316|lyfalmen|||49|100|0|50,0000|Vistor hf|Meda AS|Brómókriptín||4685||4685|7316|
423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|6810|4989|lyfalmen|V0011|4457|0|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2984||2984|4989|
424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|1629|2842|vetorma|||16|24|0|0,0000|Icepharma hf|Intervet International B.V.|||||1629|2842|
425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MYL|0|0|0|100|SEK|790|1988|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||790||790|1988|
425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|ţpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|18420|25477|lyfalmen|||52|100|0|25,0000|Vistor hf|Meda AS|Brómókriptín||18420||18420|25477|
425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|A||1|1|0|1|RBP|0|0|0|100|DKK|4795|6876|lyfsjukr|||00|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4764||4764|6876|
426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|2|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|661|1812|lyfalmen|||00|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||661||661|1812|
426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|864|2089|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||864||864|2089|
427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2667|
428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|864|2089|lyfalmen|||20|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||864||864|2089|
428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1014|2294|lyfalmen|||20|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1014||1014|2294|
428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|48480|62725|lyfsjukr|||00|2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||48480||48480|62725|
428822|C10AA0504|Atorvastatin Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|6185|3174|lyfalmen|V0113|3174|00|100|0|100,0000|Portfarma ehf|Portfarma|Atorvastatín||1657||1657|3174|
428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|27737|27751|lyfalmen|V0344|27751|00|112|0|37,3300|Lyfis ehf|Lyfis ehf|Rívastigmín||20232||20232|27751|
429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dćlu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4240|6707|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4240||4240|6707|
429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|41720|54718|lyfalmen|||AC|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||41720||41720|54718|
429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|4104|6521|lyfalmen|||00|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||4104||4104|6521|
430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1668|2407|lyfsjukr|||02|50|0|0,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||1668||1668|2407|
430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1449|2091|lyfsjukr|||02|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1449||1449|2091|
430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|3845|7556|vetalmen|||27|100|0|0,0000|Vistor hf|Intervet International BV|||3845||3845|7556|
430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|A||0|0|*|0|WIH|0|0|0|100|XEU|29401|38175|lyfalmen|V0184|38175|00|98|0|98,0000|Portfarma ehf|Williams & Halls|Anastrózól||28538||28538|38175|
430417|N03AX2101|Trobalt|filmhtfl|400|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|32576|43242|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||32576||32576|43242|
430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|2975|4199|lyfalmen|V0144|3584|00|4|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||2406||2406|4199|
430710|J07AP0301|Typhim Vi|bóluefni|||0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2461|4274|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir  mótefnavakar||2461||2461|4274|
431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|765|1954|lyfalmen|||20|15|0|15,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||765||765|1954|
431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|ţpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1141|2468|lyfalmen|||00|100|0|16,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1141||1141|2468|
431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|A||0|1|0|1|AVS|0|0|0|100|NOK|233036|294343|lyfsjukr|||00|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||233036||233036|294343|
431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PER|0|0|1|100|DKK|1420|2850|lyfalmen|||00|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1420|2850|
431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PER|0|0|1|100|DKK|4815|7494|lyfalmen|||00|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4815||4815|7494|
432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|A||0|0|E|0|NDR|0|0|0|100|SEK|36849|48605|lyfalmen|||02|12|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||36849|48605|
432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|XEU|1153|2485|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1153||1153|2485|
433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|11110|16105|lyfalmen|||0|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11110||11110|16105|
433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2598|4461|lyfalmen|V0040|3292|00|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2598||2598|4461|
433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|5688|8688|lyfalmen|||00|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5688||5688|8688|
433342|N02AA0106|Contalgin Uno|forđahlk|150|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|8682|12784|lyfalmen|||00|28|0|42,0000|Icepharma hf|Pfizer ApS|Morfín||8682||8682|12784|
433512|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|619|1754|lyfalmen|V0004|737|00|7|0|4,6700|Portfarma ehf|Portfarma|Esómeprazól||619||619|1754|
434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|1141|1990|vetorma|||99|10|0|0,0000|Icepharma hf|Intervet International B.V.|||||1141|1990|
434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|MCS|0|0|1|100|SEK|879|2110|lyfalmen|||20|50|0|50,0000|Vistor hf|McNeil Sweden AB|Blöndur||879||879|2110|
434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|MEB|0|0|1|100|DKK|5827|8878|lyfalmen|||00|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5827||5827|8878|
434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|MEB|0|0|1|100|DKK|5827|8878|lyfalmen|||00|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5827||5827|8878|
434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|0|0|ELI|0|1|0|100|XEU|10316|15019|lyfalmen|V0315|5671|00|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10316||10316|15019|
435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|ţpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|6579|9907|lyfalmen|||00|6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6579||6579|9907|
435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|ţpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4565|7152|lyfalmen|||00|6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4565||4565|7152|
435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|8118|10595|lyfalmen|V0284|9036|00|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7082||7082|10595|
435817|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|25|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|A||0|0|*|0|LVR|0|1|0|100|SEK|3321|5450|lyfalmen|V0284|5422|00|60|0|3,7500|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||3321||3321|5450|
435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2746|4664|lyfalmen|||00|250|0|41,6700|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2746||2746|4664|
436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|A||0|1|0|1|AST|0|0|0|100|DKK|237199|299567|lyfsjukr|||02|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||237199||237199|299567|
436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3553|5768|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||3553||3553|5768|
436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9860|14395|lyfalmen|V0090|5195|00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||9860||9860|14395|
436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||||||
436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|744|1925|lyfalmen|||20|15|0|15,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||744||744|1925|
436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|A||0|1|0|1|AST|0|0|0|100|DKK|243255|307168|lyfsjukr|||02|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||243255||243255|307168|
436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|938|2191|lyfalmen|||00|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||938||938|2191|
436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3431|5601|lyfalmen|||00|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3431||3431|5601|
437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|10111|12371|lyfalmen|V0029|12371|00|100|0|100,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||8380||8380|12371|
437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|A||0|1|0|1|AST|0|0|0|100|DKK|68181|87450|lyfsjukr|||02|125|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||68181||68181|87450|
438225|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|glas||N07XX07|01.12.2011||R|A||0|1|0|1|BEI|0|0|0|100|XEU|32767|43005|lyfsjukr|||00|28|0|14,0000|Biogen Idec Ltd.|Biogen Idec Ltd.|Fampridine||32767||32767|43005|
438333|N06AX1602|Efexor Depot|forđahlk|150|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|6193|9379|lyfalmen|V0265|2393|00|28|0|42,0000|Icepharma hf|Pfizer ApS|Venlafaxín||6193||6193|9379|
438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|742|1922|lyfalmen|||00|20|1|4,0000|Parlogis hf|Parlogis - óskráđ lyf|||742||742|1922|
438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|SAL|0|0|1|100|USD|1170|2508|lyfalmen|||00|10|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1170||1170|2508|
438424|N06AX1602|Efexor Depot|forđahlk|75|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|3244|5345|lyfalmen|V0259|2996|00|28|0|21,0000|Icepharma hf|Pfizer ApS|Venlafaxín||3244||3244|5345|
438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|11155|16167|lyfalmen|V0334|5984|00|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11155||11155|16167|
438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín||||||
438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||R|A|4|0|0|0|0|SCP|0|0|1|100|DKK|1890|3493|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||1890||1890|3493|
438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|5950|9047|lyfalmen|V0362|3152|00|100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||5950||5950|9047|
438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|165316|209354|lyfsjukr|||00|3|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||165316||165316|209354|
439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2660|4546|lyfalmen|||66|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2660||2660|4546|
439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8388|12382|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||8388||8388|12382|
439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||||
440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2366|lyfalmen|||00|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2366|
440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1487|2146|lyfsjukr|||00|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1487||1487|2146|
440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2348|3389|lyfsjukr|||00|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2348||2348|3389|
441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|930|2180|lyfalmen|V0046|2180|00|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||930||930|2180|
441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1232|2593|lyfalmen|||20|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Blöndur||1232||1232|2593|
441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0|0,0000|Aco Hud Nordic AB|ACO Hud AB|Permetrín||||||
441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|978|2245|lyfalmen|||00|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||978||978|2245|
442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|A||0|0|E|0|BII|0|0|0|100|DKK|11470|16598|lyfalmen|V0460|15181|00|60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11470|16598|
443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|3464|5646|lyfalmen|||02|1|0|1,0000|Vistor hf|Novo-Nordisk|Glúkagon||3464||3464|5646|
443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|26407|35500|lyfalmen|||10|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||26407||26407|35500|
444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|A||0|0|0|0|ORR|0|1|0|100|DKK|7646|11367|lyfalmen|||22|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7646||7646|11367|
444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|0|0|ELI|0|1|0|100|DKK|3139|5201|lyfalmen|V0061|3260|00|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3139||3139|5201|
444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2286|4034|lyfalmen|||00|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2286||2286|4034|
444927|M05BA0601|Bondronat|irţ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|15118|20856|lyfsjukr|||00|2|0|0,3300|Icepharma hf|Roche|Íbandrónsýra||15118||15118|20856|
445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1594|3088|lyfalmen|||00|30|0|30,0000|Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1594||1594|3088|
446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1452|2888|vetalmen|||27|50|0|0,0000|Icepharma hf|Intervet International B.V.|||1452||1452|2888|
447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|10634|15454|lyfalmen|||00|4|0|3,6000|Icepharma hf|Pfizer ApS|Dalteparín||10634||10634|15454|
447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|6060|9197|lyfalmen|||00|2|0|2,0000|Icepharma hf|Pfizer ApS|Dalteparín||6060||6060|9197|
447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|7501|11168|lyfalmen|||00|2|0|2,5000|Icepharma hf|Pfizer ApS|Dalteparín||7501||7501|11168|
447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|8927|13119|lyfalmen|||00|3|0|3,0000|Icepharma hf|Pfizer ApS|Dalteparín||8927||8927|13119|
448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|0|0|IGB|0|0|0|100|SEK|619|1754|lyfalmen|||04|10|0|0,0000|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||619||619|1754|
448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1210|2563|lyfalmen|||00|30|0|0,0000|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1210||1210|2563|
448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2126|3816|lyfalmen|V0202|3444|00|50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2126||2126|3816|
449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1367|2777|lyfalmen|||00|98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1367||1367|2777|
449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|5569|8037|lyfsjukr|||00|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5569||5569|8037|
450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|ţp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2311|lyfalmen|V0169|2296|00|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2311|
450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|ţpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|874|1676|lyfalmen|V0060|1676|00|20|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||562||562|1676|
450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3035|4009|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2267||2267|4009|
450979|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA03|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|7478|13045|vetorma|||16|2|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||7478||7478|13045|
451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|54696|71003|lyfalmen|||00|100|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||54696||54696|71003|
451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|82045|105326|lyfalmen|||00|150|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||82045||82045|105326|
451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|109392|139646|lyfalmen|||00|200|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíđ||109392||109392|139646|
451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|ţpakki||N06AB04|01.11.1999||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|5749|7987|lyfalmen|||00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5175||5175|7987|
451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|15184|21415|lyfalmen|||00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||15184||15184|21415|
452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1167|2504|lyfalmen|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1167||1167|2504|
452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|K||0|0|0|0|LHS|0|0|0|100|XEU|11204|19545|vetorma|||00|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11204||11204|19545|
452482|V07AB09|Sterilt Vann B. Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|11667|16867|lyfalmen|||00|3000|0|3,0000|Vistor hf|Laboratories 3M Santé|Imikvímóđ||11667||11667|16867|
452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|A|3|0|0|0|0|LCF|0|0|0|100|DKK|2354|4128|lyfalmen|||00|90|0|0,0000|Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2354||2354|4128|
452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2387|4173|lyfalmen|||10|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2387||2387|4173|
452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7016|10505|lyfalmen|||10|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||7016||7016|10505|
452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|4608|7211|lyfalmen|||10|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4608||4608|7211|
453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|1480|2582|vetorma|||16|6|0|0,0000|Vistor hf|Merial (MSD)|||||1480|2582|
453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|13587|19411|lyfalmen|||10|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||13587||13587|19411|
453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|8819|12971|lyfalmen|||10|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||8819||8819|12971|
453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|24765|33439|lyfalmen|||10|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||24765||24765|33439|
453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PER|0|1|0|100|DKK|2766|3992|lyfsjukr|||02|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2766||2766|3992|
453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dćla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2308|4065|lyfalmen|||00|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||2308||2308|4065|
454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|15411|21700|lyfalmen|||00|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||15411||15411|21700|
454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|43723|38963|lyfalmen|V0341|31797|00|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||29166||29166|38963|
454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|2425|3937|lyfalmen|V0004|2948|00|28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||2215||2215|3937|
454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|17300|24071|lyfalmen|||00|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||17300||17300|24071|
454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|48172|43443|lyfalmen|V0342|34173|00|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||32736||32736|43443|
454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|A||0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||04|10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól||||||
454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|SKB|0|0|0|100|GBP|51682|66743|lyfsjukr|||00|1|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||51682||51682|66743|
454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1154|2296|vetalmen|||16|100|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1154||1154|2296|
455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAP|0|0|0|100|SEK|998|2273|lyfalmen|||00|30|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||998||998|2273|
455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|ţpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAP|0|0|0|100|SEK|3584|5810|lyfalmen|||00|120|0|20,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||3584||3584|5810|
455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|22034|30012|lyfalmen|||00|21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||22034||22034|30012|
455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|925|2173|lyfalmen|||00|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||925||925|2173|
455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|1046|2338|lyfalmen|||0|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1046||1046|2338|
455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|2169|3874|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2169||2169|3874|
457119|B05DA0002|Dianeal PD1 Glucose Duo|kviđ.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9808|14155|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||9808||9808|14155|
457242|B05DB0002|Dianeal PD1 Glucose Duo|kviđ.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9561|13799|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||9561||9561|13799|
457291|B05DB0002|Dianeal PD1 Glucose Duo|kviđ.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12094|17060|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12094||12094|17060|
457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|805|2009|lyfalmen|V0003|2009|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||805||805|2009|
458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|CHE|0|0|1|100|SEK|1151|2482|lyfalmen|||00|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1151||1151|2482|
458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1449|2890|lyfalmen|||43|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1449||1449|2890|
458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|ţpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2106|3788|lyfalmen|||43|30|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2106||2106|3788|
458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|ţpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|8711|12824|lyfalmen|V0161|12824|00|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||8711||8711|12824|
458737|B05DA0003|Dianeal PD4 Glucose Duo|kviđ.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12094|17060|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12094||12094|17060|
458778|B05DB0003|Dianeal PD4 Glucose Duo|kviđ.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12094|17060|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12094||12094|17060|
458794|B05DB0003|Dianeal PD4 Glucose Duo|kviđ.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12094|17060|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12094||12094|17060|
458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|A||0|0|E|0|XEL|0|0|1|100|DKK|24334|32899|lyfalmen|||00|28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||24334||24334|32899|
459104|N05AH0310|Zalasta (LYFIS)|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|LYF|0|1|0|100|XEU|2495|3084|lyfalmen|V0278|3084|00|28|0|7,0000|LYFIS ehf|LYFIS ehf|Olanzapín||1591||1591|3084|
459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|861|1243|lyfsjukr|||02|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||861||861|1243|
459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|1576|2275|lyfsjukr|||02|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1576||1576|2275|
459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1444|2883|lyfalmen|V0370|2883|06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||1444||1444|2883|
459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1348|2751|lyfalmen|V0371|2751|06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||1348||1348|2751|
459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|A||0|0|0|0|ORR|0|1|0|100|DKK|7646|11367|lyfalmen|||22|20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7646||7646|11367|
459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2149|3847|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2149||2149|3847|
459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|ţpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4363|6876|lyfalmen|||00|60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4363||4363|6876|
460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4037|6430|lyfalmen|||51|0|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4037||4037|6430|
460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|ţpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|565|1680|lyfalmen|||23|20|0|15,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||565||565|1680|
460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|MCS|0|0|1|100|SEK|||lyflausa|||23|120|0|120,0000|Vistor hf|McNeil Sweden AB|Ketókónazól||||||
460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|7153|13907|vetalmen|||16|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||7153||7153|13907|
460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|5622|8598|lyfalmen|||51|5|0|0,0000|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsađir  mótefnavakar||5622||5622|8598|
461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|189|1166|lyfalmen|||00|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||189||189|1166|
462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|647|1792|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||647||647|1792|
462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|647|1792|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||647||647|1792|
462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7465|11119|lyfalmen|V0385|11118|56|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7465||7465|11119|
462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|A||0|0|E|0|XEL|0|0|1|100|DKK|12151|17609|lyfalmen|||0|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||12151||12151|17609|
462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|6737|13109|vetalmen|||02|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||6737|13109|
463490|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|8702|12811|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||8702||8702|12811|
463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5374|10491|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5374||5374|10491|
464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||||||
464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|LPL|0|1|0|100|DKK|1778|3340|lyfalmen|||00|100|0|8,3333|Swedish Orphan Biovitrum A/S|Lundbeck Pharmaceuticals|Melperón||1778||1778|3340|
465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|K||0|0|*|0|APC|0|0|0|100|DKK|4098|6460|lyfalmen|V0376|6460|06|8|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||4059||4059|6460|
465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|K|2|0|0|0|0|INI|0|0|0|100|DKK|1194|2375|vetalmen|||58|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1194||1194|2375|
465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1127|2242|vetalmen|||58|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1127||1127|2242|
465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1209|2405|vetalmen|||27|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1209||1209|2405|
465278|QJ51RC2301|Nafpenzal DC,  vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|636|1265|vetalmen|||16|12|0|0,0000|Icepharma hf|Intervet International B.V.|||636||636|1265|
466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|670|1824|lyfalmen|||10|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||670||670|1824|
466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2075|3746|lyfalmen|||10|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2075||2075|3746|
466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|1485|2939|lyfalmen|V0040|2939|10|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1485||1485|2939|
466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|5806|8850|lyfalmen|||10|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5806||5806|8850|
466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2762|4686|lyfalmen|||10|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2762||2762|4686|
466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|7955|11789|lyfalmen|||10|50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7955||7955|11789|
466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|4544|7123|lyfalmen|||10|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4544||4544|7123|
466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|4454|7000|lyfalmen|||64|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||4454||4454|7000|
467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|15346|21142|lyfsjukr|||00|0|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||15346||15346|21142|
467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|23517|31396|lyfsjukr|||00|0|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||23517||23517|31396|
467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|18575|25194|lyfsjukr|||00|1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||18575||18575|25194|
467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|29959|39481|lyfsjukr|||00|1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||29959||29959|39481|
467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|DKK|34041|45081|lyfalmen|||00|60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||34041||34041|45081|
467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|15520|21837|lyfalmen|||10|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||15520||15520|21837|
467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|55719|71810|lyfsjukr|||00|1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||55719||55719|71810|
467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|29550|39445|lyfalmen|||10|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||29550||29550|39445|
467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|496|716|lyfsjukr|||00|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||496||496|716|
468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6440|6617|lyfalmen|V0317|4605|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4174||4174|6617|
468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|377|544|lyfsjukr|||02|10|0|0,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||377||377|544|
468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|9377|6301|lyfalmen|V0318|4404|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3943||3943|6301|
468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|23694|12765|lyfalmen|V0320|7346|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8668||8668|12765|
468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|4530|4326|lyfalmen|V0207|4326|00|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2499||2499|4326|
469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|5662|8653|lyfalmen|||00|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5662||5662|8653|
469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|7624|11003|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7624||7624|11003|
469742|N02AX0206|Nobligan Retard|forđatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000|30.09.2011|R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1822|3400|lyfalmen|||00|20|0|13,3333|Icepharma hf|Grunenthal|Tramadól||1822||1822|3400|
469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6341|9582|lyfalmen|V0228|9568|00|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6341||6341|9582|
469866|N02AX0206|Nobligan Retard|forđatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000|30.09.2011|R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1306|2694|lyfalmen|||00|20|0|10,0000|Icepharma hf|Grunenthal|Tramadól||1306||1306|2694|
469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|5156|7961|lyfalmen|V0227|7412|00|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||5156||5156|7961|
469890|N02AX0206|Nobligan Retard|forđatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000|30.09.2011|R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|811|2017|lyfalmen|||00|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||811||811|2017|
469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3366|5512|lyfalmen|V0226|4832|00|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3366||3366|5512|
470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5700|8705|lyfalmen|||24|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5700||5700|8705|
470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|7128|10287|lyfsjukr|||02|150|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||7128||7128|10287|
471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|9514|13731|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||9514||9514|13731|
471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4414|6371|lyfsjukr|||02|100|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||4414||4414|6371|
471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|9505|13718|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||9505||9505|13718|
471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|13651|19015|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||13651||13651|19015|
471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PER|0|0|0|100|DKK|1224|2582|lyfalmen|||68|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1224||1224|2582|
471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|2135|3724|vetorma|||99|20|0|0,0000|Icepharma hf|Intervet International B.V.|||||2135|3724|
471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|3265|5374|lyfalmen|||00|100|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3265||3265|5374|
471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|4784|9359|vetalmen|||27|10|0|0,0000|Vistor hf|Orion Corporation|||4784||4784|9359|
472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2082|3654|lyfalmen|||43|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2008||2008|3654|
472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0||Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3041|5067|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3041||3041|5067|
472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|13879|16595|lyfalmen|V0012|15907|00|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||11468||11468|16595|
474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|15193|20950|lyfsjukr|||00|400|0|0,4000|Vistor hf|Meda AB|Dextran||15193||15193|20950|
474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0|0,0000|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||||
474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1002|2278|lyfalmen|||00|30|0|3,7500|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||1002||1002|2278|
474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0|0,0000|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||||
474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|ţpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|36712|47956|lyfsjukr|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||36712||36712|47956|
474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1860|3452|lyfalmen|||00|140|0|35,0000|Vistor hf|Schering-Plough|Mómetasón||1860||1860|3452|
474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|S||0|0|0|0|PHM|0|0|0|100|DKK|27775|53505|vetalmen|||02|1200|0|0,0000|Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||||27775|53505|
474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|802|1192|lyfalmen|V0266|1192|00|30|0|1,0600|Lyfis ehf|Lyfis ehf|Pramipexól||208||208|1192|
475327|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|pakki||N02BE01|01.07.2008|30.11.2011|L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól||||||
475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|930|2180|lyfalmen|||00|100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||930||930|2180|
475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3126|5184|lyfalmen|V0130|5184|23|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||3126||3126|5184|
475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|285|1297|lyfalmen|||00|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||285||285|1297|
475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|348|1383|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||348||348|1383|
475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|972|2237|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||972||972|2237|
475798|R03AC1302|Oxis Turbuhaler|innúđadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|3600|5832|lyfalmen|||00|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3600||3600|5832|
475822|R03AC1302|Oxis Turbuhaler|innúđadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|4742|7394|lyfalmen|||00|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4742||4742|7394|
475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5600|8568|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5600||5600|8568|
476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|6051|9185|lyfalmen|||51|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||6051||6051|9185|
476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|77852|99587|lyfsjukr|||00|1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||77852|99587|
476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1117|2435|lyfalmen|||00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1117||1117|2435|
476736|N05AH0311|Olanzapine Ranbaxy|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2011||R|A||0|0|*|0|RAN|0|1|0|100|XEU|11914|17205|lyfalmen|V0282|15289|00|56|0|56,0000|Gróco ehf|Ranbaxy (UK) Ltd|Olanzapín||11914||11914|17205|
477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|5008|7758|lyfalmen|||00|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5008||5008|7758|
477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|A||0|0|*|0|APC|0|0|0|100|XEU|497|1587|lyfalmen|V0500|1587|00|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||497||497|1587|
479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|A||0|1|*|0|WIL|0|0|0|100|XEU|29475|39351|lyfalmen|V0454|39351|00|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||29475||29475|39351|
479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|ţpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|9675|14142|lyfalmen|||00|98|0|130,6667|Vistor hf|Meda AS|Benazepríl||9675||9675|14142|
479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|ţpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|20218|27733|lyfalmen|||00|98|0|261,3333|Vistor hf|Meda AS|Benazepríl||20218||20218|27733|
480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|ţpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|4102|6519|lyfalmen|||00|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||4102||4102|6519|
480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|A||0|0|E|0|WIH|0|0|0|100|XEU|26293|31797|lyfalmen|V0341|31797|00|98|0|65,3333|Portfarma ehf|Williams & Halls|Dónepezíl||23456||23456|31797|
480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|ţpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|12421|17948|lyfalmen|||00|84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||12421||12421|17948|
481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|13500|19302|lyfalmen|||00|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||13500||13500|19302|
483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|2786|4021|lyfsjukr|||00|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2786||2786|4021|
483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|4808|6939|lyfsjukr|||00|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4808||4808|6939|
483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|A||0|0|E|0|AGP|0|0|1|100|XEU|292|1199|lyfalmen|V0055|1199|00|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||213||213|1199|
484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|57462|73997|lyfsjukr|||00|3|0|83,9552|Vistor hf|Ferring|Triptórelín||57462||57462|73997|
484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|5971|9075|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||5971||5971|9075|
484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|K||0|1|0|1|AEU|0|0|0|100|DKK|153794|194894|lyfsjukr|||00|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||153794||153794|194894|
484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1350|2754|lyfalmen|||00|300|0|0,0000|Vistor hf|Meda AB (V)|Benzýdamín||1350||1350|2754|
486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||||||
486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|SAL|0|0|1|100|USD|447|1519|lyfalmen|||29|5|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||447||447|1519|
486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|SAL|0|0|1|100|USD|638|1780|lyfalmen|||29|5|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||638||638|1780|
487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|ţpakki||C09AA04|01.01.1992|30.09.2011|R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|3784|6084|lyfalmen|||00|30|0|30,0000|Icepharma hf|Servier|Perindópríl||3784||3784|6084|
487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|A||0|1|*|0|WIL|0|0|0|100|XEU|32918|43671|lyfalmen|V0453|43671|00|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||32918||32918|43671|
487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|ţpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|597|1724|lyfalmen|||00|25|0|6,2500|Vistor hf|Recip AB|Nítrófúrantóín||597||597|1724|
487959|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.07.2008|30.11.2011|L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól||||||
488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|933|2184|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||933||933|2184|
488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2595|4457|lyfalmen|V0198|3682|00|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2595||2595|4457|
488114|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1345|
488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|6313|9543|lyfalmen|||67|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6313||6313|9543|
488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|11353|16438|lyfalmen|||67|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||11353||11353|16438|
489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|103775|132120|lyfsjukr|||00|2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||103775|132120|
489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1170|lyfalmen|V0188|439|67|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1170|
489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|A|3|0|0|E|0|NOH|0|0|1|100|IKR|882|1546|lyfalmen|V0188|1318|67|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1546|
490417|G03FB0504|Evorel Sequi|forđapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2335|4102|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2335||2335|4102|
490425|G03FA0104|Evorel Conti|forđapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2461|4274|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2461||2461|4274|
490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3975|6345|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3975||3975|6345|
490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10879|10557|lyfalmen|V0112|2456|00|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7054||7054|10557|
490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|5285|8137|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5285||5285|8137|
490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|15438|14338|lyfalmen|V0113|3174|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9818||9818|14338|
490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|19635|17908|lyfalmen|V0114|5976|00|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12389||12389|17908|
491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|49608|64141|lyfsjukr|||00|3|0|21,0084|Vistor hf|N.V. Organon|BCG bóluefni||49608||49608|64141|
492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3298|5419|lyfalmen|||10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3298||3298|5419|
492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||||
492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12338|17844|lyfalmen|V0002|7629|00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||12338||12338|17844|
492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|A|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||||
493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0||Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|A||0|0|0|0|APC|0|0|0|100|IKR|31723|42172|lyfalmen|V0516|42172|00|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||31723||31723|42172|
494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1400|2822|lyfalmen|||00|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1400||1400|2822|
494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|2479|4299|lyfalmen|||00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||2479||2479|4299|
494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|81213|103805|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Roche Registration Limited|Rítúxímab||81213||81213|103805|
494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|203033|256689|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Roche Registration Limited|Rítúxímab||203033||203033|256689|
494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|2023|3675|lyfalmen|||00|60|0|60,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2023||2023|3675|
494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2269|4011|lyfalmen|V0128|1851|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Estradíól||2269||2269|4011|
494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3298|5419|lyfalmen|V0410|4166|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3298||3298|5419|
494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1875|3472|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1875||1875|3472|
495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|17998|24947|lyfalmen|||00|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||17998||17998|24947|
495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7000|8125|lyfalmen|V0382|6330|02|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||5276||5276|8125|
495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|10001|12467|lyfalmen|V0383|9939|02|20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||8450||8450|12467|
495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2746|4664|lyfalmen|||00|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2746||2746|4664|
496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|30160|32640|lyfalmen|V0345|32640|00|112|0|56,0000|Lyfis ehf|Lyfis ehf|Rívastigmín||24128||24128|32640|
496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4246|8326|vetalmen|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||4246|8326|
496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|AUG|0|0|0|100|GBP|5711|8720|lyfalmen|||02|100|0|0,8333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||5711||5711|8720|
496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|AUG|0|0|0|100|GBP|1002|2278|lyfalmen|||00|50|0|8,3333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||1002||1002|2278|
496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|K||0|1|0|1|SOI|0|0|0|100|DKK|86363|110268|lyfsjukr|||00|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||86363||86363|110268|
496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|AUG|0|0|0|100|GBP|3143|5207|lyfalmen|||00|100|0|33,3333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||3143||3143|5207|
496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|471|1552|lyfalmen|||04|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||471||471|1552|
496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PER|0|0|0|100|DKK|850|2070|lyfalmen|||00|20|0|2,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||850||850|2070|
497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PER|0|0|0|100|DKK|3243|5344|lyfalmen|||00|100|0|10,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3243||3243|5344|
497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|A|2|0|0|0|0|ACA|0|0|0|100|XEU|341|1374|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||341||341|1374|
497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|505|1407|lyfalmen|V0448|1407|00|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||365||365|1407|
497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|1051|1948|lyfalmen|V0449|1948|00|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||761||761|1948|
497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|1510|2913|lyfalmen|V0369|2913|06|5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1466||1466|2913|
498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1367|2777|lyfalmen|||03|2|0|35,0000|Vistor hf|Schering-Plough|Betametasón||1367||1367|2777|
498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|17035|23738|lyfalmen|||00|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17035||17035|23738|
498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|18172|25165|lyfalmen|||00|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||18172||18172|25165|
499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|22636|30768|lyfalmen|||00|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||22636||22636|30768|
499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|27346|36679|lyfalmen|V0455|36638|00|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||27346||27346|36679|
501734|M01AB0508|Vostar-R|forđatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|2795|4731|lyfalmen|V0190|4731|67|100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||2795||2795|4731|
502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3075|5114|lyfalmen|V0434|4390|10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3075||3075|5114|
502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|2998|5008|lyfalmen|||00|100|0|25,0000|Vistor hf|Amdipharm Ltd|Maprótilín||2998||2998|5008|
503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|30237|39830|lyfsjukr|||00|1|0|27,9851|Vistor hf|Ferring|Triptórelín||30237||30237|39830|
503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|6651|7783|lyfalmen|V0343|7783|00|28|0|4,6700|Lyfis ehf|Lyfis ehf|Rívastigmín||5026||5026|7783|
503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|A|3|0|0|0|0|NOH|0|0|1|100|IKR|||lyflausa|||00|20|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||||||
504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|A||0|0|*|0|AGP|0|0|0|100|XEU|1660|3178|lyfalmen|V0494|3178|00|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1660||1660|3178|
504191|N02BA5102|Treo|freyđit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3,3333|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole||||||
504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2051|3713|lyfalmen|||00|90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2051||2051|3713|
504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1166|2502|lyfalmen|||00|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1166||1166|2502|
505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|8248|12190|lyfalmen|||00|100|0|75,0000|Vistor hf|Amdipharm Ltd|Maprótilín||8248||8248|12190|
505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|1813|2617|lyfsjukr|||02|5|0|0,0000|Icepharma hf|Pfizer ApS|Doxórúbicín||1813||1813|2617|
505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|3621|5226|lyfsjukr|||02|10|0|0,0000|Icepharma hf|Pfizer ApS|Doxórúbicín||3621||3621|5226|
505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|8262|11924|lyfsjukr|||02|25|0|0,0000|Icepharma hf|Pfizer ApS|Doxórúbicín||8262||8262|11924|
506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|2476|4294|lyfalmen|||10|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2476||2476|4294|
506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl||||||
507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|402|1457|lyfalmen|||10|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||402||402|1457|
507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|662|1155|vetorma|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||662|1155|
507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|2814|4909|vetorma|||16|120|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||2814|4909|
507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|16154|28180|vetorma|||13|1000|0|0,0000|Icepharma hf|Intervet International B.V.|||16154||16154|28180|
507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|2525|5021|vetalmen|||27|50|0|0,0000|Vistor hf|Intervet International BV|||2525||2525|5021|
508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|2569|4422|lyfalmen|||10|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2569||2569|4422|
508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|5133|10029|vetalmen|||0|100|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||5133|10029|
508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4117|8078|vetalmen|||0|50|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4117||4117|8078|
508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|12737|24630|vetalmen|||0|100|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||12737||12737|24630|
508921|L01CD0401|Jevtana|irţ|60|mg|15|ml|1|hgl|+ leysir|L01CD04|01.08.2011||R|A||0|1|0|1|SAA|0|0|0|100|NOK|716256|900784|lyfsjukr|||00|15|0||Vistor hf|Sanofi - Aventis|Cabazitaxel||716256||716256|900784|
509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|8993|13209|lyfalmen|||02|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8993||8993|13209|
509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2757|
509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|46549|60301|lyfsjukr|||00|60|0|0,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||46549||46549|60301|
510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|16715|22860|lyfsjukr|||00|2|0|12,0000|Icepharma hf|Roche|Epóetín||16715||16715|22860|
510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|25021|33284|lyfsjukr|||00|2|0|18,0000|Icepharma hf|Roche|Epóetín||25021||25021|33284|
510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|41041|53389|lyfsjukr|||00|2|0|30,0000|Icepharma hf|Roche|Epóetín||41041||41041|53389|
510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|81162|103741|lyfsjukr|||00|4|0|60,0000|Icepharma hf|Roche|Epóetín||81162||81162|103741|
510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|188449|238386|lyfsjukr|||00|1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||188449|238386|
510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|4183|5474|lyfalmen|V0445|5474|00|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||3338||3338|5474|
511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|ţpakki||C09CA07|01.03.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|2722|4631|lyfalmen|||00|28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2722||2722|4631|
511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2704|4606|lyfalmen|V0525|4606|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2704||2704|4606|
511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|22855|30566|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||22855||22855|30566|
511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|14297|19825|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||14297||14297|19825|
512608|B05XA3101|Peditrace|irţ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5279|7619|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5279||5279|7619|
513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||||||
513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|A||0|0|0|0|ORR|0|1|0|100|DKK|22938|31147|lyfalmen|||22|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||22938||22938|31147|
513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|2127|4231|vetalmen|||27|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2127||2127|4231|
514265|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2003|3647|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2003||2003|3647|
514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|A||0|0|B|0|ADG|0|0|0|100|XEU|2100|3780|lyfalmen|||00|100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2100||2100|3780|
515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|ţpakki||N06AX18|01.06.2000|31.10.2011|R|A|3|0|0|B|0|PER|0|1|0|100|DKK|1733|1497|lyfalmen|||00|20|0|10,0000|Icepharma hf|Pfizer ApS|Reboxetin||431||431|1497|
515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PER|0|1|0|100|DKK|4436|4252|lyfalmen|||00|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2445||2445|4252|
515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|100|0|10,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2504|
515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|100|0|20,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2517|
516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999|31.10.2011|R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|2017|3667|lyfalmen|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||2017||2017|3667|
517073|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|120|stk|1|ţpakki||A02BC04|01.06.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|5469|8389|lyfalmen|V0010|8389|00|120|0|120,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||5469||5469|8389|
517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|2967|4966|lyfalmen|V0462|4197|00|90|0|11,2500|Vistor hf|Novo-Nordisk|Repaglíníđ||2967||2967|4966|
517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3231|5327|lyfalmen|V0471|4489|00|90|0|22,5000|Vistor hf|Novo-Nordisk|Repaglíníđ||3231||3231|5327|
517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3474|5660|lyfalmen|V0472|4760|00|90|0|45,0000|Vistor hf|Novo-Nordisk|Repaglíníđ||3474||3474|5660|
518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|922|2169|lyfalmen|||00|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||922||922|2169|
518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|3396|5553|lyfalmen|V0190|4731|00|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3396||3396|5553|
518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2094|3772|lyfalmen|||23|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2094||2094|3772|
518337|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|200|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|A||0|0|*|0|LVR|0|1|0|100|SEK|12498|18044|lyfalmen|V0286|18022|00|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||12498||12498|18044|
518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1083|2389|lyfalmen|||08|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1083||1083|2389|
519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|A||0|0|0|0|AEG|0|0|1|100|SEK|1622|3126|lyfalmen|||01|100|0|2,5000|GlaxoSmithKline ehf|Aspen Europe GmbH|Súlfametoxazól og trímetóprím||1622||1622|3126|
519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|7293|10884|lyfalmen|V0431|9468|02|2|0|5,7222|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||7293||7293|10884|
520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|4835|7521|lyfalmen|V0142|7389|00|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4835||4835|7521|
520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5460|8376|lyfalmen|V0143|3115|00|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5460||5460|8376|
520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|15385|21668|lyfalmen|V0143|9345|00|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15385||15385|21668|
520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5856|8918|lyfalmen|V0144|3584|00|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5856||5856|8918|
520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|16202|22693|lyfalmen|V0144|10752|00|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||16202||16202|22693|
520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1355|2532|lyfalmen|V0056|2532|00|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||1188||1188|2532|
520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2163|3480|lyfalmen|V0057|3480|00|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||1881||1881|3480|
520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|ţpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|349|1385|lyfalmen|||00|30|0|8,7500|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||349||349|1385|
520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|25|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1646|
520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|25|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1656|
521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|32205|42777|lyfalmen|V0269|12934|00|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||32205||32205|42777|
521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|11102|15816|lyfsjukr|||00|100|1|0,0000|Distica|Distica - óskráđ lyf|Hýdroxýkarbamíđ||11102||11102|15816|
521954|N03AX2101|Trobalt|filmhtfl|200|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|16996|23689|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||16996||16996|23689|
521966|A10BX0202|Repaglinid Krka (LYFIS)|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|A||0|0|*|0|LYF|0|0|0|100|XEU|3030|4489|lyfalmen|V0471|4489|00|90|0|22,5000|LYFIS ehf|LYFIS ehf|Repaglíníđ||2618||2618|4489|
522003|QJ01RA0102|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ01RA01|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|8426|16352|vetalmen|||16|320|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||8426||8426|16352|
522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2293|4044|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2293||2293|4044|
522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|186801|236318|lyfsjukr|||00|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||186801||186801|236318|
522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|ţpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|GLP|0|0|1|100|SEK|326|1353|lyfalmen|V0055|1199|00|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||326||326|1353|
522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|ţpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|GLP|0|0|1|100|SEK|387|1437|lyfalmen|V0225|1435|00|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||387||387|1437|
522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|GLP|0|0|1|100|DKK|2781|4712|lyfalmen|||00|250|0|41,6600|Vistor hf|G.L.Pharma GmbH|Tramadól||2781||2781|4712|
522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|GLP|0|0|1|100|DKK|396|1449|lyfalmen|||02|10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||396||396|1449|
522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörđ|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7214|10776|lyfalmen|||00|120|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||7214||7214|10776|
523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|444|1515|lyfalmen|||00|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||444||444|1515|
523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0,0000|Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1323|
523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1256|2626|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1256||1256|2626|
524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|436|1504|lyfalmen|||43|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||436||436|1504|
524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2748|4666|lyfalmen|||43|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||2748||2748|4666|
524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|A||0|0|E|0|EIS|0|0|0|100|IKR|8619|7381|lyfalmen|V0010|6851|00|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||4732||4732|7381|
524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1196|
524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1908|3795|vetalmen|||00|1|0||Icepharma hf|Intervet International B.V.|Vedaprófen||1908||1908|3795|
525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|ţpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|856|2078|lyfalmen|||00|100|0|29,2000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||856||856|2078|
525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|777|1970|lyfalmen|||00|15|0|3,7500|Vistor hf|Novartis Healthcare A/S-|Díklófenak||777||777|1970|
525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1497|2955|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1497||1497|2955|
525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4989|7732|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||4989||4989|7732|
525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|10161|14807|lyfalmen|||00|30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||10161||10161|14807|
525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|5441|7853|lyfsjukr|||00|1000|0|1,0000|Actavis Group hf|Braun|Kalíumklóríđ||5441||5441|7853|
525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|4954|7150|lyfsjukr|||00|1000|0|1,0000|Actavis Group hf|Braun|Natríumklóríđ||4954||4954|7150|
525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
526004|V07AB09|Sterilt Vann B. Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|4475|7029|lyfalmen|V0435|7029|00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4475||4475|7029|
526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4166|6606|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4166||4166|6606|
526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|IBV|0|0|0|100|DKK|6693|13024|vetalmen|||16|188|0|0,0000|Vistor hf|Intervet International BV|||6693||6693|13024|
526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3563|5781|lyfalmen|||10|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3563||3563|5781|
527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|A||0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||00|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||||||
527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|15183|20937|lyfsjukr|||00|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||15183||15183|20937|
527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1181|2523|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Emedastín||1181||1181|2523|
528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|A||0|0|0|0|LVR|0|0|0|100|SEK|9613|13222|lyfalmen|V0356|12084|00|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9002||9002|13222|
529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|ţpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|A|1,5|0|0|0|0|PAL|0|0|0|100|DKK|4509|8831|vetalmen|||16|72|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4509||4509|8831|
529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4795|9380|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4795||4795|9380|
529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|68834|88269|lyfsjukr|||00|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||68834||68834|88269|
530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|A||0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|||00|50|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||6794|
530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3113|5166|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3113||3113|5166|
530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|5984|8636|lyfsjukr|||00|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||5984||5984|8636|
531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2910|4888|lyfalmen|||43|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2910||2910|4888|
531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|8229|11877|lyfsjukr|||00|240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||8229||8229|11877|
532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|ţpakki||L04AA06|01.03.2011||R|A||0|1|*|0|LYF|0|0|0|100|XEU|20291|19648|lyfalmen|V0187|19648|00|50|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||13776||13776|19648|
532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|643|1787|lyfalmen|||01|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||643||643|1787|
532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|340|1372|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||340||340|1372|
532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|988|2259|lyfalmen|||00|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||988||988|2259|
532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|273|1281|lyfalmen|||00|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||273||273|1281|
532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|1740|3288|lyfalmen|||00|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1740||1740|3288|
533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1973|3606|lyfalmen|||43|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||1973||1973|3606|
535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|100|0|0,0000|Icepharma hf|Bioglan AB|Dísúlfíram í blöndum||||||
535844|N05AH0310|Zalasta (LYFIS)|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|LYF|0|1|0|100|XEU|3262|3909|lyfalmen|V0279|3909|00|28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||2194||2194|3909|
535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|ţpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6499|9798|lyfalmen|||00|84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6499||6499|9798|
536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|SAL|0|0|0|100|USD|416|1476|lyfalmen|||06|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||416||416|1476|
536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|SAL|0|0|0|100|USD|531|1634|lyfalmen|||06|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||531||531|1634|
536115|C10AA0504|Atorvastatin Portfarma|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|IKR|12900|18549|lyfalmen|V0115|18549|00|100|0|400,0000|Portfarma ehf|Portfarma|Atorvastatín||12900||12900|18549|
536840|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|glas||N07XX07|01.12.2011||R|A||0|1|0|1|BEI|0|0|0|100|XEU|65534|84128|lyfsjukr|||00|56|0|28,0000|Biogen Idec Ltd.|Biogen Idec Ltd.|Fampridine||65534||65534|84128|
536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|ţpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|9409|13778|lyfalmen|||52|100|0|12,5000|Vistor hf|Meda AS|Brómókriptín||9409||9409|13778|
537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|591|1031|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||591|1031|
537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|A||0|0|0|1|FRP|0|0|0|100|DKK|6338|9147|lyfsjukr|||00|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6338||6338|9147|
537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2344|
538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|ţpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda||||||
538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|ţpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda||||||
538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|ţpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda||||||
538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|132134|167711|lyfsjukr|||00|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||132134||132134|167711|
539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|10418|15159|lyfalmen|||00|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10418||10418|15159|
539152|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|100|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|A||0|0|*|0|LVR|0|1|0|100|SEK|7846|11640|lyfalmen|V0285|11631|00|60|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||7846||7846|11640|
539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|221|1210|lyfalmen|||00|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||221||221|1210|
539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|550|1660|lyfalmen|||00|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||550||550|1660|
539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||20|15|0|15,0000|Vistor hf|Janssen-Cilag AB|Blöndur||||||
539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|1802|3372|lyfalmen|||23|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1802||1802|3372|
540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|2799|4736|lyfalmen|||00|250|0|250,0000|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2799||2799|4736|
540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|5905|8985|lyfalmen|V0373|8969|06|15|0|0,0000|Vistor hf|M.S.D.|Tímólól í blöndum||5905||5905|8985|
541060|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1964|3594|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1964||1964|3594|
541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|9547|13967|lyfalmen|V0199|13967|10|200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||9547||9547|13967|
541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|15464|21767|lyfalmen|V0200|21767|10|200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||15464||15464|21767|
541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|ţpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl|.|J01GB03|01.08.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|5893|8505|lyfsjukr|||00|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5893||5893|8505|
542803|C08DA0103|Isoptin retard|forđatfl|240|mg|28|stk|1|ţpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1502|2962|lyfalmen|||10|28|0|28,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1502||1502|2962|
542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|4756|7413|lyfalmen|||00|100|1|100,0000|Parlogis hf|Parlogis - óskráđ lyf|Dapsón||4756||4756|7413|
543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|2918|4899|lyfalmen|||00|98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||2918||2918|4899|
543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|2222|3947|lyfalmen|V0373|2990|06|5|0||Portfarma ehf|Portfarma|Tímólól í blöndum||2222||2222|3947|
543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)||||||
543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|8|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|A|3|0|1|*|0|ASP|0|0|0|100|XEU|13044|18730|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||13044||13044|18730|
544919|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|980|2248|lyfalmen|V0005|1575|00|7|0|9,3300|Portfarma ehf|Portfarma|Esómeprazól||980||980|2248|
545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|948|2204|lyfalmen|||00|15|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||948||948|2204|
545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|909|2151|lyfalmen|||00|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||909||909|2151|
545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|2205|3924|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2205||2205|3924|
545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|30345|40442|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||30345||30345|40442|
546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|24466|33064|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||24466||24466|33064|
546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|30524|40667|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||30524||30524|40667|
546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|25932|34904|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||25932||25932|34904|
546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól||||||
546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|XEU|900|2047|lyfalmen|||10|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||833||833|2047|
546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|DKK|8292|12250|lyfalmen|||00|56|1|37,3333|Parlogis hf|Parlogis - óskráđ lyf|||8292||8292|12250|
547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||23|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4720|
547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|3430|2948|lyfalmen|V0004|2948|00|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1492||1492|2948|
547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|9940|14346|lyfsjukr|||00|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||9940||9940|14346|
547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3276|4728|lyfsjukr|||00|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3276||3276|4728|
547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|7830|11618|lyfalmen|||63|0|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||7830||7830|11618|
547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000|30.09.2011|R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4074|6480|lyfalmen|||63|0|0|0,6667|Vistor hf|N.V. Organon|Follitrópín beta||4074||4074|6480|
548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|ţpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|5311|8173|lyfalmen|||00|28|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5311||5311|8173|
548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|ţpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|15285|21542|lyfalmen|||00|84|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||15285||15285|21542|
549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|94923|121011|lyfsjukr|||17|1|0|0,0000|Vistor hf|Abbott Laboratories Ltd|Palivisumab||94923||94923|121011|
549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|9296|13624|lyfalmen|||02|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9296||9296|13624|
549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|140562|178288|lyfsjukr|||17|1|0|0,0000|Vistor hf|Abbott Laboratories Ltd|Palivisumab||140562||140562|178288|
550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2075|3746|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsađir  mótefnavakar||2075||2075|3746|
550061|N02BE0102|Panodil Brus|freyđit|500|mg|24|stk|1|ţpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||00|24|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1520|
550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||||||
550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||00|10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||||||
551183|N05AH0310|Zalasta (LYFIS)|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|A||0|0|*|0|LYF|0|1|0|100|XEU|11322|12285|lyfalmen|V0280|12285|00|56|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||8317||8317|12285|
551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|10489|15256|lyfalmen|V0235|15256|00|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||10489||10489|15256|
551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1791|3357|lyfalmen|||03|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1791||1791|3357|
551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|3823|6137|lyfalmen|V0198|6137|00|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||3823||3823|6137|
551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|738|1917|lyfalmen|||00|20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|1917|
551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|2157|2130|lyfalmen|V0466|1887|00|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||894||894|2130|
551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3931|4230|lyfalmen|V0467|3775|00|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||2429||2429|4230|
551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|1415|2843|lyfalmen|V0003|1005|00|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||1415||1415|2843|
551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3631|2009|lyfalmen|V0003|2009|00|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||805||805|2009|
551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|7648|3948|lyfalmen|V0010|3915|00|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||2223||2223|3948|
552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BAP|0|0|0|100|SEK|3494|5687|lyfalmen|||63|100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||3494||3494|5687|
552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|4930|7651|lyfalmen|||00|500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||4930||4930|7651|
552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3304|5427|lyfalmen|||00|100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3304||3304|5427|
552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3112|5164|lyfalmen|V0241|3802|00|50|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3112||3112|5164|
553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|A||0|0|E|0|PER|0|0|0|100|DKK|12050|17482|lyfalmen|V0237|17482|00|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||12050|17482|
553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|4121|6545|lyfalmen|V0237|5827|00|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||4121||4121|6545|
554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|7638|14839|vetalmen|||27|500|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||7638||7638|14839|
556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|K||0|1|0|1|EMA|0|0|0|100|SEK|26137|34684|lyfsjukr|||00|1|0|9,0070|Icepharma hf|E. Merck AB|Sómatrópín||26137||26137|34684|
556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|4895|7603|lyfalmen|V0241|7603|00|100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||4895||4895|7603|
556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6657|10014|lyfalmen|V0242|6981|00|50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||6657||6657|10014|
556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|9543|13962|lyfalmen|V0242|13962|00|100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||9543||9543|13962|
557546|D10AF0202|Zineryt|áburđur|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1602|3099|lyfalmen|||38|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1602||1602|3099|
558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|281758|355489|lyfsjukr|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||281758|355489|
559013|C08DA0103|Isoptin retard|forđatfl|120|mg|28|stk|1|ţpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|850|2070|lyfalmen|||10|28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||850||850|2070|
559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1951|3576|lyfalmen|||10|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1951||1951|3576|
559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994|30.09.2011|R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|221|1210|lyfalmen|||10|20|0|3,3333|Icepharma hf|Grunenthal|Tramadól||221||221|1210|
559104|N02AX0201|Nobligan|eţ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|662|1813|lyfalmen|||04|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||662||662|1813|
559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994|30.09.2011|R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|677|1833|lyfalmen|||02|10|0|1,6667|Icepharma hf|Grunenthal|Tramadól||677||677|1833|
559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Icepharma hf|STADA Arzneimittel AG|Heparínóíđ||||||
559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|1567|3051|lyfalmen|||06|5|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1567||1567|3051|
559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|0,0000|Icepharma hf|STADA Arzneimittel AG|Heparínóíđ||||||
559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|5747|8769|lyfalmen|||23|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5747||5747|8769|
559963|C01DA0201|Discotrine|forđapl|5|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|2722|4631|lyfalmen|||23|30|0|30,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||2722||2722|4631|
559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3423|5590|lyfalmen|||23|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3423||3423|5590|
559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|SEK|12968|18157|lyfsjukr|||00|240|0|0,0000|Icepharma hf|Baxter|Desflúran||12968||12968|18157|
560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0,0000|Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1352|
560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|2961|4958|lyfalmen|||00|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||2961||2961|4958|
560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||20|2|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír||||||
560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1474|2924|lyfalmen|||07|4|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1474||1474|2924|
560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|5644|8628|lyfalmen|||00|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5644||5644|8628|
560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6120|9279|lyfalmen|||00|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6120||6120|9279|
560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|100623|128164|lyfsjukr|||00|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||100623||100623|128164|
560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|465350|542398|lyfsjukr|||00|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||430690||430690|542398|
561145|N03AX2101|Trobalt|filmhtfl|150|mg|63|stk|1|ţpakki|21x50mg+42x100mg|N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|5469|8389|lyfalmen|||00|63|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||5469||5469|8389|
561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|1721|3262|lyfalmen|||06|5|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1721||1721|3262|
562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|A||0|0|B|0|APC|0|0|0|100|XEU|2505|4334|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||2505||2505|4334|
562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|K||0|1|0|1|GGL|0|0|0|100|GBP|99144|126308|lyfsjukr|||00|1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||99144||99144|126308|
563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|21244|29021|lyfalmen|V0431|28405|02|6|0|17,1667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||21244||21244|29021|
563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|35842|47341|lyfalmen|V0431|47341|02|10|0|28,6111|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||35842||35842|47341|
563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|729|1905|lyfalmen|||20|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||729||729|1905|
563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A||0|0|B|0|GSK|0|0|1|100|GBP|659|1809|lyfalmen|||20|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||659||659|1809|
563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|1387|2805|lyfalmen|||10|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1387||1387|2805|
563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|206645|261699|lyfalmen|||02|60|0|171,6667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||206645||206645|261699|
563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|3592|5821|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3592||3592|5821|
563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|3723|6000|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3723||3723|6000|
563899|QP54AA0105|Noromectin|áhella|0,5|w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|A||0|0|0|0|NOB|1|0|0|100|XEU|11400|19887|vetorma|||00|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||11400||11400|19887|
564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|82195|105037|lyfsjukr|||00|168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||82195||82195|105037|
565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|5190|8007|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|||5190||5190|8007|
565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||01|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||
565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|7789|11562|lyfalmen|||00|100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|||7789||7789|11562|
565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|1377|2791|lyfalmen|||00|28|1|4,6667|Parlogis hf|Parlogis - óskráđ lyf|||1377||1377|2791|
565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|11595|16769|lyfalmen|||00|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||11595||11595|16769|
566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1319|2712|lyfalmen|V0444|2077|06|5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíđ||1319||1319|2712|
566661|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|74101|94879|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||74101||74101|94879|
567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|2235|3965|lyfalmen|||00|100|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||2235||2235|3965|
567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|A||0|0|B|0|ALK|0|0|1|100|DKK|5827|8878|lyfalmen|||00|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5827|8878|
567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|3287|5404|lyfalmen|V0291|3303|00|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3287||3287|5404|
567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|6654|10010|lyfalmen|V0292|5494|00|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6654||6654|10010|
567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|9725|14211|lyfalmen|V0293|8107|00|60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||9725||9725|14211|
567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|12772|18388|lyfalmen|V0294|10395|00|60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||12772||12772|18388|
567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||24|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín||||||
567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||00|240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||
568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1059|2356|lyfalmen|||00|3|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1059||1059|2356|
568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|XEU|1410|2836|lyfalmen|V0058|2836|10|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1410||1410|2836|
568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|XEU|2234|3963|lyfalmen|V0059|3963|10|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2234||2234|3963|
569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|17256|23539|lyfsjukr|||02|5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||17256||17256|23539|
569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|19842|26784|lyfsjukr|||02|20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||19842||19842|26784|
569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2306|4062|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum međ öđrum toxóíđum||2306||2306|4062|
571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||00|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||
572612|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|A||0|0|0|0|APC|0|0|0|100|IKR|16141|22616|lyfalmen|V0253|22616|00|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||16141||16141|22616|
572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|145899|184986|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||145899||145899|184986|
572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|185732|234976|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||185732||185732|234976|
572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|359267|452763|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||359267||359267|452763|
572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||00|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||
573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|10437|7800|lyfalmen|V0011|7800|00|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||5039||5039|7800|
573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|A||0|0|E|0|ACA|0|0|0|100|IKR|5300|8158|lyfalmen|V0245|8158|00|98|0|49,0000|Actavis Group hf|Actavis hf|Lamótrigín||5300||5300|8158|
573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|A||0|0|*|0|ALC|0|0|0|100|USD|3384|5537|lyfalmen|V0464|4844|00|2|0||K.Pétursson hf|Alcon|Tímólól í blöndum||3384||3384|5537|
573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3171|5245|lyfalmen|V0129|5245|23|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3171||3171|5245|
573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|97005|123624|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Roche|Trastuzumab||97005||97005|123624|
573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|23438|31297|lyfsjukr|||00|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||23438||23438|31297|
573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|39685|51687|lyfsjukr|||00|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||39685||39685|51687|
573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|A|3|0|0|E|0|NOH|0|0|1|100|IKR|2756|2587|lyfalmen|V0189|2044|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2587|
575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|2483|2039|lyfalmen|V0151|1977|00|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||827||827|2039|
575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|7737|6891|lyfalmen|V0322|4175|00|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4374||4374|6891|
575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|4580|2039|lyfalmen|V0152|1977|00|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||827||827|2039|
575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|13712|6891|lyfalmen|V0323|6605|00|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4374||4374|6891|
575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0|0,0000|Icepharma hf|Norpharma |Malatíón||||||
575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|6850|9886|lyfsjukr|||00|12|0|0,0000|Vistor hf|Sanofi - Aventis|Adenósín||6850||6850|9886|
576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|A||0|0|E|0|ACA|0|0|0|100|IKR|1150|2481|lyfalmen|V0243|2481|00|42|0|5,2500|Actavis Group hf|Actavis hf|Lamótrigín||1150||1150|2481|
578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|A||0|0|0|0|ICE|0|0|0|100|USD|5423|9460|vetorma|||00|20|0||Icepharma hf|Icepharma hf|||5423||5423|9460|
579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1263|2635|lyfalmen|||02|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1263||1263|2635|
579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|4800|6300|lyfalmen|V0005|6300|00|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||3942||3942|6300|
579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|709|1877|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||709||709|1877|
580227|A10BX0202|Repaglinid Krka (LYFIS)|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|A||0|0|*|0|LYF|0|0|0|100|XEU|2922|4197|lyfalmen|V0462|4197|00|90|0|11,2500|LYFIS ehf|LYFIS ehf|Repaglíníđ||2405||2405|4197|
581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|A||0|0|*|0|LYF|0|0|0|100|XEU|3372|4760|lyfalmen|V0472|4760|00|90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||2816||2816|4760|
581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|A||0|0|0|0|ANI|1|0|0|100|XEU|14437|27894|vetalmen|||27|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14437||14437|27894|
581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|A||0|0|*|0|ALC|0|0|0|100|USD||3918|lyfalmen|||00|2|0||K.Pétursson hf|Alcon|Cýklópentólat||2201||2201|3918|
582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|28206|37281|lyfsjukr|||02|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||28206||28206|37281|
582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|54434|70197|lyfsjukr|||02|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||54434||54434|70197|
582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|108867|138511|lyfsjukr|||02|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||108867||108867|138511|
582213|R01AA0503|Nezeril|nefúđi|0,1|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||23|8|0|1,8750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|A||0|0|0|1|GEH|0|0|0|100|NOK|65614|84228|lyfsjukr|||02|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||65614||65614|84228|
582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|4986|8698|vetorma|||16|50|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4986||4986|8698|
582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|18788|32775|vetorma|||16|200|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||18788||18788|32775|
582451|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|A||0|0|0|0|POF|0|0|0|100|XEU|4730|7049|lyfalmen|V0011|4457|00|56|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||4490||4490|7049|
582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|44121|57254|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||44121||44121|57254|
582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|100376|127854|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||100376||100376|127854|
582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|ţpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|799|2000|lyfalmen|||00|28|0|18,6667|Vistor hf|AstraZeneca A/S DK|Metóprólól||799||799|2000|
582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|48637|62922|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||48637||48637|62922|
582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|K||0|1|0|1|EMA|0|0|0|100|SEK|52231|67432|lyfsjukr|||00|2|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||52231||52231|67432|
583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|96720|123266|lyfsjukr|||02|2000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||96720||96720|123266|
583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1076|2379|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1076||1076|2379|
583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|115444|146765|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||115444||115444|146765|
583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|52714|68039|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||52714||52714|68039|
583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|108589|138162|lyfsjukr|||02|2000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||108589||108589|138162|
583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|118701|150852|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||118701||118701|150852|
583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3817|5509|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||3817||3817|5509|
584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2312|3337|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2312||2312|3337|
584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|1811|3385|lyfalmen|||64|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||1811||1811|3385|
585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|9980|14404|lyfsjukr|||02|20|0|50,0000|Vistor hf|LEO Pharma A/S|Heparín||9980||9980|14404|
585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|3635|5246|lyfsjukr|||02|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3635||3635|5246|
585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988|30.09.2011|R|A|2|0|0|0|1|MSD|0|0|0|100|DKK|37073|48409|lyfsjukr|||00|12|0|3,0000|Vistor hf|M.S.D.|Imipenem og ensímhemill||37073||37073|48409|
585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4291|6777|lyfalmen|||02|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4291||4291|6777|
586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|32615|43291|lyfalmen|||00|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||32615||32615|43291|
586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|1738|3285|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1738||1738|3285|
586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|14178|19676|lyfsjukr|||00|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||14178||14178|19676|
588395|N03AX2101|Trobalt|filmhtfl|50|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|A||0|0|E|0|GGL|0|0|0|100|GBP|4466|7017|lyfalmen|||00|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||4466||4466|7017|
588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|2190|3903|lyfalmen|V0461|3902|43|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2190||2190|3903|
588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|9520|13930|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||9520||9520|13930|
588772|H05BA0103|Miacalcic Nasal|nefúđi|200|ae/sk|2|ml|1|úđagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|8785|12925|lyfalmen|||23|2|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||8785||8785|12925|
589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6088|10620|vetorma|||16|3|0|0,0000|Icepharma hf|Pfizer Animal Health|||6088||6088|10620|
589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2359|4115|vetorma|||16|1|0|0,0000|Icepharma hf|Pfizer Animal Health|||2359||2359|4115|
589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|5874|10247|vetorma|||16|6|0|0,0000|Icepharma hf|Pfizer Animal Health|||5874||5874|10247|
589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3172|5533|vetorma|||16|1|0|0,0000|Icepharma hf|Pfizer Animal Health|||3172||3172|5533|
589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3295|5748|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Animal Health|||3295||3295|5748|
589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|DKK|3179|5546|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Animal Health|||3179||3179|5546|
589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|USD|5840|8896|lyfalmen|||00|8|1|7,5000|Parlogis hf|Parlogis - óskráđ lyf|Lyf viđ vörtum og líkţornum||5840||5840|8896|
589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|USD|7418|11055|lyfalmen|||00|8|1|7,5000|Parlogis hf|Parlogis - óskráđ lyf|Lyf viđ vörtum og líkţornum||7418||7418|11055|
590244|N03AF0202|Trileptal (D.A.C.)|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.07.2011||R|A||0|0|E|0|DAC|0|0|0|100|DKK|3110|5162|lyfalmen|V0241|3802|00|50|0|15,0000|D.A.C. ehf|D.A.C. ehf|Oxkarbazepín||3110||3110|5162|
590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||00|20|0|20,0000|Icepharma hf|Bayer AB|Klótrímazól||||||
590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|2030|3684|lyfalmen|V0041|3684|10|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||2030||2030|3684|
590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|22483|30576|lyfalmen|||02|10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||22483||22483|30576|
590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|180211|228047|lyfsjukr|||00|1|0|1,2500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||180211||180211|228047|
592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||||
592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|ţpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|1,6000|Actavis Group hf|Actavis hf|Paracetamól||||||
593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|518|1616|lyfalmen|V0238|721|00|50|0|3,1250|Icepharma hf|Roche|Klónazepam||518||518|1616|
593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|917|2162|lyfalmen|V0238|2162|00|150|0|9,3750|Icepharma hf|Roche|Klónazepam||917||917|2162|
593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1352|2757|lyfalmen|||00|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1352||1352|2757|
593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|A||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín||||||
594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|20337|27882|lyfalmen|||03|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||20337||20337|27882|
594408|C10AA0504|Atorvastatin Portfarma|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|7867|5976|lyfalmen|V0114|5976|00|100|0|200,0000|Portfarma ehf|Portfarma|Atorvastatín||3705||3705|5976|
594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|338|590|vetorma|||16|10|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||338|590|
594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|2814|4909|vetorma|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||2814|4909|
595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|5973|8621|lyfsjukr|||02|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||5973||5973|8621|
595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|599|1727|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir  mótefnavakar||599||599|1727|
596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||||
596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|64967|83416|lyfsjukr|||00|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||64967|83416|
597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|2340|4108|lyfalmen|||43|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2340||2340|4108|
597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Vistor hf|McNeil Sweden AB|Ekónazól||||||
598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|450|1523|lyfalmen|||00|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||450||450|1523|
692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|A||1|0|0|0|PCO|0|0|0|100|DKK|4121|6545|lyfalmen|||00|100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||4121|6545|
801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|LDR|0|0|0|100|DKK|1332|2729|lyfalmen|||00|20|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|||1332||1332|2729|
912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|SEK|4962|7695|lyfalmen|||00|50|1|25,0000|Distica|Distica - óskráđ lyf|Flunarizín||4962||4962|7695|
916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|SEK|2704|4606|lyfalmen|||00|100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||2704||2704|4606|
923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1564|lyfalmen|||00|4|1|0,0000|Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1564|
924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|12095|17539|lyfalmen|||00|20|1|200,0000|Distica|Distica - óskráđ lyf|||12095||12095|17539|
938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|11317|16388|lyfalmen|||00|100|1|160,0000|Parlogis hf|Parlogis - óskráđ lyf|||11317||11317|16388|
938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|GBP|5971|9075|lyfalmen|||00|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||5971||5971|9075|
938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|50663|65941|lyfalmen|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|Pentósan pólýsúlfat natríum||50663||50663|65941|
938665|A12CX0001|K-Phos Neutral|töflur|||100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|4071|6476|lyfalmen|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|Málmlyf ýmisleg||4071||4071|6476|
938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|GBP|17155|23889|lyfalmen|||00|100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||17155||17155|23889|
939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|GBP|10320|15025|lyfalmen|||00|10|1|100,0000|Distica|Distica - óskráđ lyf|||10320||10320|15025|
940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|2721|4630|lyfalmen|||00|1|1|83,3300|Distica|Distica - óskráđ lyf|Estradíól||2721||2721|4630|
940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|5426|8330|lyfalmen|||00|1|1|166,6700|Distica|Distica - óskráđ lyf|Estradíól||5426||5426|8330|
940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998|30.11.2011|R|A||0|0|E|0|PCO|0|0|0|100|DKK|9430|13807|lyfalmen|||00|1|1|333,3300|Distica|Distica - óskráđ lyf|Estradíól||9430||9430|13807|
940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|2799|4736|lyfalmen|||00|1|1|1,3900|Distica|Distica - óskráđ lyf|Testósterón||2799||2799|4736|
944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|DKK|5415|8315|lyfalmen|||00|100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5415||5415|8315|
944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1375|lyfalmen|||00|12|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|||342||342|1375|
944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|664|1816|lyfalmen|||00|12|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1816|
945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|4044|lyfalmen|||00|10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4044|
947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|5033|7792|lyfalmen|||00|100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|||5033||5033|7792|
948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1800|3370|lyfalmen|||00|100|1|33,3300|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1800||1800|3370|
950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1182|1706|lyfsjukr|||55|10|1|0,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1182||1182|1706|
951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|838|2054|lyfalmen|||00|21|1|21,0000|Parlogis hf|Parlogis - óskráđ lyf|||838||838|2054|
951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|PCO|0|0|1|100|DKK|5415|8315|lyfalmen|||00|100|1||Distica|Distica - óskráđ lyf|Hýdrókortisón||5415||5415|8315|
954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1870|3465|lyfalmen|||00|60|1||Parlogis hf|Parlogis - óskráđ lyf|Fúrósemíđ||||1870|3465|
954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5690|8691|lyfalmen|||00|150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||||5690|8691|
960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|DKK|17198|23466|lyfsjukr|||00|30|1|112,0000|Distica|Distica - óskráđ lyf|||17198||17198|23466|
961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1960|3589|lyfalmen|||00|20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1960||1960|3589|
961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1850|3438|lyfalmen|||00|20|1||Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1850||1850|3438|
961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|4320|6817|lyfalmen|||00|25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||4320||4320|6817|
962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3451|5628|lyfalmen|||00|100|1|266,6600|Parlogis hf|Parlogis - óskráđ lyf|||||3451|5628|
962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2360|4136|lyfalmen|||00|30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||2360||2360|4136|
963802|M01AB0107|Indometacin|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.10.2010||R|A||0|0|E|0|PCO|0|0|1|100|GBP|406|1463|lyfalmen|||04|10|1|10,0000|Distica|Distica - óskráđ lyf|Indómetacín||406||406|1463|
965767|A03AA0703|Dicykloverin Syrup|mixtúra|2|mg/ml|120|ml|1|glas||A03AA07|01.08.2011||R|A||0|1|E|0|LDR|0|0|0|100|IKR|8480|12508|lyfalmen|||00|120|1|3,0000|Parlogis hf|Parlogis - óskráđ lyf|Dícýklóverín||8480||8480|12508|